
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Targeting the interplay of cGAS-STING and ferroptosis by nanomedicine in the treatment of cancer - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15253A818AF20C13053A810015A1C43B.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jeccr">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372235/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Experimental &amp; Clinical Cancer Research : CR">
<meta name="citation_title" content="Targeting the interplay of cGAS-STING and ferroptosis by nanomedicine in the treatment of cancer">
<meta name="citation_author" content="Chunfei Li">
<meta name="citation_author_institution" content="Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004 China">
<meta name="citation_author" content="Wenyan Zhao">
<meta name="citation_author_institution" content="Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004 China">
<meta name="citation_author" content="Donghua Geng">
<meta name="citation_author_institution" content="Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004 China">
<meta name="citation_author" content="Yuzi Jin">
<meta name="citation_author_institution" content="Department of Pediatrics, Central Hospital Affiliated to Shenyang Medical College, Shenyang, 110020 China">
<meta name="citation_author" content="Wenzheng Guan">
<meta name="citation_author_institution" content="Center of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, 110004 China">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="44">
<meta name="citation_firstpage" content="249">
<meta name="citation_doi" content="10.1186/s13046-025-03520-6">
<meta name="citation_pmid" content="40846966">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372235/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372235/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372235/pdf/13046_2025_Article_3520.pdf">
<meta name="description" content="The cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway senses cytosolic DNA and triggers innate immune responses. Pharmacological activation of the cGAS-STING pathway by cGAS-STING agonists to overcome cancer drug ...">
<meta name="og:title" content="Targeting the interplay of cGAS-STING and ferroptosis by nanomedicine in the treatment of cancer">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway senses cytosolic DNA and triggers innate immune responses. Pharmacological activation of the cGAS-STING pathway by cGAS-STING agonists to overcome cancer drug ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372235/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372235">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s13046-025-03520-6"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/13046_2025_Article_3520.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372235%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372235/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372235/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372235/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jeccr.png" alt="Journal of Experimental &amp; Clinical Cancer Research : CR logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Journal of Experimental &amp; Clinical Cancer Research : CR" title="Link to Journal of Experimental &amp; Clinical Cancer Research : CR" shape="default" href="https://jeccr.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Exp Clin Cancer Res</button></div>. 2025 Aug 22;44:249. doi: <a href="https://doi.org/10.1186/s13046-025-03520-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s13046-025-03520-6</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Exp%20Clin%20Cancer%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Exp%20Clin%20Cancer%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Exp%20Clin%20Cancer%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Exp%20Clin%20Cancer%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Targeting the interplay of cGAS-STING and ferroptosis by nanomedicine in the treatment of cancer</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Chunfei Li</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Chunfei Li</span></h3>
<div class="p">
<sup>1</sup>Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chunfei Li</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Wenyan Zhao</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Wenyan Zhao</span></h3>
<div class="p">
<sup>1</sup>Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wenyan Zhao</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Geng%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Donghua Geng</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Donghua Geng</span></h3>
<div class="p">
<sup>1</sup>Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Geng%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Donghua Geng</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jin%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Yuzi Jin</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Yuzi Jin</span></h3>
<div class="p">
<sup>2</sup>Department of Pediatrics, Central Hospital Affiliated to Shenyang Medical College, Shenyang, 110020 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jin%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuzi Jin</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guan%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Wenzheng Guan</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Wenzheng Guan</span></h3>
<div class="p">
<sup>3</sup>Center of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, 110004 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guan%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wenzheng Guan</span></a>
</div>
</div>
<sup>3,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, 110004 China </div>
<div id="Aff2">
<sup>2</sup>Department of Pediatrics, Central Hospital Affiliated to Shenyang Medical College, Shenyang, 110020 China </div>
<div id="Aff3">
<sup>3</sup>Center of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, 110004 China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jul 10; Accepted 2025 Aug 15; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>. The Creative Commons Public Domain Dedication waiver (<a href="https://creativecommons.org/publicdomain/zero/1.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372235  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40846966/" class="usa-link">40846966</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">The cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway senses cytosolic DNA and triggers innate immune responses. Pharmacological activation of the cGAS-STING pathway by cGAS-STING agonists to overcome cancer drug resistance offers substantial potential to promote antitumor immunity. However, small-molecule STING agonists show rapid excretion, low bioavailability, non-specificity, and adverse effects, which limit their therapeutic efficacy and in vivo applications. The recent emergence of nanomedicine has profoundly revolutionized STING agonist delivery, promoting tumor-targeted delivery and offering new opportunities for tumor-specific immunotherapy. A growing body of evidence has shown that cGAS-STING interacts with ferroptosis in cancer cells. Targeting the interplay between cGAS-STING and ferroptosis using nanomedicines offers a novel cancer treatment regimen. In this review, we outline the principal components of the cGAS-STING signaling cascade and discuss its role in cancer biology. We also review the role of the interplay between cGAS-STING and ferroptosis in cancer genesis. We then focus on providing an overview of the latest findings and emerging concepts that leverage the interplay between cGAS-STING and ferroptosis by nanomedicine to kill cancers. Finally, we discuss the key limitations of the current therapeutic paradigm and possible strategies to overcome them. This article highlights some promising therapeutic avenues that leverage the interplay of cGAS-STING and ferroptosis by nanomedicine, which could be used to treat cancer.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s13046-025-03520-6.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Cancer, cGAS-STING, Ferroptosis, Nanomedicine</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Cancer metastasis refers to the growth and colonization of cancer cells in organs distant from the organ of origin. Metastasis, which characterizes a malignant tumor and distinguishes it from a benign tumor, is a hallmark of cancer associated with invasiveness [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Metastasis is the ultimate and most lethal manifestation of cancer, leading to the vast majority (90%) of cancer deaths [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Immunotherapeutic agents such as anti-programmed death-ligand 1 (PD-L1) and anti-cytotoxic T lymphocyte -associated protein 4 (CTLA-4) inhibitors have emerged as revolutionary cancer treatments [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. However, their low response rates, resistance, and toxicity pose substantial challenges. Blocking the programmed cell death protein 1 (PD-1)/PD-L1 pathway alone often fails to generate effective antitumor immune responses. Thus, developing rational drug combinations based on a deeper understanding of the molecular mechanisms underlying therapeutic resistance can help enhance treatment efficacy [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>].</p>
<p id="Par3">The cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) axis serves as a critical regulator of tissue homeostasis and the innate immune defense. Dysfunction of this pathway aberrantly activates pro-inflammatory cascades, contributing to the pathogenesis of inflammatory disorders, autoimmune conditions, degenerative diseases, and carcinogenesis [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>–<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. In oncology research, cGAS -STING activation has been shown to contribute to antitumor effects by triggering spontaneous antitumor immunity, enhancing senescence in premalignant cells, facilitating conventional cancer therapy responses, and inducing regulated cell death through interferon (IFN)-dependent and IFN-independent pathways [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Thus, this tumor-suppressor pathway can serve as a therapeutic target. Although recent advances in the development of cGAS-STING activators have contributed to tumor immunotherapy [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>], the limitations of cGAS-STING activators, including drug resistance, low stability, poor half-life, off-target effects, and toxicity, have hampered their clinical application and greatly reduced their therapeutic efficacy. Because of these limitations, nonspecific delivery of cGAS-STING activators leads to unexpected immunotoxicities [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. However, the emergence of nanomedicine has profoundly revolutionized STING agonist delivery, promoting tumor-targeted delivery and offering new opportunities for tumor-specific immunotherapy [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>–<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>].</p>
<p id="Par4">A growing body of evidence has shown that cGAS-STING interacts with regulated cell death (RCD), resulting in ferroptosis in cancers [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>–<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Ferroptosis, a form of RCD induced by iron, is triggered by toxic accumulation of lipid peroxides on cellular membranes [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. Conventional therapeutic modalities, including chemotherapy, immunotherapy, targeted cancer therapies, and radiotherapy, mediate tumor killing by inducing ferroptosis [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>–<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. Therefore, ferroptosis offers great potential in cancer therapy, and targeting ferroptosis may provide new therapeutic opportunities for cancer treatment. Emerging evidence has shown that targeting the interplay between cGAS-STING and ferroptosis using nanomedicine represents a novel therapeutic regimen for cancers [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>–<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>].</p>
<p id="Par5">In this review, we first outline the principal components of the cGAS-STING signaling cascade and discuss its role in cancer biology. Then, we review the role of the interplay between cGAS-STING and ferroptosis in cancer genesis. We then focus on providing an overview of the latest findings and emerging concepts that leverage the interplay between cGAS-STING and ferroptosis by nanomedicine to kill cancers. Finally, we discuss the key limitations of the current therapeutic paradigm and propose possible strategies to overcome them. This article highlights some promising therapeutic avenues that leverage the interplay between cGAS-STING and ferroptosis using nanomedicine, which could be used to treat cancer.</p></section><section id="Sec2"><h2 class="pmc_sec_title">cGAS-STING signaling pathway</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Overview of the cGAS-STING signaling pathway</h3>
<p id="Par6">The cGAS-STING signaling axis consists of the synthase for the second messenger cyclic GMP–AMP (cGAS) and the cyclic GMP–AMP receptor STING (Fig. <a href="#Fig1" class="usa-link">1</a>). cGAS is located upstream of STING [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. The cGAS-STING signaling axis detects pathogenic extranuclear DNA and triggers a type I interferon (IFN) innate immune response, which is physiologically used against microbial infections, making cGAS-STING a crucial component of the innate immune system [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. cGAS senses microbial (viral, bacterial, and protozoan) double-stranded DNA (dsDNA) in a sequence-independent manner. It can be activated by endogenous DNA, mitochondria-released DNA, and genotoxic stress-mediated extranuclear chromatin, making cGAS-STING an important axis in autoimmunity, sterile inflammatory responses, and cellular senescence [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. In mammalian cells, cGAS, the secondary messenger cyclic GMP–AMP (cGAMP) produced by cGAS, and cGAMP bound to STING form a crucial cytosolic DNA-sensing mechanism. Upon binding of dsDNA to cGAS, a conformational change occurs, activating it and initiating its enzymatic activity [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>–<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. Active cGAS catalyzes and converts guanosine triphosphate (GTP) and adenosine triphosphate (ATP) into 2′,3′-cyclic GMP–AMP (cGAMP) [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Subsequently, 2ʹ3ʹ-cGAMP binds to and activates STING, a ~ 40-kDa endoplasmic reticulum (ER)-localized transmembrane protein adapter [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>, <a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>, <a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>], to form dimers, tetramers, and higher-order oligomers [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>, <a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. After activation, STING translocates from the ER to ER-Golgi intermediate compartments, where STING recruits TANK binding kinase 1 (TBK1) and IκB kinase (IKK), which respectively phosphorylate and activate interferon regulatory factor 3 (IRF3) and the nuclear factor (NF)-κB inhibitor IκBα [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. TBK1 trans-phosphorylates itself, the C-terminal domain of STING, and subsequently IRF3 [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Meanwhile, STING engages with and activates IKK to trigger NF-κB signaling [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>], which works together with a robust IFN response to orchestrate inflammatory immune responses to eliminate pathogens such as intracellular bacteria, retroviruses, and DNA viruses [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. IRF3 dimerizes and translocates to the nucleus to transcriptionally activate genes encoding type I interferons such as IFN-β that together orchestrate antiviral defense mechanisms [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. The phosphorylation of IκBα leads to translocation of NF-κB to the nucleus to enhance the transcription of genes encoding pro-inflammatory cytokines such as tumor necrosis factor (TNF) and IL-6 [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. After activation, STING is trafficked to endolysosomes for degradation [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. cGAS senses cytosolic dsDNA in response to tissue injury or pathogenic invasion, which allows the cGAS-STING axis to regulate various cellular functions such as protein synthesis, IFN/cytokine production, autophagy, senescence, metabolism, and specific mechanisms of cell death [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. The cGAS-STING axis is vital for tissue homeostasis and host defense, and cGAS-STING dysfunction activates pro-inflammatory signaling pathways, resulting in inflammatory, autoimmune, and degenerative diseases and cancer [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>].</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/bb032b6eba30/13046_2025_3520_Fig1_HTML.jpg" loading="lazy" id="d33e373" height="583" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The cGAS-STING Signaling Cascade. The cGAS-STING pathway is initiated by the accumulation of cytosol double-stranded DNA(dsDNA), which are introduced by virus, bacteria, dead cells, mitochondria and cancer cells, et al. cGAS recognizes dsDNA exposed during pathogen infection or cellular stress, leading to produce the second messenger, 2′3′ cyclic GMP-AMP (cGAMP). Upon accumulation, cGAMP binds to STING located on the endoplasmic reticulum (ER) membrane and facilitates further pathway activation. The binding of cGAMP to STING mediates STING dimerization and translocation from the ER to the Golgi apparatus, where STING forms a complex with TANK-binding kinase 1 (TBK1), which, through auto-phosphorylation and STING phosphorylation, mediates recruitment </p></figcaption></figure></section><section id="Sec4"><h3 class="pmc_sec_title">cGAS-STING in cancer</h3>
<p id="Par8">The epigenetic silencing of cGAS-STING represents a pervasive mechanism of immune evasion in cancer. Suppression of cGAS-STING has been reported in various human malignancies [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>, <a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. The mechanisms underlying this suppression include epigenetic modifications, posttranslational modifications (PTMs), and various intracellular metabolic pathways that contribute significantly to therapeutic resistance. Enzymes that regulate these processes, such as DNA/histone modifiers, non-coding RNAs (ncRNAs), and 5-methylcytosine (m<sup>5</sup>C) modification writers, have also been identified. Abnormal epigenetic modifications contribute to disease initiation and progression by disrupting gene expression, altering protein profiles, and promoting the development of malignant phenotypes [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. Recent studies have revealed that DNA methylation [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>], histone methylation/demethylation [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>–<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>], m<sup>5</sup>C modification [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>], and non-coding RNA (ncRNA)-mediated epigenetic modifications [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>, <a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>] induce the suppression of cGAS and STING in cancer. Emerging evidence has demonstrated that PTMs, including phosphorylation [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>–<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>], ubiquitination [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>–<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>], palmitoylation [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>], methylation [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>, <a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>], and lactylation [<a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>], critically modulate the expression of cGAS and STING in cancer through multiple mechanisms. Emerging studies have also elucidated the metabolic pathways regulating cGAS and STING in cancer, including serine [<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>], fatty acid [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>], glucose [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>], purine synthesis [<a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>], and ATP metabolism [<a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>]. A better understanding of metabolic reprogramming mechanisms can reveal vulnerabilities that can be exploited to reactivate cGAS-STING signaling and enhance antitumor immunity.</p>
<p id="Par9">In oncology, cGAS-STING activation contributes to antitumor effects by triggering spontaneous antitumor immunity, enhancing senescence in premalignant cells, facilitating conventional cancer therapy responses, and inducing RCD through IFN-dependent and IFN-independent pathways [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR82" class="usa-link" aria-describedby="CR82">82</a>], establishing it as a tumor-suppressor pathway that can be therapeutically targeted. However, monotherapy with STING agonists has shown limited clinical efficacy and poor outcomes in patients with advanced cancer. Recent preclinical research, including in vitro and in vivo studies, have expanded our understanding of the molecular mechanisms by which cancer cells autonomously and non-autonomously evade cGAS-STING activation [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>, <a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>, <a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>, <a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>, <a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>].</p></section></section><section id="Sec5"><h2 class="pmc_sec_title">Ferroptosis in cancers</h2>
<section id="Sec6"><h3 class="pmc_sec_title">Core mechanism of ferroptosis</h3>
<p id="Par10">Ferroptosis, a type of non-apoptotic RCD, is characterized by iron-dependent lipid peroxidation (LPO) and a decline in antioxidant capacity [<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>]. Ferroptosis is a non-apoptotic form of RCD (Fig. <a href="#Fig2" class="usa-link">2</a>) [<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>–<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>]. Ferroptosis is primarily caused by iron accumulation and LPO, which results in plasma membrane rupture [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>]. A subtle imbalance between ferroptosis defense systems and ferroptosis-promoting factors dictates the induction and execution of ferroptosis, which is highly regulated by ferroptosis inducers and inhibitors [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. The inhibition of the solute carrier family 7 member 11 (SLC7A11)-glutathione (GSH)-glutathione peroxidase 4 (GPX4) system and the accumulation of free iron are the two primary‌ signals that trigger ferroptosis [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>]88].</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/b3b44c674de7/13046_2025_3520_Fig2_HTML.jpg" loading="lazy" id="d33e516" height="540" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Core mechanisms of ferroptosis. Ferroptosis is induced by an imbalance of pro-ferroptotic factors and anti-ferroptotic defense mechanisms. The SLC7A11 /SLC3A2 system imports cystine for GSH synthesis to quench lipid peroxides, along with other endogenous antioxidant mechanisms: GCH1, FSP1, MBOAT1/2, and SC5D. Iron import and mobilization through POR/NOXs/ALOXs catalyzes ROS synthesis, which may alongside the Fenton reaction induce the synthesis of lipid peroxides. Lipid peroxides accumulate in the plasma membrane and lead to cell lysis</p></figcaption></figure><p id="Par12">Iron plays a pivotal role in ferroptosis, particularly through its involvement in the production of reactive oxygen species (ROS) and propagation of LPO, which are central to the induction of ferroptosis. Excessive accumulation of free iron within cells contributes to the buildup of lethal lipid peroxides, triggering ferroptosis [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>]. Iron facilitates LPO through two distinct pathways. The first is the non-enzymatic Fenton reaction, in which free iron catalyzes the conversion of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) into highly reactive hydroxyl radicals (•OH). These radicals initiate LPO by reacting with polyunsaturated fatty acid-containing phospholipids (PUFA-PLs). The second mechanism involves enzymatic processes, where iron functions as a cofactor for specific peroxidases, such as arachidonate lipoxygenases (ALOXs) and cytochrome P450 oxidoreductase (POR), which enhance LPO, ROS production, and PUFA-PL oxidation [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>–<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]. Iron primarily exists in two oxidation states: ferric (Fe³⁺) and ferrous (Fe²⁺). In its ferrous form, iron reacts with PUFA-PL hydroperoxides (PUFAs-PL-OOH) to produce <sup>•</sup>OH. These radicals, in turn, attack PUFAs, perpetuating the LPO chain reaction and driving ferroptosis [<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>]. In the enzymatic LPO pathway, Fe²⁺ acts as an indispensable cofactor for iron-dependent peroxidases, amplifying their activity and initiating PUFA-PL dioxygenation within membranes [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>, <a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>]. This pathway begins with the enzyme ACSL4, which activates free PUFAs by conjugating them with coenzyme A (CoA) to form polyunsaturated fatty acid (PUFA)-CoA molecules. These activated molecules are re-esterified into phospholipids by LPCAT3, which incorporates PUFA-CoAs into membrane phospholipids [<a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>–<a href="#CR96" class="usa-link" aria-describedby="CR96">96</a>]. The resulting PUFA-PLs are subsequently oxidized by iron-dependent enzymes such as ALOXs and PORs, producing PUFA-PL-OOH with the aid of labile iron and molecular oxygen [<a href="#CR97" class="usa-link" aria-describedby="CR97">97</a>–<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>]. Recent reviews have elaborated the lipid sources and mechanisms underlying ferroptosis in detail [<a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>–<a href="#CR102" class="usa-link" aria-describedby="CR102">102</a>]. In the non-enzymatic LPO pathway, iron drives ferroptosis by initiating direct Fenton reaction-mediated peroxidation of PUFA-PLs [<a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>]. During this process, iron catalyzes the conversion of H₂O₂ into •OH, a highly reactive and mobile form of ROS. These radicals interact with PUFA-PLs to form PUFA-PL-OOH, thereby initiating LPO [<a href="#CR103" class="usa-link" aria-describedby="CR103">103</a>–<a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>]. Once formed, with the help of labile iron, PUFA-PL-OOH can propagate peroxidation to adjacent PUFA-PL molecules, particularly when these peroxides are not efficiently neutralized. Consequently, cellular conditions that increase the labile iron pool (LIP), including suppression of the iron exporter ferroportin [<a href="#CR106" class="usa-link" aria-describedby="CR106">106</a>–<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>], autophagic degradation of ferritin [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>, <a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>], and heightened transferrin uptake, enhance the susceptibility of cells to ferroptosis [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>, <a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>].</p>
<p id="Par13">Ferroptosis is regulated by robust antioxidant systems within the cell, and the coupled enzyme-metabolite systems collectively termed ferroptosis defense mechanisms are designed to directly neutralize lipid peroxides and prevent the onset of ferroptosis [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>, <a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>, <a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>]. Recently, both GPX4-dependent and GPX4-independent pathways with distinct subcellular localizations have been identified as critical regulators of ferroptosis, including the GPX4-GSH axis [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR114" class="usa-link" aria-describedby="CR114">114</a>], FSP1-CoQH<sub>2</sub> system [<a href="#CR115" class="usa-link" aria-describedby="CR115">115</a>–<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>], GCH1-BH<sub>4</sub> system [<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>, <a href="#CR119" class="usa-link" aria-describedby="CR119">119</a>], DHODH-CoQH<sub>2</sub> system [<a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>], MBOAT1/2-MUFA system [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>], and SC5D-7-DHC axis (Fig. <a href="#Fig2" class="usa-link">2</a>) [<a href="#CR122" class="usa-link" aria-describedby="CR122">122</a>, <a href="#CR123" class="usa-link" aria-describedby="CR123">123</a>].</p></section><section id="Sec7"><h3 class="pmc_sec_title">Induction of ferroptosis to kill cancer</h3>
<p id="Par14">Ferroptosis has attracted considerable attention in cancer research. Targeting ferroptosis may offer therapeutic strategies for cancer treatment [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>, <a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>]. Ferroptosis acts as an innate tumor suppressor in cancer cells that are usually resistant to apoptosis, and traditional therapies are extremely vulnerable to ferroptosis, underscoring its potential as a treatment approach for cancers, especially refractory cancers [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. Ferroptosis can be leveraged to kill cancer cells and overcome cancer drug resistance [<a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>–<a href="#CR128" class="usa-link" aria-describedby="CR128">128</a>]. The pharmacological induction of ferroptosis can reverse drug resistance in tumors [<a href="#CR128" class="usa-link" aria-describedby="CR128">128</a>, <a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>]. Moreover, induction of ferroptosis can reverse resistance to targeted therapies [<a href="#CR130" class="usa-link" aria-describedby="CR130">130</a>, <a href="#CR131" class="usa-link" aria-describedby="CR131">131</a>] and immunotherapies [<a href="#CR132" class="usa-link" aria-describedby="CR132">132</a>]. In addition, induction of ferroptosis using new methods such as proteolysis-targeting chimeras (PROTACs), sonodynamic therapy (SDT), photodynamic therapy (PDT), and nanomaterials has been attempted for cancer therapy [<a href="#CR133" class="usa-link" aria-describedby="CR133">133</a>, <a href="#CR134" class="usa-link" aria-describedby="CR134">134</a>]. The combination of ferroptosis and nanotechnology provides effective antitumor responses, and ferroptosis-based nanomedicines offer new strategies for cancer treatment [<a href="#CR135" class="usa-link" aria-describedby="CR135">135</a>, <a href="#CR136" class="usa-link" aria-describedby="CR136">136</a>]. The combination of nanomedicines and ferroptosis has shown a close relationship with high efficacy in treating various cancer types [<a href="#CR134" class="usa-link" aria-describedby="CR134">134</a>, <a href="#CR136" class="usa-link" aria-describedby="CR136">136</a>, <a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>]. Nanomedicines targeting ferroptosis can overcome anticancer resistance [<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>, <a href="#CR138" class="usa-link" aria-describedby="CR138">138</a>]. Various ferroptosis nano-inducers have shown an extensive range of functions in reversing resistance to therapy [<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>, <a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>].</p></section></section><section id="Sec8"><h2 class="pmc_sec_title">Interplay of cGAS-STING and ferroptosis in cancers</h2>
<section id="Sec9"><h3 class="pmc_sec_title">Activation of cGAS-STING triggers ferroptosis in cancers</h3>
<p id="Par15">Emerging evidence has revealed that crosstalk between cGAS-STING and ferroptosis regulates cancer pathogenesis. In 2020, Dang et al. reported that the cGAS-STING1 pathway is involved in mitochondrial DNA (mtDNA) stress-induced ferroptosis in cancer through the activation of autophagy [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Nuclear translocation of lysosomal cysteine protease cathepsin B (CTSB) activates the cGAS-STING pathway, which induces autophagy and triggers ferroptosis by degrading GPX4 in human pancreatic cancer cells [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Genetic inhibition of CTSB-dependent STING1 activation has been shown to suppress ferroptosis in cell culture and animal models [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. This observation was corroborated by a study by the same group that reported that cGAS-STING activation contributes to ferroptosis by activating autophagy in cancer [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. Zalcitabine, an antiviral drug for human immunodeficiency virus infection, has been shown to induce oxidative mtDNA damage and decrease mitochondrial function and cause degradation of the mitochondrial transcription factor TFAM, resulting in the activation of the cGAS-STING pathway, induction of autophagy, and subsequent autophagy-dependent ferroptosis through LPO [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. A subsequent study replicated these findings [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. The findings of the subsequent study further demonstrated that STING activation triggers ferroptosis in human pancreatic cancer cell lines by enhancing MFN1/2-dependent mitochondrial fusion and mitophagy-mediated mitochondrial removal [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. Erastin, a classic ferroptosis inducer, induces the accumulation of STING in mitochondria, where it binds to MFN1/2 to trigger mitochondrial fusion, leading to the subsequent production of ROS and LPO. Loss of STING or MFN1/2 has been shown to decrease the sensitivity of pancreatic cancer cells to ferroptosis in in vitro or xenograft mouse models. These results established a new mitochondrial fusion-dependent mechanism of ferroptosis and highlight a potential strategy for enhancing ferroptosis-based therapy by activating the cGAS-STING pathway [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>].</p>
<p id="Par16">In acute myeloid leukemia (AML), inhibition of phosphoseryl-tRNA kinase (PSTK), a critical enzyme in selenoprotein biosynthesis, has been shown to selectively impair AML growth and eradicate chemoresistant leukemic stem cells while sparing normal hematopoietic cells [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Mechanistic studies have revealed that PSTK inhibition triggers mitochondrial ROS accumulation, leading to the release of mtDNA into the cytosol, which activates the cGAS-STING pathway [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Activated STING promotes ferritinophagy (via NCOA4), releasing free iron, which exacerbates LPO and ROS generation to ultimately drive ferroptosis [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. PSTK inhibition synergizes with chemotherapy to eliminate residual chemoresistant cells and reduces relapse in AML models [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Genetic or pharmacological inhibition of STING with H151 has been shown to rescue the ferroptotic cell death and ROS accumulation induced by PSTK inhibition, although selenoprotein levels (e.g., GPX4) remain low [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Activation of STING with diABZI has been shown to synergize with PSTK inhibition to amplify ROS and ferroptosis [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. The cGAS-STING pathway amplifies ROS and iron dysregulation, creating a self-reinforcing cycle that culminates in an oxidative crisis and ferroptosis. Thus, although ROS/mtDNA release initiates this cascade, cGAS-STING activation is a critical upstream regulator of ferroptosis. This interplay forms a PSTK-cGAS-STING-ROS loop that is essential for oxidative crisis and ferroptosis in AML [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Liao et al. confirmed that USP34 promoted the progression of cervical cancer by upregulating prolyl isomerase 1 (PIN1) expression via SUMOylation, thereby inhibiting ferroptosis by suppressing the cGAS-STING pathway [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. In summary, activation of the cGAS-STING pathway in tumors can induce ferroptosis, thereby achieving therapeutic effects against cancer. Thus, pharmacological targeting of the cGAS-STING-ferroptosis pathway represents a novel therapeutic strategy for cancer.</p>
<p id="Par17">This section establishes that activation of the cGAS-STING pathway drives ferroptosis in multiple cancers through interconnected mechanisms: inducing autophagy (degrading GPX4), promoting mitochondrial fusion/mitophagy, and triggering ferritinophagy. Despite the establishment of cGAS-STING as a critical ferroptosis regulator, key questions remain unresolved, including the context-dependent molecular switches that determine whether pathway activation promotes ferroptosis versus other outcomes (e.g., inflammation and senescence) across cancer types and the influence of chronic versus acute STING activation on therapeutic efficacy and resistance. Future studies should aim to delineate tissue-specific regulatory mechanisms, identify biomarkers predicting ferroptotic responses to STING modulation, and develop optimized combinatorial strategies (e.g., with chemotherapy, immunotherapy, or other ferroptosis inducers) that can maximize tumor-selective ferroptosis while minimizing systemic toxicity in preclinical and clinical settings.</p></section><section id="Sec10"><h3 class="pmc_sec_title">Induction of ferroptosis activates cGAS-STING in cancers</h3>
<p id="Par18">Ferroptosis has been identified as an upstream event that activates the cGAS/STING pathway in cancer [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. This study also demonstrated that ferroptosis and radiotherapy (RT)-induced formation of dsDNA are parallel upstream events that converge upon cGAS-STING activation [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. The findings of this study further demonstrated that BIBR1532, a telomerase inhibitor, synergizes with radiotherapy (RT) to enhance radiosensitivity and antitumor immunity in non-small cell lung cancer (NSCLC) through two interconnected mechanisms: inhibition of DNA damage repair and induction of ferroptosis [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. RT induces DNA double-strand breaks (DSBs), while BIBR1532 suppresses ATM /ATR/CHK1-mediated DNA repair pathways, leading to persistent cytoplasmic accumulation of dsDNA, which activates the cGAS-STING pathway and triggers type I IFN-β production, dendritic cell (DC) maturation, and CD8⁺ T cell -mediated adaptive immunity [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. BIBR1532 amplifies RT-induced ferroptosis, as evidenced by increased LPO, ROS accumulation, and Fe²⁺ overload while downregulating anti-ferroptosis proteins (e.g., GPX4, SLC7A11). Ferroptosis causes mitochondrial stress, releasing mtDNA into the cytoplasm, which further activates cGAS-STING to create a positive feedback loop for immune activation [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. However, this study did not support reverse causality (i.e., cGAS -STING directly induces ferroptosis). Instead, it suggested that ferroptosis-associated mitochondrial dysfunction and ROS production create conditions that enhance cGAS -STING signaling [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>].</p>
<p id="Par19">Transforming growth factor-beta-activated kinase 1 (TAK1) deficiency in hepatocytes induces ferroptosis through oxidative stress and iron dysregulation [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Ferroptosis causes oxidative DNA damage (e.g., 8-OHdG), and the damaged DNA is released into the extracellular space. The damaged DNA activates macrophage cGAS -STING signaling, driving inflammation, fibrosis, and liver tumorigenesis. Inhibiting ferroptosis (with Fer-1) or blocking STING (with C-176) has been shown to attenuate liver injury and tumor progression [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Blocking ferroptosis (through Fer-1) has been shown to suppress cGAS-STING activation in macrophages. STING inhibition does not reverse ferroptosis, but mitigates its downstream inflammatory effects, indicating that ferroptosis precedes STING activation [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Targeting ferroptosis or cGAS-STING can synergistically treat diseases involving oxidative stress, chronic inflammation, and cancer [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Taken together, these results indicate that ferroptosis in tumors can activate the cGAS-STING pathway, thereby exerting therapeutic effects against cancer cells. Thus, the pharmacological targeting of the ferroptosis-cGAS -STING pathway may serve as a novel therapeutic strategy for tumor treatment. On the basis of these findings, drug-targeted modulation of the crosstalk between cGAS -STING and ferroptosis has emerged as a novel approach for cancer therapy.</p>
<p id="Par20">Emerging evidence has shown that ferroptosis is an upstream activator of the cGAS-STING pathway in multiple cancers. Ferroptosis-induced mitochondrial or oxidative DNA damage directly triggers cytoplasmic cGAS-STING activation, which drives antitumor immunity or inflammation/fibrosis. Critically, ferroptosis initiates a self-reinforcing cycle, in which subsequent cGAS-STING signaling amplifies immune or inflammatory responses. Combined treatment with ferroptosis inducers and STING agonists has demonstrated synergistic therapeutic potential.</p>
<p id="Par21">Key unresolved questions include defining the precise molecular sensors and spatiotemporal dynamics linking distinct ferroptosis drivers (e.g., LPO and iron overload) to specific damage-associated molecular patterns (DAMPs; mtDNA vs. nuclear DNA) that activate cGAS-STING and elucidating why this axis drives antitumor immunity in some contexts but pathogenic inflammation in others. Future studies must also aim to identify biomarkers predicting directional fidelity (ferroptosis→STING vs. STING→ferroptosis) across tissues, delineate mechanisms of crosstalk with other cell death or DNA repair pathways, and develop optimized combinatorial regimens (e.g., ferroptosis inducers + immunotherapy/STING modulators) that can maximize tumor-specific immune activation while avoiding pro-tumorigenic inflammation in translational models.</p></section></section><section id="Sec11"><h2 class="pmc_sec_title">Nanomedicines can target the interplay of cGAS-STING and ferroptosis in cancers</h2>
<section id="Sec12"><h3 class="pmc_sec_title">Nanomedicines can activate cGAS-STING to induce ferroptosis</h3>
<p id="Par22">A manganese-based nanoenzyme (Mn(III)-SS NEs) was developed to synergize ferroptosis induction and immunotherapy for enhanced breast cancer theranostics [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>] (Fig. <a href="#Fig3" class="usa-link">3</a>; Table <a href="#Tab1" class="usa-link">1</a>). This nanoplatform leverages triple tumor microenvironment (TME)-responsive mechanisms by GSH depletion, ROS generation, cGAS-STING activation, and an immune-driven ferroptosis loop [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Mn(III)-SS NEs consume intracellular GSH through disulfide-thiol exchange and Mn³⁺/Mn²⁺ redox reactions, inhibiting GPX4 activity [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Concurrently, Mn²⁺ catalyzes a Fenton-like reaction with H₂O₂ to produce <sup>•</sup>OH, exacerbating LPO and ferroptosis [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Mn²⁺ released from the nanoplatform activates the cGAS-STING pathway, promoting dendritic cell maturation and CD8⁺ T cell infiltration. This enhances IFN-γ secretion, which downregulates SLC7A11 (a cystine/glutamate transporter), further reducing GSH synthesis and amplifying ferroptosis [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Ferroptosis-induced immunogenic cell death (ICD) releases DAMPs (e.g., HMGB1 and CRT), recruiting more CD8⁺ T cells to sustain IFN-γ production. This creates an antitumor immune “closed loop,” effectively inhibiting both primary and distant tumors [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. The nanoplatform significantly suppressed tumor growth and prolonged survival in 4T1 tumor-bearing mice. Mn(III)-SS NEs represent a multifunctional theranostic platform for cGAS -STING activation-mediated induction of ferroptosis to immune activation. This strategy highlights the potential of metal-based nanoenzymes for precise, immune -enhanced cancer treatment [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>].</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/4bdf41d51a5e/13046_2025_3520_Fig3_HTML.jpg" loading="lazy" id="d33e863" height="473" width="669" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic illustration of the synthesis and therapeutic mechanism of manganese-based nanoenzyme TME-responsive Mn(III)-SS NEs for ferroptosis -enhanced ICD and immune-driven ferroptosis</p></figcaption></figure><section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Overview of nanoparticles activate cGAS-STING to induce ferroptosis in cancer treatment</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Nanoparticles</th>
<th align="left" colspan="1" rowspan="1">Nanomaterials composition</th>
<th align="left" colspan="1" rowspan="1">Cancer</th>
<th align="left" colspan="1" rowspan="1">Tested model</th>
<th align="left" colspan="1" rowspan="1">Effects OR Involved mechanism</th>
<th align="left" colspan="1" rowspan="1">Ref</th>
</tr></thead>
<tbody><tr>
<td align="left" colspan="1" rowspan="1">Mn(III)-SS NEs</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1 tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">ZCUNH synergize ferroptosis induction to boost immunotherapy by activating cGAS-STING pathway in osteosarcoma</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]</td>
</tr></tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p30"><p>U-104,a novel carbonic anhydrase inhibitor</p></div></div></section></section><section id="Sec13"><h3 class="pmc_sec_title">Nanomedicine induce ferroptosis to activate cGAS-STING</h3>
<p id="Par25">In this section, we describe how rationally designed nanomaterials, from metal-organic frameworks to exosome hybrids, orchestrate ferroptosis induction and subsequent STING activation through spatially controlled ion release, redox disruption, and DAMP generation (Table <a href="#Tab2" class="usa-link">2</a>). These systems not only amplify ICD, but also reprogram the tumor microenvironment, transforming transient cytotoxic responses into sustained antitumor immunity. The following synthesis highlights the material innovations, mechanistic convergence, and therapeutic synergy, thereby defining this rapidly evolving frontier.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Overview of nanoparticles induce ferroptosis to activate cGAS-STING in cancer treatment</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Nanoparticles</th>
<th align="left" colspan="1" rowspan="1">Loaded agent</th>
<th align="left" colspan="1" rowspan="1">Cancer</th>
<th align="left" colspan="1" rowspan="1">Tested model</th>
<th align="left" colspan="1" rowspan="1">Effects OR Involved mechanism</th>
<th align="left" colspan="1" rowspan="1">Ref</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Cu/ZIF-8@U-104@siNFS1-HA</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Osteosarcoma</td>
<td align="left" colspan="1" rowspan="1">MG-63 tumor-bearing C57BL/6J mice</td>
<td align="left" colspan="1" rowspan="1">ZCUNH synergize ferroptosis induction to boost immunotherapy by activating cGAS-STING pathway in osteosarcoma.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DHA@MIL-101</td>
<td align="left" colspan="1" rowspan="1">U-104</td>
<td align="left" colspan="1" rowspan="1">NSCLC</td>
<td align="left" colspan="1" rowspan="1">Lewis lung cancer cells tumor-bearing C57 mice</td>
<td align="left" colspan="1" rowspan="1">DHA@MIL-101 enhances anti-cancer immunotherapy by inducing Ferroptosis to activate cGAS-STING for reprogramming of macrophage.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Exo@MnIO&amp;BG</td>
<td align="left" colspan="1" rowspan="1">Dihydroartemisinin</td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1 tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">Exo@MnIO&amp;BG enhances anti-cancer immunotherapy by boosting ferroptosis to activate cGAS-STING.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fe-THBQ/SR</td>
<td align="left" colspan="1" rowspan="1">SR-717</td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1 tumor-bearing mouse</td>
<td align="left" colspan="1" rowspan="1">Fe-THBQ/SR promotes tumor immunotherapy via synergistic ferroptosis and STING activation.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CMS</td>
<td align="left" colspan="1" rowspan="1">Ca²⁺ &amp; Mn</td>
<td align="left" colspan="1" rowspan="1">TNBC</td>
<td align="left" colspan="1" rowspan="1">4T1-tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">The CMS-induced ferroptosis- and Mn²⁺-mediated STING pathway activation promoted tumor -associated macrophage (TAM) polarization toward antitumor phenotypes and dendritic cell (DC) maturation for antigen presentation.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MG-LAAO</td>
<td align="left" colspan="1" rowspan="1">Gallium -magnesium</td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1-tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">MG-LAAO blocks tumor cell autophagy, neutralizes acidic TME via H⁺ scavenging, and inhibits lactic acid accumulation, thereby dismantling cytoprotective mechanisms and preventing immune evasion.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MMP NDs</td>
<td align="left" colspan="1" rowspan="1">Mo/Mn</td>
<td align="left" colspan="1" rowspan="1">CRC</td>
<td align="left" colspan="1" rowspan="1">CT26 tumor bearing mice.</td>
<td align="left" colspan="1" rowspan="1">MMP NDs exploit the synergistic redox activity of high-valence Mo/Mn to deplete tumor-overexpressed glutathione (GSH), inducing ferroptosis while activating the cGAS-STING pathway to amplify antitumor immunity. This dual mechanism triggers a self-reinforcing therapeutic cycle: ferroptosis releases tumor antigens, activating CD8⁺ T cells to secrete interferon-γ (IFN-γ), which suppresses GPX4 expression and exacerbates lipid peroxidation, thereby sustaining ferroptotic cell death.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR144" class="usa-link" aria-describedby="CR144">144</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BQR@MLipo</td>
<td align="left" colspan="1" rowspan="1">Brequinar</td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1-tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">BQR@MLipo inhibit DHODH to trigger mitochondrial LPO and ROS overproduction, resulting in ferroptosis. This process releases immunogenic damage-associated molecular patterns (DAMPs), including calreticulin (CRT), ATP, and HMGB1, while mitochondrial DNA (mtDNA) leakage activates the cGAS-STING pathway to stimulate IFN-β secretion.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR145" class="usa-link" aria-describedby="CR145">145</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HBMn-FA</td>
<td align="left" colspan="1" rowspan="1">Hemin, BSO and Mn2+</td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1-tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">HBMn-FA nanoplatform drives ferroptosis in tumor cells, generating high levels of ROS that induce mitochondrial stress and release endogenous mtDNA, which synergizes with Mn²⁺ to activate the cGAS-STING pathway, while tumor-derived cytosolic dsDNA from ferroptotic cell debris further amplifies STING signaling in dendritic cells (DCs) and other antigen-presenting cells.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HMG nanoparticles</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1-tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">HMG induces ferroptosis to intensify DNA damage in 4T1 breast cancer cells and synergizes with radiotherapy to activate the Mn²⁺-mediated cGAS-STING pathway, triggering robust systemic antitumor immunity.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR147" class="usa-link" aria-describedby="CR147">147</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p34"><p>DHODH, dihydroorotate dehydrogenase; U-104,a novel carbonic anhydrase inhibitor</p></div></div></section><p id="Par27">A bimetallic nanoplatform (ZCUNH) was synthesized in three steps, i.e. Cu²⁺-doped ZIF-8 nanoparticles (NPs) were synthesized with a one-pot method using a metal-organic framework (MOF) template, with U-104 (a CA IX inhibitor) loaded into the porous structure. siRNA targeting NFS1 (cysteine desulfurase) was then adsorbed onto the NPs through electrostatic interactions. Hyaluronic acid (HA) was coated onto the surface to stabilize siNFS1 through hydrogen bonding and van der Waals forces, thereby enhancing tumor targeting through CD44 receptor binding (Fig. <a href="#Fig4" class="usa-link">4</a>; Table <a href="#Tab2" class="usa-link">2</a>) [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Co-suppression of carbonic anhydrase (CA) IX and cysteine desulfurase (NFS1) increases the LIP and acidifies the TME, enhancing Fe²⁺-driven Fenton reactions. Cu²⁺ depletes GSH, reduces GPX4 activity, and generates •OH, amplifying LPO and ferroptosis [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Zn²⁺ released from ZCUNH upregulates cGAS -STING expression, which cooperates with ferroptosis to trigger ICD and remodel the immunosuppressive TME. Ferroptosis-induced DNA damage and DAMPs release promote DC maturation, M1 macrophage polarization, and cytotoxic T cell infiltration, leading to robust antitumor immunity. This study established ferroptosis as an upstream event that activated the cGAS-STING pathway [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. ZCUNH synergizes with ferroptosis induction to boost immunotherapy by activating the cGAS-STING pathway in osteosarcoma [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. This study suggests that cGAS-STING activation acts downstream to amplify ICD and antitumor immunity. Thus, targeting ferroptosis -cGAS-STING crosstalk offers a dual-pronged strategy for enhancing both tumor cell death and antitumor immunity, addressing the limitations of conventional therapies.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/4c401a853483/13046_2025_3520_Fig4_HTML.jpg" loading="lazy" id="d33e1149" height="557" width="669" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic illustration of the synthetic process and therapeutic mechanism of ZCUNH</p></figcaption></figure><p id="Par29">An iron-based MOF nanoreactor, DHA@MIL-101, was successfully developed for encapsulation of dihydroartemisinin (DHA). DHA@MIL-101 exhibited high uptake by tumor-associated macrophages (TAMs) in the TME while preserving their viability (Fig. <a href="#Fig5" class="usa-link">5</a>) [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. DHA@MIL-101 selectively accumulated in tumor tissues and was preferentially phagocytosed by TAMs over cancer cells, leveraging the enhanced permeability and retention (EPR) effect and macrophage phagocytic activity [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. DHA@MIL-101 triggered ferroptosis in TAMs through iron ion release and GPX4 inhibition. Degradation of the iron-based MOF in the acidic TAM microenvironment released iron ions [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. DHA directly binds to and inhibits GPX4. Ferroptosis -induced DNA damage in TAMs activated the cGAS-STING pathway, leading to NF-κB and IRF3 activation. DHA@MIL-101 effectively reprogrammed TAMs into antitumor M1 macrophages through ferroptosis-driven activation of the cGAS-STING pathway [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. This dual mechanism combines direct tumor cell killing (through iron overload in cancer cells) and immune modulation (through TAM reprogramming) [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. In contrast, blocking ferroptosis impaired DHA@MIL-101-induced activation of STING signaling and phenotypic remodeling. This study highlights the potential of nanocarrier-phytopharmaceutical hybrids to modulate the tumor immune microenvironment, offering a novel strategy for cancer immunotherapy. These results provide a paradigm for leveraging ferroptosis and innate immune cGAS-STING pathways to enhance antitumor immunity [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>].</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/caf84a18b996/13046_2025_3520_Fig5_HTML.jpg" loading="lazy" id="d33e1183" height="509" width="669" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic diagram of DHA nanoreactor-triggered M1 polarization of TAMs via ferroptosis-driven activation of the cGAS/STING signaling pathway. (1) Low-dose DHA iron-based nanoreactors enrich in lung cancer and are subsequently taken up by TAMs. (2) Collapse of the DHA nanoreactor releases iron ions and DHA (which binds and inhibits GPX4), synergistically inducing ferroptosis. (3) Ferroptosis products damage DNA, activating the STING signaling pathway to drive TAM polarization into the M1 phenotype. (4) M1-mediated anti-lung cancer immune effects are thereby initiated</p></figcaption></figure><p id="Par31">A multifunctional exosome-based platform co-loaded with manganese-doped iron oxide nanoparticles (MnIOs), the exocytosis inhibitor GW4869, and the glutathione synthesis blocker l-buthionine sulfoximine (BSO) was engineered to synergistically disrupt iron metabolism and redox homeostasis and thereby amplify tumor immunotherapy (Fig. <a href="#Fig6" class="usa-link">6</a>) [<a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>]. By leveraging the exosomes’ efficient delivery of MnIO and GW4869-mediated suppression of iron efflux, the system achieved remarkable iron retention in tumors [<a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>]. This iron overload, combined with the BSO-induced glutathione depletion and elevated oxidative stress, drove robust ferroptosis in cancer cells. The dual homeostasis-disruption strategy not only amplified LPO but also activated the cGAS-STING pathway, triggering potent antitumor immunity [<a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>]. In orthotopic breast cancer models, this engineered exosome platform demonstrated superior efficacy in suppressing primary tumor progression and pulmonary metastasis, establishing a paradigm for the precise modulation of tumor microenvironmental vulnerabilities to enhance immunotherapeutic outcomes [<a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>].</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/bae4b426d45b/13046_2025_3520_Fig6_HTML.jpg" loading="lazy" id="d33e1210" height="475" width="669" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic illustration of the preparation process of Exo@MnIO&amp;BG. Therapeutic mechanism of Exo@MnIO&amp;BG for ferroptosis-based immunotherapy</p></figcaption></figure><p id="Par33">A multifunctional nanoplatform (Fe-THBQ/SR) was engineered by encapsulating the STING agonist SR-717 into an iron-tetrahydroxy-1,4-benzoquinone (Fe-THBQ) MOF (Fig. <a href="#Fig7" class="usa-link">7</a>) [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>]. Under 1064-nm laser irradiation, Fe-THBQ demonstrated exceptional efficacy as an NIR-II photosensitizer, generating substantial ROS, which downregulated heat shock protein (HSP) expression to enable mild photothermal therapy (mild-PTT) and triggered ferroptosis through GSH depletion and GPX4 inactivation [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>]. Meanwhile, Fe-THBQ/SR exhibited GSH-responsive release of SR-717, which synergistically amplified STING activation by coupling with ROS-induced double-stranded DNA damage [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>]. This dual-action mechanism promoted tumor vasculature normalization and alleviated hypoxia, significantly enhancing the efficacy of PDT [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>]. Remarkably, the single-laser-triggered nanoplatform achieved NIR-II PDT, NIR-II mild-PTT, and STING pathway activation in a reinforcing cycle. Together, these synergistic effects elevated tumor immunogenicity, reprogrammed the immunosuppressive TME, and boosted cytotoxic T lymphocyte infiltration, ultimately improving therapeutic outcomes [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>]. These findings highlight the use of Fe-THBQ/SR as a pioneering strategy for integrating multimodal tumor ablation with immune modulation, offering a robust solution for overcoming resistance in cancer therapy [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>].</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/022f5f8354fa/13046_2025_3520_Fig7_HTML.jpg" loading="lazy" id="d33e1244" height="741" width="669" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic illustration of Fe-THBQ/SR as an NIR-II PDT and NIR-II mild-PTT agent under 1064 nm laser irradiation, inducing ferroptosis, STING activation, and vasculature normalization</p></figcaption></figure><p id="Par35">A Ca²⁺- &amp; Mn-based dual-ion hybrid nanostimulator (CMS) has been shown to function as a dual-functional agent for triple-negative breast cancer (TNBC) therapy by enhancing antitumor immunity through induction of ferroptosis to activate innate immune responses (Fig. <a href="#Fig8" class="usa-link">8</a>) [<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>]. The mixed-valence manganese in CMS drives GSH depletion and ROS generation, while its role as an exogenous Ca²⁺ source triggers mitochondrial Ca²⁺ overload, and the consequent amplification of oxidative stress collectively inactivates GPX4 and induces lethal LPO, culminating in robust ferroptosis in cancer cell [<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>]. The induced ferroptosis- and Mn²⁺-mediated STING pathway activation promoted TAM polarization toward antitumor phenotypes and DC maturation for antigen presentation [<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>]. This dual-action strategy fosters tumor -specific cytotoxic T lymphocyte (CTL) infiltration and establishes a potent adaptive immune response [<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>]. Collectively, CMS represents a groundbreaking approach that integrates ferroptosis induction with innate immune activation, thereby offering a transformative paradigm for TNBC immunotherapy [<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>].</p>
<figure class="fig xbox font-sm" id="Fig8"><h4 class="obj_head">Fig. 8.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/0d151582360a/13046_2025_3520_Fig8_HTML.jpg" loading="lazy" id="d33e1276" height="613" width="669" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic illustration of the nanostimulator (CMS) inducing tumor cell ferroptosis while simultaneously awakening TAMs and DCs to boost anti-tumor immune responses</p></figcaption></figure><p id="Par37">Current tumor immunotherapies face several challenges, including poor immunogenicity, an immunosuppressive TME, and cytoprotective mechanisms that dampen immune activation. l-amino acid oxidase (LAAO)-loaded gallium -magnesium layered double hydroxide (MG-LAAO) was engineered to address these limitations by amplifying antitumor immunity through multi-pathway synergy (Fig. <a href="#Fig9" class="usa-link">9</a>) [<a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>]. MG-LAAO induces pyroptosis through the caspase-1/GSDMD and caspase-3/GSDME pathways, triggering ICD, while the released Ga³⁺ disrupts mitochondrial iron homeostasis to drive ferroptosis [<a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>]. Concurrently, MG-LAAO blocks tumor cell autophagy, neutralizes acidic TME by H⁺ scavenging, and inhibits lactic acid accumulation, thereby dismantling cytoprotective mechanisms and preventing immune evasion [<a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>]. These coordinated actions robustly activate the cGAS-STING pathway, generating potent systemic antitumor immunity. These results underscore the critical interplay of autophagy inhibition, pyroptosis, ferroptosis, and ICD in reshaping the immunosuppressive TME and elevating immunogenicity [<a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>].</p>
<figure class="fig xbox font-sm" id="Fig9"><h4 class="obj_head">Fig. 9.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig9_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/ddf1bb6c274d/13046_2025_3520_Fig9_HTML.jpg" loading="lazy" id="d33e1303" height="472" width="669" alt="Fig. 9"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic diagram of MG-LAAO action: Degradation in the mildly acidic TME neutralizes H⁺ and inhibits tumor cell autophagy, concurrently releasing Ga³⁺ and LAAO. Ga³⁺ upregulates HMOX-1, causing mitochondrial iron overload and Fe³⁺ release. Fe³⁺ reacts with GSH, reducing to Fe²⁺ which downregulates GPX4 and participates in the Fenton reaction. This consumes LAAO-produced H₂O₂, generating cytotoxic ROS and promoting LPO accumulation, ultimately triggering ferroptosis. Additionally, MG-LAAO induces pyroptosis via canonical (caspase-1/GSDMD) and non-canonical (caspase-3/GSDME) pathways, further promoting ICD, activating the STING pathway, and enhancing anti-tumor immunity</p></figcaption></figure><p id="Par39">Lei et al. developed polyethylene glycol-modified manganese molybdate nanoparticles (MMP NDs) as a novel metalloimmunotherapy platform for cancer treatment (Fig. <a href="#Fig10" class="usa-link">10</a>) [<a href="#CR144" class="usa-link" aria-describedby="CR144">144</a>]. MMP NDs exploit the synergistic redox activity of high-valence Mo/Mn to deplete tumor-overexpressing GSH, induce ferroptosis, and activate the cGAS-STING pathway to amplify antitumor immunity [<a href="#CR144" class="usa-link" aria-describedby="CR144">144</a>]. This dual mechanism triggers a self-reinforcing therapeutic cycle: ferroptosis releases tumor antigens, activating CD8⁺ T cells to secrete interferon-γ (IFN-γ), which suppresses GPX4 expression and exacerbates LPO, thereby sustaining ferroptotic cell death [<a href="#CR144" class="usa-link" aria-describedby="CR144">144</a>].</p>
<figure class="fig xbox font-sm" id="Fig10"><h4 class="obj_head">Fig. 10.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig10_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/6178e2b4d34b/13046_2025_3520_Fig10_HTML.jpg" loading="lazy" id="d33e1327" height="398" width="669" alt="Fig. 10"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig10/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>MMP NDs with dual cGAS-STING activation for cancer metalloimmunotherapy. Metal cations and anions exhibiting the strongest cGAS -STING activation were screened using 293-Dual™ mSTING cells and utilized to construct bimetallic oxide MMO NDs; MMP NDs were then obtained by DSPE-PEG₅ₖ modification. MMP NDs containing Mn²⁺ and MoO₄²⁻ effectively activate cGAS-STING. Following systemic administration, MMP NDs consume highly expressed tumor GSH, disrupt redox balance, inhibit GPX4 activity, and subsequently induce tumor cell ferroptosis. Tumor debris containing MMP NDs then triggers tumor-specific cellular immunity</p></figcaption></figure><p id="Par41">A mitochondrial-targeted liposomal system loaded with brequinar (BQR@MLipo) was engineered to amplify mitochondrial ferroptosis for in situ bladder cancer therapy (Fig. <a href="#Fig11" class="usa-link">11</a>) [<a href="#CR145" class="usa-link" aria-describedby="CR145">145</a>]. BQR@MLipo selectively accumulates in mitochondria, to inhibit dihydroorotate dehydrogenase (DHODH). This process releases immunogenic DAMPs, including calreticulin (CRT), ATP, and HMGB1, while mitochondrial DNA (mtDNA) leakage activates the cGAS -STING pathway to stimulate IFN-β secretion [<a href="#CR145" class="usa-link" aria-describedby="CR145">145</a>]. This immunomodulation enhances dendritic cell-mediated antigen cross-presentation and macrophage phagocytosis [<a href="#CR145" class="usa-link" aria-describedby="CR145">145</a>]. In vivo, BQRs@MLipo demonstrated preferential tumor accumulation, driving robust CD8 + T cell infiltration into the bladder TME, and achieving potent growth suppression [<a href="#CR145" class="usa-link" aria-describedby="CR145">145</a>]. These results provide evidence for the first time that DHODH inhibition induces mitochondrial ferroptosis in bladder cancer immunotherapy, establishing BQR@MLipo as a clinically translatable strategy to synergize ferroptotic tumor elimination with antitumor immunity activation.</p>
<figure class="fig xbox font-sm" id="Fig11"><h4 class="obj_head">Fig. 11.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig11_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/a7f218403f5b/13046_2025_3520_Fig11_HTML.jpg" loading="lazy" id="d33e1354" height="444" width="669" alt="Fig. 11"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig11/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mechanism of BQR@MLipo for enhancing mitochondria-related ferroptosis to potentiate checkpoint blockade immunotherapy</p></figcaption></figure><p id="Par43">Hemin, buthionine sulfoximine (BSO), and Mn²⁺ were co-encapsulated into a poly(lactic-co-glycolic acid) (PLGA) matrix to synthesize HBMn nanoparticles (NPs) (Fig. <a href="#Fig12" class="usa-link">12</a>) [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]. The PLGA surface was then further functionalized with DSPE -PEG-FA, a folate receptor-targeting stabilizer, yielding the optimized HBMn-FA nanotherapeutic platform [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]. The HBMn-FA nanoplatform drives ferroptosis in tumor cells, generating high levels of ROS that induce mitochondrial stress and release endogenous mtDNA, which synergizes with Mn²⁺ to activate the cGAS -STING pathway, while tumor-derived cytosolic dsDNA from ferroptotic cell debris further amplifies STING signaling in DCs and other antigen-presenting cells [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]. This dual activation mechanism bridges ferroptosis with innate immunity by priming robust systemic antitumor responses [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]. The amplified cGAS-STING axis enhances the efficacy of checkpoint blockade, achieving potent suppression of both localized and metastatic tumors. HBMn-FA establishes a paradigm for next -generation immunotherapies that exploit innate immune pathways for precise cancer treatment by coupling ferroptosis induction with STING pathway activation [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>].</p>
<figure class="fig xbox font-sm" id="Fig12"><h4 class="obj_head">Fig. 12.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig12_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/0d6e72fab48e/13046_2025_3520_Fig12_HTML.jpg" loading="lazy" id="d33e1392" height="463" width="669" alt="Fig. 12"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig12/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic of the synthesis and cGAS-STING pathway activation mechanism of HBMn-FA. <strong>(a)</strong> Preparation process of the HBMn-FA nanotherapeutic platform. <strong>(b)</strong> Mechanism of HBMn-FA-mediated cGAS-STING pathway activation for initiating systemic antitumor immunity and enhancing the therapeutic efficacy of checkpoint blockade against both localized and metastatic tumors</p></figcaption></figure><p id="Par45">Hu et al. engineered a multifunctional nanoplatform (HfO2@MnO2@GOx, HMG) by layering a manganese dioxide (MnO₂) shell onto a clinically established radiosensitizer, hafnium oxide (HfO₂), and surface-doping it with glucose oxidase (GOx) (Fig. <a href="#Fig13" class="usa-link">13</a>) [<a href="#CR147" class="usa-link" aria-describedby="CR147">147</a>]. This design leverages dual ferroptosis induction via GSH depletion and ROS amplification to enhance radiotherapy efficacy [<a href="#CR147" class="usa-link" aria-describedby="CR147">147</a>]. The ferroptotic cascade not only intensifies DNA damage in 4T1 breast cancer cells but also synergizes with radiotherapy to activate the Mn²⁺-mediated cGAS-STING pathway, triggering robust systemic antitumor immunity [<a href="#CR147" class="usa-link" aria-describedby="CR147">147</a>].</p>
<figure class="fig xbox font-sm" id="Fig13"><h4 class="obj_head">Fig. 13.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig13_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/9dba5cb93c00/13046_2025_3520_Fig13_HTML.jpg" loading="lazy" id="d33e1417" height="468" width="669" alt="Fig. 13"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig13/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic illustration of the mechanism of HfO₂@MnO₂@GOx nanoparticles in breast cancer combination therapy</p></figcaption></figure><p id="Par47">This section demonstrates that diverse nanomedicine platforms (e.g., ZCUNH, DHA@MIL-101, Fe-THBQ/SR, and CMS) can induce tumor ferroptosis through metal ion-driven redox dysregulation (e.g., GSH depletion, GPX4 inhibition, and iron overload), which subsequently activates the cGAS-STING pathway through ferroptosis-derived DAMPs (e.g., mtDNA and dsDNA). This cascade remodels the immunosuppressive TME by promoting ICD, DC maturation, M1 macrophage polarization, and cytotoxic T cell infiltration, thus establishing a self-reinforcing cycle in which ferroptosis-triggered innate immunity amplifies antitumor responses. Nanocarriers exploit intrinsic properties (e.g., Mn²⁺-mediated STING potentiation, EPR effect) to spatially coordinate ferroptosis induction and immune activation, validating the ferroptosis→cGAS -STING axis as a therapeutic paradigm.</p>
<p id="Par48">Critical unresolved questions include defining nanomaterial-specific thresholds for optimal DAMP release (e.g., mtDNA vs. nuclear DNA) that maximize STING activation without systemic inflammation and elucidating how nanocarrier composition (e.g., metal valence and surface charge) dictates crosstalk between ferroptotic damage and immune cell recruitment across tumor types. Future studies must establish standardized preclinical metrics for comparing nanoplatform efficacy (e.g., DAMP quantification and immune cell spatial mapping), develop strategies to circumvent nanoparticle-induced STING tolerance, and validate whether in vivo ferroptosis-immune synergies persist in metastatic or therapy-resistant settings through longitudinal studies. Clinical translation requires addressing metal ion biodistribution/toxicity and identifying biomarkers to stratify the patients most likely to benefit from ferroptosis-directed nanotherapies.</p></section><section id="Sec14"><h3 class="pmc_sec_title">Nanomedicine simultaneously activate ferroptosis and cGAS-STING</h3>
<p id="Par49">Innovative nanomedicine strategies have emerged that simultaneously co-activate ferroptosis and the cGAS-STING pathway within tumors. By engineering multifunctional nanoparticles with tumor-targeting capabilities, stimuli-responsive payload release, and synergistic component design, these platforms achieve spatiotemporally resolved dual-pathway activation through metal ions (Fe²⁺/Mn²⁺), STING agonists, or ferroptosis inducers: self-reinforcing therapeutic cycles where ferroptosis-derived DAMPs (mtDNA, HMGB1) activate cGAS-STING, while STING-driven interferon responses exacerbate oxidative stress and iron dysregulation; remodeling of immunosuppressive microenvironments through enhanced ICD, dendritic cell maturation, and cytotoxic T cell infiltration. The following section describes how rationally designed nanoplatforms leverage this dual-pathway synergy to enhance therapeutic precision, overcome resistance mechanisms, and generate systemic antitumor immunity across diverse malignancies (Table <a href="#Tab3" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Overview of nanoparticles simultaneously activate ferroptosis and cGAS-STING in cancer treatment</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Nanoparticles</th>
<th align="left" colspan="1" rowspan="1">Loaded agent</th>
<th align="left" colspan="1" rowspan="1">Cancer</th>
<th align="left" colspan="1" rowspan="1">Tested model</th>
<th align="left" colspan="1" rowspan="1">Effects OR Involved mechanism</th>
<th align="left" colspan="1" rowspan="1">Ref</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">PMZFNs</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Prostate cancer</td>
<td align="left" colspan="1" rowspan="1">PC3 cells tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">PMZFNs drive dual therapeutic mechanisms by inducing ferroptosis that directly killing cancer cells while releasing tumor-associated antigens to trigger ICD and activating cGAS-STING, which amplifying ICD efficacy through interferon-β production and dendritic cell priming.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">IFNγ/uMn-LDHs nanoplatform</td>
<td align="left" colspan="1" rowspan="1">Mn + IFNγ</td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1-tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">IFNγ/uMn-LDHs induces ferroptosis in cancer cell and activates the cGAS-STING pathway in TEM.Ferroptosis-induced immunogenic cell death (ICD) further liberates tumor-associated antigens, synergizing with STING-driven IFN-β production to recruit cytotoxic T lymphocytes (CTLs).</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CMArg@Lip</td>
<td align="left" colspan="1" rowspan="1">ML385</td>
<td align="left" colspan="1" rowspan="1">Cholangiocarcinoma</td>
<td align="left" colspan="1" rowspan="1">C57BL/6 mice</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR148" class="usa-link" aria-describedby="CR148">148</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">REV@SR780Fe@LEV-RS17 NPs</td>
<td align="left" colspan="1" rowspan="1">SR780Fe + Reversine</td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1-tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">REV@SR780Fe@LEV-RS17 NPs synergistically combine photodynamic therapy (PDT), ferroptosis, and cGAS-STING pathway activation to enhance antitumor immunity.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MnFe₅O₈@(M1M-DOX) NPs</td>
<td align="left" colspan="1" rowspan="1">MnFe₅O₈+DOX</td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1-tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">This platform enables tumor-targeted delivery, Fe²⁺/Fe³⁺-mediated ferroptosis, and Mn²⁺-driven cGAS-STING activation.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DP-HBN/RA nanomedicine</td>
<td align="left" colspan="1" rowspan="1">RSL3 and diABZi</td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1-tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">DP-HBN/RA nanomedicine amplify radiotherapy efficacy through dual ferroptosis induction and systemic immune activation.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">C5-AFt nanoparticle</td>
<td align="left" colspan="1" rowspan="1">Ruthenium + apoferritin</td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1-tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">C5-AFt NPs inducing ferroptosis via mitochondrial damage (ROS overproduction, GSH depletion, and GPX4/SLC7A11 downregulation) and activating the cGAS-STING pathway by promoting mtDNA leakage into the cytoplasm.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FeMn@cGAMP@M</td>
<td align="left" colspan="1" rowspan="1">Fe3O4@MnO + cGAMP</td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">4T1-tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">FeMn@cGAMP@M induces dual ROS-mediated ferroptosis and cGAS-STING immune activation.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">OMV/SaFeFA</td>
<td align="left" colspan="1" rowspan="1">Fe²⁺+agonist-4</td>
<td align="left" colspan="1" rowspan="1">CRC</td>
<td align="left" colspan="1" rowspan="1">Colon tumor-bearing mouse</td>
<td align="left" colspan="1" rowspan="1">Ferroptosis-derived damage-associated molecular patterns (DAMPs, e.g., calreticulin) prime DCs for antigen presentation, while STING-driven IFN-γ suppresses SLC7A11, creating a self-reinforcing loop that intensifies ferroptosis and immune activation.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NA-Ir</td>
<td align="left" colspan="1" rowspan="1">Iridium(III)</td>
<td align="left" colspan="1" rowspan="1">Melanoma</td>
<td align="left" colspan="1" rowspan="1">A375 cells-tumor bearing mice</td>
<td align="left" colspan="1" rowspan="1">Under light irradiation, NA-Ir induce ferroptosis and activates the cGAS-STING pathway, which promotes ferritinophagy and ensued ferroptosis,.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR155" class="usa-link" aria-describedby="CR155">155</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AMO</td>
<td align="left" colspan="1" rowspan="1">AgNO3</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">AMO triggers ferroptosis and pyroptosis, and concurrently activate the cGAS-STING pathway, which amplifies innate immunity.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PtMnIr</td>
<td align="left" colspan="1" rowspan="1">CAT, OXD, SOD, POD, GPx</td>
<td align="left" colspan="1" rowspan="1">Melanoma</td>
<td align="left" colspan="1" rowspan="1">B16-F10 melanoma-bearing C57BL/6 mice</td>
<td align="left" colspan="1" rowspan="1">The PtMnIr induce ferroptosis by downregulating GPX4 and promoting LPO, while simultaneously activating the cGAS-STING pathway through Mn²⁺ release, which sensitizes tumor cells to innate immune responses.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fe-PU/CD-IPI@cBSA</td>
<td align="left" colspan="1" rowspan="1">IPI-549 + IPI-549</td>
<td align="left" colspan="1" rowspan="1">CRC</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Fe-PU/CD-IPI@cBSA induced ferroptosis, activatied STING signaling pathway, and the repolarized macrophages in the mice with spontaneous tumor in the colorectal area and tumor-bearing mice.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fe0@HMON@DNA-Exo</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">TNBC</td>
<td align="left" colspan="1" rowspan="1">4T1 tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">Fe0@HMON@DNA-Exo induced ferroptosis, activatied STING signaling pathway.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AHA@MnP/QCT nanoparticles</td>
<td align="left" colspan="1" rowspan="1">Manganese phosphate + quercetin</td>
<td align="left" colspan="1" rowspan="1">NSCLC</td>
<td align="left" colspan="1" rowspan="1">Lewis’s cancer cell-bearing C57 mice</td>
<td align="left" colspan="1" rowspan="1">The AHA@MnP/QCT NPs vector sustainably releases QCT and Mn2 + into the acidic environment, which induces apoptosis and promotes ferroptosis in cells via the Fenton-like reactions. Free Mn2 + induces immunogenic cell death by activating DCs and promoting the activation and proliferation of T cells. Non-invasive imaging is achieved by accumulating AHA@MnP/QCT and enhancing T2-MRI signal at the tumor site.</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR160" class="usa-link" aria-describedby="CR160">160</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MGNH nanocomplex</td>
<td align="left" colspan="1" rowspan="1">NLG919</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FMPH</td>
<td align="left" colspan="1" rowspan="1">Plinabulin</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p70"><p>DOX, doxorubicin; MGNH, MnFe2O4@NaGdF4@NLG919@HA; NLG919, immune checkpoint indoleamine 2,3-dioxygenase (IDO) inhibitor</p></div></div></section><p id="Par51">Prostate cancer therapy is hindered by inadequate drug accumulation, apoptosis resistance, and immunosuppression due to impaired ICD and cGAS-STING pathway inhibition. Magnetic nanomaterials can leverage the EPR effect under external magnetic fields, and their efficacy diminishes with distance, which is a critical limitation given the deep pelvic location of prostate tumors. Wang et al. developed PEGylated manganese-zinc ferrite nanocrystals (PMZFNs) and introduced an innovative strategy involving intratumoral implantation of micromagnets to establish a sustained internal magnetic field (Fig. <a href="#Fig14" class="usa-link">14</a>; Table <a href="#Tab3" class="usa-link">3</a>) [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. This approach actively recruits intravenously administered PMZFNs, achieving highly efficient tumor accumulation and bypassing the spatial constraints of external magnets. PMZFNs drive dual therapeutic mechanisms by inducing ferroptosis that directly kills cancer cells while releasing tumor-associated antigens to trigger ICD and activating cGAS -STING, which amplify the efficacy of ICD through interferon-β production and dendritic cell priming [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. The synergy between ferroptotic tumor ablation and STING-mediated immune activation reshapes the immunosuppressive microenvironment and fosters cytotoxic T cell infiltration [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. In vivo, this system demonstrates potent tumor suppression with minimal systemic toxicity [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. This study pioneered a paradigm shift from passive EPR reliance to active magnetic targeting, offering a translatable solution to enhance therapeutic precision and overcome resistance in deep-seated malignancies.</p>
<figure class="fig xbox font-sm" id="Fig14"><h4 class="obj_head">Fig. 14.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig14_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/333d8ce3bdd5/13046_2025_3520_Fig14_HTML.jpg" loading="lazy" id="d33e1770" height="558" width="669" alt="Fig. 14"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig14/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>(A)</strong> Synthetic process of ultrathin Mn-based LDH nanosheets (uMn-LDHs) and subsequent IFN loading via electrostatic interaction. <strong>(B)</strong> Therapeutic mechanism of IFN/uMn-LDHs for co-enhancement of ferroptosis and antitumor immunity. Internalized IFN/uMn-LDHs consume excessive intracellular GSH and release Mn²⁺ to produce toxic ·OH via Fenton-like reactions, inducing ferroptosis. Delivered IFN downregulates membrane-localized SLC7A11 expression, inhibiting cystine uptake and subsequently interrupting GSH biosynthesis, cooperating with uMn-LDHs to enhance ferroptosis. In the TME, IFN/uMn-LDHs activate the cGAS-STING signaling pathway and stimulate DC maturation. Combined with ferroptosis-mediated ICD, cytotoxic T cell tumor infiltration is facilitated; secreted IFN cytokines further promote ferroptotic cancer cell death, achieving a “closed-loop” therapy that targets primary and distant tumors. (Abbreviations: GSH, glutathione; ·OH, hydroxyl radical; IFN, interferon; TME, tumor microenvironment; DC, dendritic cell; ICD, immunogenic cell death)</p></figcaption></figure><p id="Par53">The IFN-γ/uMn-LDH nanoplatform operates through a dual-action mechanism to synergistically amplify ferroptosis and antitumor immunity [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. Upon tumor cell internalization, IFN-γ/uMn-LDH deplete intracellular GSH through Mn²⁺-mediated Fenton-like reactions, generating cytotoxic •OH to drive ferroptosis [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. Concurrently, IFN-γ suppresses cystine uptake by downregulating membrane -localized SLC7A11, disrupting GSH biosynthesis, and enhancing vulnerability to ferroptosis [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. In the TME, the released Mn²⁺ activates the cGAS-STING pathway, stimulating DC maturation and antigen presentation [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. Ferroptosis-induced ICD further liberates tumor-associated antigens and synergizes with STING-driven IFN-β production to recruit CTLs. Critically, infiltrating CTLs secrete IFN-γ, establishing a self-reinforcing cycle that enhances ferroptosis while sustaining immune activation [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. This “closed-loop” strategy not only eradicates primary tumors but also induces systemic immunity to suppress distant metastases, overcoming the traditional limitations of monotherapeutic approaches [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>].</p>
<p id="Par54">Hu et al. developed an innovative nanoplatform (CMArg@Lip) that synergistically integrates photodynamic therapy, nitric oxide (NO)-mediated gas therapy, and NRF2 pathway inhibition through ML385 [<a href="#CR148" class="usa-link" aria-describedby="CR148">148</a>]. This system overcomes TME limitations by concurrently generating cytotoxic reactive species (ROS/RNS including ONOO⁻) through Ce6 photosensitization and l-arginine-derived NO production, while ML385 disrupts NRF2-mediated antioxidant defenses (GSH/GPX4 axis) to amplify oxidative stress [<a href="#CR148" class="usa-link" aria-describedby="CR148">148</a>]. In cholangiocarcinoma models, CMArg@Lip induced ferroptosis through GPX4/GSH depletion and triggered mitochondrial DNA release from myeloid-derived suppressor cells (MDSCs), thereby activating the cGAS-STING pathway [<a href="#CR148" class="usa-link" aria-describedby="CR148">148</a>]. This dual mechanism achieved reversal of immunosuppression through reprogramming of MDSCs to pro-immunogenic phenotypes, enhanced CTL activity through PD-L1 downregulation, amplified ICD via ferroptosis-mediated DAMP release (HMGB1, ATP), and dendritic cell maturation and T cell infiltration potentiation. The platform establishes a self -reinforcing therapeutic cycle where STING activation and ferroptosis-derived immunostimulation cooperatively remodel the TME, creating sustained antitumor immunity [<a href="#CR148" class="usa-link" aria-describedby="CR148">148</a>].</p>
<p id="Par55">pH-activatable hybrid nanovesicles (REV@SR780Fe@LEV-RS17 NPs) derived from M1 macrophage extracellular vesicles (EVs) and liposomes have been developed in another study (Fig. <a href="#Fig15" class="usa-link">15</a>) [<a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>]. These nanoparticles synergistically combined PDT, ferroptosis, and cGAS-STING pathway activation to enhance antitumor immunity [<a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>]. An acidic TME triggers the release of SR780 (a photosensitizer) and Fe<sup>3+</sup>, which are reduced to Fe<sup>2+</sup> by GSH, inducing LPO and ferroptosis, which generates ROS to cause mtDNA leakage and ICD, releasing DAMPs (e.g., ATP, HMGB1, and CRT) to activate DCs [<a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>]. Reversine (REV), a cGAS-STING agonist, activates innate immunity, promoting the production of cytokines (e.g., IFN-β) and T cell infiltration. Triple therapy inhibits primary tumor growth, metastasis (lung/liver), and recurrence in 4T1 breast cancer models while reprogramming the immunosuppressive TME through M1 macrophage polarization [<a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>].</p>
<figure class="fig xbox font-sm" id="Fig15"><h4 class="obj_head">Fig. 15.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig15_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/87f17b7a3f79/13046_2025_3520_Fig15_HTML.jpg" loading="lazy" id="d33e1847" height="450" width="669" alt="Fig. 15"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig15/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Illustration of REV@SR780Fe@LEV-RS17 NPs and their antitumor mechanisms. <strong>(a)</strong> Fabrication of REV@SR780Fe@LEV-RS17 NPs. <strong>(b)</strong> Structure conversion of SR780 and SR780Fe in Fe³⁺-rich and acidic environments, respectively. <strong>(c)</strong> SR780Fe activation in the TME: Released SR780 produces ROS under 808 nm laser irradiation; released Fe³⁺ ions are reduced to Fe²⁺ by GSH, inducing ferroptosis; REV activates the cGAS-STING pathway to enhance innate immunity</p></figcaption></figure><p id="Par57">Chen et al. developed MnFe₅O₈@(M1M-DOX) NPs, integrating manganese ferrite (MnFe₅O₈), low-dose doxorubicin (DOX), and M1 macrophage membranes (M1M) (Fig. <a href="#Fig16" class="usa-link">16</a>) [<a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>]. This platform enables tumor-targeted delivery, Fe²⁺/Fe³⁺ -mediated ferroptosis, and Mn²⁺-driven cGAS-STING activation. Fe²⁺/Fe³⁺ and DOX synergistically triggered tumor ferroptosis through LPO and GPX4 suppression, releasing DAMPs (e.g., mtDNA, HMGB1) to activate ICD [<a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>]. Fe²⁺/Fe³⁺ promoted M2-to-M1 macrophage repolarization via NF-κB signaling, enhancing antitumor cytokine secretion [<a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>]. Mn²⁺ amplified cGAS-STING signaling in dendritic cells (DCs), boosting IFN-β production and antigen presentation. Coactivation of NF-κB and cGAS-STING pathways induced robust DC maturation, TAM reprogramming, and cytotoxic T cell infiltration, suppressing primary tumor growth and recurrence in 4T1 breast cancer models [<a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>].</p>
<figure class="fig xbox font-sm" id="Fig16"><h4 class="obj_head">Fig. 16.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig16_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/0d2659d3f68f/13046_2025_3520_Fig16_HTML.jpg" loading="lazy" id="d33e1874" height="468" width="669" alt="Fig. 16"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig16/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic Illustration of MnFe₅O₈@(M1M-DOX) NPs Preventing Primary Tumor Progression and Recurrence. Fabrication of MnFe₅O₈@(M1M-DOX) NPs: MnFe₅O₈ and DOX are encased within the M1 macrophage membrane (M1M) via ultrasonication and mechanical extrusion. Regulatory mechanism in the TME: Fe²⁺/Fe³⁺ released by MnFe₅O₈@(M1M-DOX) drives TAMs into an M1-like state via the NF-κB pathway, promotes STING activation, enhances macrophage maturation, and primes T cells into active subtypes. Concurrently, Fe²⁺/Fe³⁺ and DOX induce tumoral ferroptosis, exposing endogenous tumor antigens. Mn²⁺/Mn³⁺ promotes DC activation via the cGAS-STING pathway. STING activation triggers downstream NF-κB signaling, inducing a pronounced pro-inflammatory cytokine response</p></figcaption></figure><p id="Par59">Aishajiang et al. developed pH-responsive DP-HBN/RA, a TME-responsive nanoplatform integrating hollow Bi2Se3 with RSL3 and diABZi to amplify the efficacy of radiotherapy through dual ferroptosis induction and systemic immune activation (Fig. <a href="#Fig17" class="usa-link">17</a>) [<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a>]. The Bi2Se3 core enhances X-ray energy deposition, generating tumor-localized ROS bursts that drive LPO-mediated ferroptosis. Acid-triggered RSL3 release in tumors disrupts GPX4 activity and intensifies ferroptotic cell death [<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a>]. Radiation-induced DNA fragmentation activates cGAS -STING signaling, which is synergistically enhanced by diABZi to promote dendritic cell maturation and T cell infiltration and sustain systemic antitumor immunity. Ferroptosis-derived DAMPs and STING-mediated immune activation create a feed-forward loop for TME remodeling [<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a>].</p>
<figure class="fig xbox font-sm" id="Fig17"><h4 class="obj_head">Fig. 17.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig17_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/9f0d1a33c46e/13046_2025_3520_Fig17_HTML.jpg" loading="lazy" id="d33e1899" height="469" width="669" alt="Fig. 17"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig17/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic illustration of the therapeutic mechanism of DP-HBN/RA with concurrent amplification of ferroptosis and immune system activation</p></figcaption></figure><p id="Par61">A delivery system using binuclear ruthenium(II) complex (C5) and its apoferritin nanoparticle (C5-AFt NPs) was developed to exert potent antitumor effects against TNBC (Fig. <a href="#Fig18" class="usa-link">18</a>) [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]. C5 selectively accumulates in the mitochondria, inducing ferroptosis via mitochondrial damage (ROS overproduction, GSH depletion, and GPX4/SLC7A11 downregulation) and activating the cGAS-STING pathway by promoting mtDNA leakage into the cytoplasm [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]. C5-AFt NPs enhanced tumor targeting, reduced systemic toxicity, and improved therapeutic outcomes in vivo [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>].</p>
<figure class="fig xbox font-sm" id="Fig18"><h4 class="obj_head">Fig. 18.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig18_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/8489b7aada38/13046_2025_3520_Fig18_HTML.jpg" loading="lazy" id="d33e1923" height="548" width="669" alt="Fig. 18"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig18/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mechanism of C5 inhibiting TNBC growth and metastasis through integrated chemotherapy and immunotherapy</p></figcaption></figure><p id="Par63">Chai et al. developed engineered tumor membrane-coated Fe3O4@MnO @cGAMP nanoparticles (FeMn@cGAMP@M) that were used for dual ROS -mediated ferroptosis and cGAS-STING immune activation (Fig. <a href="#Fig19" class="usa-link">19</a>) [<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>]. Fe<sup>3+</sup>/Fe<sup>2+</sup> redox cycling depletes GSH and generates •OH via Fenton reactions, inducing LPO and ferroptosis [<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>]. Acid-triggered Mn<sup>2+</sup> and cGAMP release synergistically activate the cGAS-STING pathway, stimulating macrophage recruitment, secretion of pro-inflammatory cytokines (e.g., TNF-α, IFN-β), and T/B cell infiltration [<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>]. The homologous membrane coating enhances tumor specificity, prolongs circulation, and protects cGAMP from degradation, achieving 76% tumor suppression in vivo with minimal systemic toxicity. This study established a dual-action paradigm where ferroptosis and cGAS-STING activation mutually potentiate oxidative damage and immune activation, offering a novel strategy for refractory cancer therapy [<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>].</p>
<figure class="fig xbox font-sm" id="Fig19"><h4 class="obj_head">Fig. 19.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig19_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/cdd3daf55755/13046_2025_3520_Fig19_HTML.jpg" loading="lazy" id="d33e1957" height="472" width="669" alt="Fig. 19"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig19/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Illustration of the preparation of membrane-cloaked FeMn@cGAMP and its cancer therapy mechanism</p></figcaption></figure><p id="Par65">Sun et al. developed a tumor-targeted nanoplatform (OMV/SaFeFA) by engineering bacterial outer membrane vesicles (OMVs) with Fe²⁺ ions, a STING agonist (agonist-4), and folate receptor-targeting DSPE-PEG-FA [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>] (Fig. <a href="#Fig20" class="usa-link">20</a>). This system synergistically induces ferroptosis and activates the cGAS-STING pathway to enhance the antitumor efficacy. Fe²⁺ catalyzes H₂O₂ into •OH, triggering LPO and depleting GSH by inhibition of SLC7A11/GPX4, thereby amplifying oxidative damage [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]. Released agonist-4 activates cGAS-STING signaling in dendritic cells (DCs), promoting IFN-β secretion and DC maturation, which enhances T cell infiltration (CD8⁺/CD4⁺) and systemic antitumor immunity [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]. Ferroptosis -derived DAMPs, e.g., calreticulin, prime DCs for antigen presentation, while STING-driven IFN-γ suppresses SLC7A11, creating a self-reinforcing loop that intensifies ferroptosis and immune activation [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]. OMV/SaFeFA achieved 77.6% tumor weight inhibition in colon cancer models with minimal toxicity, demonstrating biocompatibility and translational potential. Together, the integration of Fe²⁺-driven ferroptosis and STING agonist-triggered immunotherapy in OMV/SaFeFA represents a potent strategy to synergize oxidative damage and immune activation, offering a biocompatible and effective approach for refractory cancer therapy [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>].</p>
<figure class="fig xbox font-sm" id="Fig20"><h4 class="obj_head">Fig. 20.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig20_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/5839e9e9d4f1/13046_2025_3520_Fig20_HTML.jpg" loading="lazy" id="d33e1994" height="456" width="669" alt="Fig. 20"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig20/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>(a)</strong> Preparation process of OMV/SaFeFA using engineered outer membrane vesicles (OMVs) derived from Escherichia coli. <strong>(b)</strong> Schematic illustration of OMV/SaFeFA for tumor ferroptosis activation and antitumor immune response elicitation</p></figcaption></figure><p id="Par67">Li et al. designed an H<sub>2</sub>S-responsive iridium(III) complex, NA-Ir, which selectively targets H<sub>2</sub>S-rich cancer cells, localizes to the mitochondria, and induces ferroptosis via photodynamic therapy (PDT) (Fig. <a href="#Fig21" class="usa-link">21</a>) [<a href="#CR155" class="usa-link" aria-describedby="CR155">155</a>]. Under light irradiation, NA-Ir generates ROS, depletes GSH, and downregulates GPX4, triggering LPO, a hallmark of ferroptosis. Crucially, the mtDNA damage caused by NA-Ir activates the cGAS-STING pathway, which links DNA damage sensing to ferroptosis amplification. Activation of cGAS-STING promotes ferritinophagy (autophagic degradation of ferritin) and releases stored iron into the cytosol. Iron overload exacerbates LPO and ferroptosis, and STING-driven autophagy further enhances these processes [<a href="#CR155" class="usa-link" aria-describedby="CR155">155</a>]. Thus, cGAS-STING activation acts synergistically with ferroptosis by modulating iron homeostasis and amplifying oxidative stress, establishing a novel therapeutic axis for cancer-specific therapies [<a href="#CR155" class="usa-link" aria-describedby="CR155">155</a>]. This study pioneered the integration of cGAS-STING activation and ferroptosis induction, offering a dual-pathway strategy to overcome the limitations of monotherapy [<a href="#CR155" class="usa-link" aria-describedby="CR155">155</a>].</p>
<figure class="fig xbox font-sm" id="Fig21"><h4 class="obj_head">Fig. 21.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig21_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/f68bde0955c6/13046_2025_3520_Fig21_HTML.jpg" loading="lazy" id="d33e2026" height="476" width="669" alt="Fig. 21"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig21/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic Illustration of the Mechanisms of Cancer-Specific Complex NA-Ir: Selective Lighting of H₂S-Rich Cancer Cells, Mitochondrial Localization, Mitochondrial Function Disruption, and Ultimate Induction of LPO-Mediated Ferroptosis through Different Pathways under Light Irradiation</p></figcaption></figure><p id="Par69">Chen et al. synthesized silver molybdate nanoparticles (AMO) that induced pyroptosis and ferroptosis to enhance antitumor immunity (Fig. <a href="#Fig22" class="usa-link">22</a>) [<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>]. AMO responds to TME cues (H<sub>2</sub>O<sub>2</sub> and GSH) to release Ag<sup>++</sup> and MoO<sub>4</sub><sup>2−</sup> ions, generating ROS and depleting GSH. This triggers ferroptosis via downregulation of LPO and GPX4. MoO<sub>4</sub><sup>2−</sup> uniquely upregulates GSDME expression, redirecting caspase-3 -mediated apoptosis to pyroptosis and enhancing immunogenicity. Concurrently, ROS and DNA damage activate the cGAS-STING pathway, which amplifies innate immunity by promoting type I interferon production and immune cell recruitment [<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>].</p>
<figure class="fig xbox font-sm" id="Fig22"><h4 class="obj_head">Fig. 22.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig22_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/6cf7db524e13/13046_2025_3520_Fig22_HTML.jpg" loading="lazy" id="d33e2061" height="520" width="669" alt="Fig. 22"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig22/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic illustration of the synthesis, anti-tumor effect, and immune activation of AMO. AMO is synthesized via a rapid solvothermal method. Upon entering tumor cells, AMO consumes GSH, degrades H₂O₂ to generate ROS, and releases MoO₄²⁻ and Ag⁺. Intracellular GSH depletion and ROS induction lead to ferroptosis. Additionally, MoO₄²⁻ upregulates intracellular GSDME, and combined with ROS and Ag⁺ stimuli, cells undergo caspase-3/GSDME-mediated pyroptosis. Ferroptosis and pyroptosis synergistically enhance the immune response</p></figcaption></figure><p id="Par71">The study demonstrated the development of PtMnIr nanozymes, which exhibit multienzymatic activities (CAT, OXD, SOD, POD, GPx) to generate ROS and deplete GSH in a self-sustaining “inner catalytic loop,” synergized with electrodynamic therapy (EDT) under alternating current (Fig. <a href="#Fig23" class="usa-link">23</a>) [<a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>]. The PtMnIr induce ferroptosis by downregulating GPX4 and promoting LPO, while simultaneously activating the cGAS-STING pathway through Mn²⁺ release, which sensitizes tumor cells to innate immune responses [<a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>]. The interplay between ferroptosis and cGAS-STING is pivotal: ferroptosis-driven ICD releases DAMPs (e.g., HMGB1, CRT), while Mn²⁺ amplifies cGAS-STING signaling to enhance type I interferon production, collectively inhibiting tumor growth and metastasis. PtMnIr suppressed primary tumor progression and almost completely eradicated lung metastases in the combined EDT/nanozyme treatment of B16-F10 melanoma-bearing C57BL/6 mice, underscoring the dual ferroptosis-immunotherapy mechanism [<a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>].</p>
<figure class="fig xbox font-sm" id="Fig23"><h4 class="obj_head">Fig. 23.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig23_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/192fb6b6cfa5/13046_2025_3520_Fig23_HTML.jpg" loading="lazy" id="d33e2085" height="468" width="669" alt="Fig. 23"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig23/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic diagram of the antitumor mechanism of PtMnIr nanozymes</p></figcaption></figure><p id="Par73">Zheng et al. developed a ferric ion-punicalagin coordination network (Fe-PU) that functions as a ferroptosis inducer and a nanocarrier for co-loading cGAMP and IPI-549, yielding the nanocomposite Fe-PU/CD-IPI (Fig. <a href="#Fig24" class="usa-link">24</a>) [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]. To enhance tumor-targeted delivery, Fe-PU/CD-IPI was further modified with cyclic arginine -glycine-aspartic acid (cRGD) peptide-conjugated bovine serum albumin (cRGD -BSA) to generate the optimized formulation, Fe-PU/CD-IPI@cBSA [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]. Fe-PU/CD -IPI@cBSA induced ferroptosis, activated the STING signaling pathway, and repolarized macrophages in mice with spontaneous tumors in the colorectal area and in tumor-bearing mice [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]. Mechanistically, cGAMP and IPI-549 synergistically remodeled the immunosuppressive TME by amplifying ICD and inhibiting PI3K-γ-mediated immune evasion [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]. The nanohybrid system exhibited potent antitumor efficacy in in vitro models, patient-derived organoids, and in vivo settings, highlighting its translational potential for colorectal cancer therapy through coordinated ferroptosis induction and immune modulation [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>].</p>
<figure class="fig xbox font-sm" id="Fig24"><h4 class="obj_head">Fig. 24.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig24_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/c4d931474b86/13046_2025_3520_Fig24_HTML.jpg" loading="lazy" id="d33e2116" height="778" width="669" alt="Fig. 24"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig24/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The synthetic process of Fe-PU/CD-IPI@cBSA and its comprehensive cancer therapy mechanism</p></figcaption></figure><p id="Par75">Guo et al. presented a GSH-responsive nanoplatform, Fe0@HMON@DNA -Exo, constructed through in situ synthesis of elemental iron (Fe0) within degradable hollow mesoporous organosilica nanoparticles (HMON) followed by encapsulation with engineered EVs (DNA-Exo) derived from SN38-treated 4T1 breast cancer cells [<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>]. The DNA-Exo membrane confers tumor-targeting specificity through inherent homing mechanisms, thereby enabling precise delivery to TNBC cells. The system employs a dual biological logic-gate framework to orchestrate spatially controlled therapeutic responses, and OR-gated activation of the STING pathway in antigen-presenting cells (APCs) triggers robust immunostimulation, whereas an AND-gated mechanism selectively initiates Fe0 -mediated ferroptosis in TNBC cells contingent upon concurrent ROS accumulation [<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>]. This combinatorial logic achieved conditional payload release, simultaneously generating immunogenic ferroptosis and activating antitumor immunity [<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>].</p>
<p id="Par76">A pH-responsive core-shell nanoplatform of AHA@MnP/QCT NPs was developed. This multifunctional system leverages quercetin (QCT) and Mn²⁺ to establish a dual-modality mechanism, i.e., induction of ferroptotic cell death and activation of the cGAS-STING axis to stimulate dendritic cell maturation and CTL infiltration, orchestrating ICD while establishing antitumor immune memory (Fig. <a href="#Fig25" class="usa-link">25</a>) [<a href="#CR160" class="usa-link" aria-describedby="CR160">160</a>]. The demonstrated tumor-selective action coupled with immune microenvironment remodeling positions the AHA@MnP/QCT NPs as a transformative paradigm in precision oncology, offering a clinically translatable solution to bridge diagnostic imaging and personalized therapy in NSCLC treatment [<a href="#CR160" class="usa-link" aria-describedby="CR160">160</a>].</p>
<figure class="fig xbox font-sm" id="Fig25"><h4 class="obj_head">Fig. 25.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig25_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/2abbf8e9a9e9/13046_2025_3520_Fig25_HTML.jpg" loading="lazy" id="d33e2148" height="466" width="669" alt="Fig. 25"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig25/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic of AHA@MnP/QCT nanoparticle preparation and its one-stone-for-two-birds strategy for integrated diagnosis and treatment of non-small cell lung cancer. The AHA@MnP/QCT NP vector sustainably releases QCT and Mn²⁺ in the acidic tumor environment, inducing apoptosis and promoting ferroptosis via Fenton-like reactions. Free Mn²⁺ induces immunogenic cell death by activating DCs and promoting T cell activation and proliferation. Non-invasive imaging is achieved through tumor accumulation of AHA@MnP/QCT, enhancing the T₂-MRI signal at the tumor site</p></figcaption></figure><p id="Par78">Wang et al. developed an ultra-small Janus-structured MnFe₂O₄@NaGdF₄@ NLG919@HA(MGNH) nanocomplex engineered to overcome the immunosuppressive TME through synergistic ferroptosis activation and immune modulation (Fig. <a href="#Fig26" class="usa-link">26</a>) [<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>]. The hierarchical design integrates tumor-targeting HA with a heterostructured MnFe₂O₄@NaGdF₄ (MG) core and immune checkpoint inhibitor NLG919, enabling triple-modal theranostic functionality. HA-mediated active targeting ensures precise tumor accumulation of both the MG Janus nanoparticles and NLG919, while the MG core serves as a dual T₁/T₂ MRI contrast agent and photothermal converter for imaging-guided photothermal therapy (PTT) [<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>]. The nanocomplex orchestrates ferroptosis through three-pronged catalysis, which depletes GSH, amplifies ROS production through H<sub>2</sub>O<sub>2</sub> conversion, and suppresses GPX4 expression to drive lethal LPO accumulation [<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>]. Concurrently, Mn<sup>2+</sup> ions activate the cGAS-STING pathway to stimulate antitumor immunity, synergizing with NLG919’s blockade of the IDO-mediated tryptophan/kynurenine axis to inhibit Treg differentiation and reverse immunosuppression [<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>]. The ultra-small Janus architecture enhances tumor penetration and renal clearance and mitigates long-term biosafety concerns [<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>]. By unifying ferroptosis potentiation (through chemodynamic therapy/PTT), immune reprogramming, and real-time imaging within a single biodegradable platform, this work establishes a paradigm for next-generation nanomedicines that concurrently dismantle biochemical and immunological barriers in solid tumors, offering a clinically translatable strategy for precision TME remodeling [<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>].</p>
<figure class="fig xbox font-sm" id="Fig26"><h4 class="obj_head">Fig. 26.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig26_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/84a749842c4f/13046_2025_3520_Fig26_HTML.jpg" loading="lazy" id="d33e2188" height="476" width="669" alt="Fig. 26"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig26/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic diagram of the synthesis method and anti-tumor mechanism of MGNH</p></figcaption></figure><p id="Par80">Li et al. developed an engineered Fe-MOF@MnO₂@PB@HA (FMPH), a multifunctional nanoplatform integrating an iron-based MOF (Fe-MOF) core encapsulating plinabulin (PB), a microtubule-destabilizing and vascular-disrupting agent that inhibits tumor proliferation, with a manganese dioxide (MnO₂) shell enhancing chemodynamic therapy (CDT) through GSH depletion and •OH generation and HA surface modification for tumor-targeted delivery and systemic toxicity reduction (Fig. <a href="#Fig27" class="usa-link">27</a>) [<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>]. The MnO₂ component further enables near-infrared (NIR) -responsive hyperthermia while synergistically amplifying cGAS-STING activation to induce ICD and antitumor immune activation. In vitro and in vivo studies have demonstrated robust tumor suppression by FMPH, with NIR-triggered photothermal therapy augmenting the therapeutic efficacy. This multimodal nanomedicine, which combines ferroptosis induction, immunomodulation, targeted drug delivery, and photothermal enhancement, represents a promising strategy for synergistic cancer therapy [<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>].</p>
<figure class="fig xbox font-sm" id="Fig27"><h4 class="obj_head">Fig. 27.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372235_13046_2025_3520_Fig27_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12372235/1fad4fe5c62d/13046_2025_3520_Fig27_HTML.jpg" loading="lazy" id="d33e2210" height="474" width="669" alt="Fig. 27"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig27/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic illustration of FMPH preparation and molecular mechanisms for effective tumor therapy</p></figcaption></figure><p id="Par82">This section demonstrates that rationally designed nanomedicines (e.g., PMZFNs, IFN-γ/uMn-LDHs, CMArg@Lip, FeMn@cGAMP@M) can simultaneously activate ferroptosis and cGAS-STING signaling across diverse cancers through synergistic mechanisms: (1) metal ion-mediated catalysis (Fe²⁺/Mn²⁺) depletes antioxidants (GSH/GPX4), driving LPO and ferroptosis; (2) ferroptosis-derived DAMPs (mtDNA, HMGB1) or co-delivered STING agonists (cGAMP, diABZi) activate cGAS-STING, amplifying ICD and dendritic cell/T cell responses; (3) self-reinforcing cycles emerge when STING-driven IFN-γ suppresses SLC7A11 to enhance ferroptosis, while ferroptosis liberates antigens/DAMPs to potentiate STING immunity. These platforms can overcome therapeutic barriers (drug resistance and immunosuppression) through tumor-targeted delivery, TME-responsive activation, and combinatorial remodeling of the tumor microenvironment, thereby achieving potent antitumor efficacy with minimal toxicity in preclinical models.</p>
<p id="Par83">Critical unresolved challenges include elucidating the long-term biosafety profiles of metal-ion-releasing nanomaterials (e.g., Mn²⁺/Fe³⁺ accumulation), defining biomarkers to predict and monitor the dynamic interplay between nanomedicine -induced ferroptosis and immune activation in clinical settings, and addressing tumor heterogeneity-driven variations in therapeutic response across cancer types. Future studies must prioritize clinical translation by optimizing scalable nanomanufacturing, establishing tissue-specific biodistribution and clearance mechanisms, developing imaging-guided strategies to track the spatiotemporal coactivation of both pathways in vivo, and designing adaptive “logic-gated” nanosystems that can intelligently balance the ferroptotic and immunostimulatory outputs on the basis of real-time TME cues to prevent systemic hyperinflammation or off-target toxicity.</p></section></section><section id="Sec15"><h2 class="pmc_sec_title">Conclusions and perspectives</h2>
<p id="Par84">Targeting the cGAS-STING pathway in tumor immunotherapy has recently emerged as an important research direction, promoting the development of small-molecule STING agonists. Due to the limitations of STING agonists, including adverse effects, nonspecific accumulation, and rapid clearance, extensive research on nanomaterials has emerged as a breakthrough for safe and effective cancer immunotherapy with STING agonists. A growing body of evidence has shown that cGAS-STING interacts with ferroptosis in cancer, which can be leveraged by nanomedicines to offer a novel cancer regimen. Therefore, we reviewed the role of the interplay between cGAS/STING and ferroptosis in cancer genesis. We then focused on providing an overview of the latest findings and emerging concepts that leverage the interplay between cGAS-STING and ferroptosis by nanomedicine to kill cancers.</p>
<p id="Par85">Although preliminary progress has been made in the use of nanomedicines targeting the interplay between cGAS-STING and ferroptosis, studies on nanomedicines that can simultaneous target cGAS-STING and ferroptosis in tumors are still in their infancy. Several critical challenges remain to be addressed in future studies. First, the mechanisms underlying the interaction between cGAS-STING and ferroptosis in tumors remain unclear and warrant further investigation. Such research could lay a solid foundation for precise targeting of the interplay between cGAS-STING and ferroptosis, thereby advancing therapeutic strategies. Future research should aim to design and develop stimuli-responsive nanomaterials (e.g., pH-/ROS-/enzyme-activated systems) to co-deliver cGAS-STING agonists (e.g., CDNs) and ferroptosis inducers (e.g., FINs or iron-loaded nanoparticles) with spatiotemporal precision. Multi-omics approaches and CRISPR screening should be used to decode the molecular interplay between cGAS-STING signaling and ferroptosis execution in tumor and immune cells, and immunocompetent tumor organoids or humanized mouse models should be employed to evaluate dual-target nanomedicine efficacy, immune memory, and systemic safety. AI-driven nanoparticle design and molecular dynamics simulations can be utilized to optimize the dual-targeting efficiency and pharmacokinetics.</p>
<p id="Par86">Future research directions remain an open conundrum, and the mechanisms underlying the crosstalk between cGAS-STING and ferroptosis remain to be determined. Future studies should aim to investigate how cGAS-STING activation regulates ferroptosis sensitivity (e.g., via IFN-driven lipid metabolism reprogramming) and vice versa. Hybrid nanomaterials (e.g., metal-organic frameworks or lipid-polymer composites) should be designed to synchronously target tumor cells (ferroptosis) and immune cells (cGAS-STING activation). A central issue that has not been addressed is the screening of translational biomarkers, i.e., identifying predictive biomarkers (e.g., STING /GPX4 expression ratios and LPO levels) to stratify patients for dual-targeted nanotherapy. The development of engineered tumor-selective targeting ligands (e.g., anti-PDL1-decorated nanoparticles) to minimize off-target effects on healthy tissues is also a key focus.</p>
<p id="Par87">In summary, emerging preclinical studies have demonstrated the feasibility of combining cGAS-STING activation with ferroptosis induction using nanomaterials, leveraging the unique properties of this approach, such as tumor-specific drug delivery, controlled release, and synergistic immunomodulatory effects. However, challenges persist, including an insufficient mechanistic understanding of cGAS-STING-ferroptosis crosstalk, suboptimal spatiotemporal control of dual-target nanocarriers, and potential off-target toxicity. Bridging the gap between mechanistic complexity and nanomedicine innovations is critical for unlocking the full potential of dual cGAS-STING/ferroptosis targeting for next-generation cancer therapies.</p></section><section id="Sec16"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12372235/bin/13046_2025_3520_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (271.9KB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>N/A.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>CL and WZ researched data for the article and contributed substantially to discussion of the content. CL and WZ wrote the article. DG and WG reviewed and/or edited the manuscript before submission. CL and WG prepared figures. CL and WG conceived of and designed the study. WG and YJ provided administrative support. All authors analysed and interpreted the data. All authors read and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported in part by the Natural Science Foundation of Liaoning Province(2023-MS-09).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par88">Not applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par89">All of the authors are aware of and agree to the content of the paper and their being listed as a co-author of the paper.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par90">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Chunfei Li and Wenyan Zhao contributed equally to this work.</p></div>
</div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31–46.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-21-1059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35022204/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hanahan%20D.%20Hallmarks%20of%20cancer:%20new%20dimensions.%20Cancer%20Discov.%202022;12:31%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Kuang F, Liu J, Li C, Kang R, Tang D. Cathepsin B is a mediator of organelle-specific initiation of ferroptosis. Biochem Biophys Res Commun. 2020;533:1464–9.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2020.10.035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33268027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kuang%20F,%20Liu%20J,%20Li%20C,%20Kang%20R,%20Tang%20D.%20Cathepsin%20B%20is%20a%20mediator%20of%20organelle-specific%20initiation%20of%20ferroptosis.%20Biochem%20Biophys%20Res%20Commun.%202020;533:1464%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Gerstberger S, Jiang Q, Ganesh K. Metastasis Cell. 2023;186:1564–79.
</cite> [<a href="https://doi.org/10.1016/j.cell.2023.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10511214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37059065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gerstberger%20S,%20Jiang%20Q,%20Ganesh%20K.%20Metastasis%20Cell.%202023;186:1564%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
</cite> [<a href="https://doi.org/10.1016/j.cell.2011.02.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21376230/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hanahan%20D,%20Weinberg%20RA.%20Hallmarks%20of%20cancer:%20the%20next%20generation.%20Cell.%202011;144:646%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Pascual G, Majem B, Aznar-Benitah S. Targeting lipid metabolism in cancer metastasis. Biochim Biophys Acta Rev Cancer. 2023;1879:189051.
</cite> [<a href="https://doi.org/10.1016/j.bbcan.2023.189051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38101461/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pascual%20G,%20Majem%20B,%20Aznar-Benitah%20S.%20Targeting%20lipid%20metabolism%20in%20cancer%20metastasis.%20Biochim%20Biophys%20Acta%20Rev%20Cancer.%202023;1879:189051." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Sethi N, Kang Y. Unravelling the complexity of metastasis - molecular Understanding and targeted therapies. Nat Rev Cancer. 2011;11:735–48.
</cite> [<a href="https://doi.org/10.1038/nrc3125" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10961136/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21941285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sethi%20N,%20Kang%20Y.%20Unravelling%20the%20complexity%20of%20metastasis%20-%20molecular%20Understanding%20and%20targeted%20therapies.%20Nat%20Rev%20Cancer.%202011;11:735%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Chin EN, Sulpizio A, Lairson LL. Targeting STING to promote antitumor immunity. Trends Cell Biol. 2023;33:189–203.
</cite> [<a href="https://doi.org/10.1016/j.tcb.2022.06.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35931610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chin%20EN,%20Sulpizio%20A,%20Lairson%20LL.%20Targeting%20STING%20to%20promote%20antitumor%20immunity.%20Trends%20Cell%20Biol.%202023;33:189%E2%80%93203." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Dentro SC, Leshchiner I, Haase K, Tarabichi M, Wintersinger J, Deshwar AG, Yu K, Rubanova Y, Macintyre G, Demeulemeester J et al. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell. 2021;184:2239-54.e39.</cite> [<a href="https://doi.org/10.1016/j.cell.2021.03.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8054914/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33831375/" class="usa-link">PubMed</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Zhang B, Xu P, Ablasser A. Regulation of the cGAS-STING pathway. Annu Rev Immunol. 2025;43(1):667–92.</cite> [<a href="https://doi.org/10.1146/annurev-immunol-101721-032910" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40085836/" class="usa-link">PubMed</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Wang H, Fleishman JS, Wu S, Wang G, Du L, Li J, Du J. cGAS-STING targeting offers novel therapeutic opportunities in neurological diseases. Ageing Res Rev. 2025;105:102691.
</cite> [<a href="https://doi.org/10.1016/j.arr.2025.102691" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39954791/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20H,%20Fleishman%20JS,%20Wu%20S,%20Wang%20G,%20Du%20L,%20Li%20J,%20Du%20J.%20cGAS-STING%20targeting%20offers%20novel%20therapeutic%20opportunities%20in%20neurological%20diseases.%20Ageing%20Res%20Rev.%202025;105:102691." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Wang Y, Zhang X, Wang W, Zhang Y, Fleishman JS, Wang H. cGAS-STING targeting offers therapy choice in lung diseases. Biol Direct. 2025;20:20.
</cite> [<a href="https://doi.org/10.1186/s13062-025-00611-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11806777/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39920718/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Zhang%20X,%20Wang%20W,%20Zhang%20Y,%20Fleishman%20JS,%20Wang%20H.%20cGAS-STING%20targeting%20offers%20therapy%20choice%20in%20lung%20diseases.%20Biol%20Direct.%202025;20:20." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Zhou Q, Luo J, Chai X, Yang J, Zhong S, Zhang Z, Chang X, Wang H. Therapeutic targeting the cGAS-STING pathway associated with protein and gene: an emerging and promising novel strategy for aging-related neurodegenerative disease. Int Immunopharmacol. 2025;156:114679.
</cite> [<a href="https://doi.org/10.1016/j.intimp.2025.114679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40252469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20Q,%20Luo%20J,%20Chai%20X,%20Yang%20J,%20Zhong%20S,%20Zhang%20Z,%20Chang%20X,%20Wang%20H.%20Therapeutic%20targeting%20the%20cGAS-STING%20pathway%20associated%20with%20protein%20and%20gene:%20an%20emerging%20and%20promising%20novel%20strategy%20for%20aging-related%20neurodegenerative%20disease.%20Int%20Immunopharmacol.%202025;156:114679." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Wang Y, Wang W, Zhang Y, Gao P, Fleishman JS, Wang H. cGAS-STING targeting offers a novel therapeutic paradigm in cardiovascular diseases. Eur J Pharm Sci. 2025;211:107137.</cite> [<a href="https://doi.org/10.1016/j.ejps.2025.107137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40412728/" class="usa-link">PubMed</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Mou J, Chen Y, Zhu X, Xu B, Wang M, Xie J, Lin T, Gu Q, Wu Q, Che Z, et al. Emerging role of the cGAS-STING pathway in cardiovascular diseases: biologic function, mechanisms and targeted therapy. Mol Med. 2025;31:218.
</cite> [<a href="https://doi.org/10.1186/s10020-025-01273-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12135543/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40461989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mou%20J,%20Chen%20Y,%20Zhu%20X,%20Xu%20B,%20Wang%20M,%20Xie%20J,%20Lin%20T,%20Gu%20Q,%20Wu%20Q,%20Che%20Z,%20et%20al.%20Emerging%20role%20of%20the%20cGAS-STING%20pathway%20in%20cardiovascular%20diseases:%20biologic%20function,%20mechanisms%20and%20targeted%20therapy.%20Mol%20Med.%202025;31:218." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Zhang Z, Zhang C. Regulation of cGAS-STING signalling and its diversity of cellular outcomes. Nat Rev Immunol. 2025.</cite> [<a href="https://doi.org/10.1038/s41577-024-01112-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39774812/" class="usa-link">PubMed</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Guo J, Huang L. Nanodelivery of cGAS-STING activators for tumor immunotherapy. Trends Pharmacol Sci. 2022;43:957–72.
</cite> [<a href="https://doi.org/10.1016/j.tips.2022.08.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36089410/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20J,%20Huang%20L.%20Nanodelivery%20of%20cGAS-STING%20activators%20for%20tumor%20immunotherapy.%20Trends%20Pharmacol%20Sci.%202022;43:957%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Liu Y, Lu X, Qin N, Qiao Y, Xing S, Liu W, Feng F, Liu Z, Sun H. STING, a promising target for small molecular immune modulator: A review. Eur J Med Chem. 2021;211:113113.
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2020.113113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33360799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Lu%20X,%20Qin%20N,%20Qiao%20Y,%20Xing%20S,%20Liu%20W,%20Feng%20F,%20Liu%20Z,%20Sun%20H.%20STING,%20a%20promising%20target%20for%20small%20molecular%20immune%20modulator:%20A%20review.%20Eur%20J%20Med%20Chem.%202021;211:113113." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Wang Y, Luo J, Alu A, Han X, Wei Y, Wei X. cGAS-STING pathway in cancer biotherapy. Mol Cancer. 2020;19:136.
</cite> [<a href="https://doi.org/10.1186/s12943-020-01247-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7472700/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32887628/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Luo%20J,%20Alu%20A,%20Han%20X,%20Wei%20Y,%20Wei%20X.%20cGAS-STING%20pathway%20in%20cancer%20biotherapy.%20Mol%20Cancer.%202020;19:136." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Peng S, Hou X, Liu J, Huang F. Advances in polymer nanomaterials targeting cGAS-STING pathway for enhanced cancer immunotherapy. J Control Release. 2025;381:113560.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2025.02.056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40023225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Peng%20S,%20Hou%20X,%20Liu%20J,%20Huang%20F.%20Advances%20in%20polymer%20nanomaterials%20targeting%20cGAS-STING%20pathway%20for%20enhanced%20cancer%20immunotherapy.%20J%20Control%20Release.%202025;381:113560." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Zhang H, Xu X, Li S, Huang H, Zhang K, Li W, Wang X, Yang J, Yin X, Qu C, et al. Advances in nanoplatform-based multimodal combination therapy activating STING pathway for enhanced anti-tumor immunotherapy. Colloids Surf B Biointerfaces. 2025;250:114573.
</cite> [<a href="https://doi.org/10.1016/j.colsurfb.2025.114573" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39983453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20H,%20Xu%20X,%20Li%20S,%20Huang%20H,%20Zhang%20K,%20Li%20W,%20Wang%20X,%20Yang%20J,%20Yin%20X,%20Qu%20C,%20et%20al.%20Advances%20in%20nanoplatform-based%20multimodal%20combination%20therapy%20activating%20STING%20pathway%20for%20enhanced%20anti-tumor%20immunotherapy.%20Colloids%20Surf%20B%20Biointerfaces.%202025;250:114573." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Li Y, Li X, Yi J, Cao Y, Qin Z, Zhong Z, Yang W. Nanoparticle-Mediated STING activation for cancer immunotherapy. Adv Healthc Mater. 2023;12:e2300260.
</cite> [<a href="https://doi.org/10.1002/adhm.202300260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36905358/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Y,%20Li%20X,%20Yi%20J,%20Cao%20Y,%20Qin%20Z,%20Zhong%20Z,%20Yang%20W.%20Nanoparticle-Mediated%20STING%20activation%20for%20cancer%20immunotherapy.%20Adv%20Healthc%20Mater.%202023;12:e2300260." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Zhang M, Ji Y, Liu M, Dai Y, Zhang H, Tong S, Cai Y, Liu M, Qu N. Nano-delivery of STING agonists: unraveling the potential of immunotherapy. Acta Biomater. 2025;197:104–20.
</cite> [<a href="https://doi.org/10.1016/j.actbio.2025.03.054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40164370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20M,%20Ji%20Y,%20Liu%20M,%20Dai%20Y,%20Zhang%20H,%20Tong%20S,%20Cai%20Y,%20Liu%20M,%20Qu%20N.%20Nano-delivery%20of%20STING%20agonists:%20unraveling%20the%20potential%20of%20immunotherapy.%20Acta%20Biomater.%202025;197:104%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Fu G, Zhao Y, Mao C, Liu Y. Enhancing nano-immunotherapy of cancer through cGAS-STING pathway modulation. Biomater Sci. 2025;13:2235–60.
</cite> [<a href="https://doi.org/10.1039/d4bm01532k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40111213/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fu%20G,%20Zhao%20Y,%20Mao%20C,%20Liu%20Y.%20Enhancing%20nano-immunotherapy%20of%20cancer%20through%20cGAS-STING%20pathway%20modulation.%20Biomater%20Sci.%202025;13:2235%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Ying X, Chen Q, Yang Y, Wu Z, Zeng W, Miao C, Huang Q, Ai K. Nanomedicines Harnessing cGAS-STING pathway: sparking immune revitalization to transform ‘cold’ tumors into ‘hot’ tumors. Mol Cancer. 2024;23:277.
</cite> [<a href="https://doi.org/10.1186/s12943-024-02186-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11664935/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39710707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ying%20X,%20Chen%20Q,%20Yang%20Y,%20Wu%20Z,%20Zeng%20W,%20Miao%20C,%20Huang%20Q,%20Ai%20K.%20Nanomedicines%20Harnessing%20cGAS-STING%20pathway:%20sparking%20immune%20revitalization%20to%20transform%20%E2%80%98cold%E2%80%99%20tumors%20into%20%E2%80%98hot%E2%80%99%20tumors.%20Mol%20Cancer.%202024;23:277." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Li C, Zhang Y, Liu J, Kang R, Klionsky DJ, Tang D. Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death. Autophagy. 2021;17:948–60.
</cite> [<a href="https://doi.org/10.1080/15548627.2020.1739447" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8078708/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32186434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20C,%20Zhang%20Y,%20Liu%20J,%20Kang%20R,%20Klionsky%20DJ,%20Tang%20D.%20Mitochondrial%20DNA%20stress%20triggers%20autophagy-dependent%20ferroptotic%20death.%20Autophagy.%202021;17:948%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Li C, Liu J, Hou W, Kang R, Tang D. STING1 promotes ferroptosis through MFN1/2-Dependent mitochondrial fusion. Front Cell Dev Biol. 2021;9:698679.
</cite> [<a href="https://doi.org/10.3389/fcell.2021.698679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8236825/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34195205/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20C,%20Liu%20J,%20Hou%20W,%20Kang%20R,%20Tang%20D.%20STING1%20promotes%20ferroptosis%20through%20MFN1/2-Dependent%20mitochondrial%20fusion.%20Front%20Cell%20Dev%20Biol.%202021;9:698679." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>He L, Zhao T, Leong WZ, Sharda A, Mayerhofer C, Mei S, Bonilla GM, Menendez-Gonzalez JB, Gustafsson K, Fukushima T, et al. PSTK Inhibition activates cGAS-STING, precipitating ferroptotic cell death in leukemic stem cells. Blood. 2025;145:1903–14.
</cite> [<a href="https://doi.org/10.1182/blood.2024026040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39912669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?He%20L,%20Zhao%20T,%20Leong%20WZ,%20Sharda%20A,%20Mayerhofer%20C,%20Mei%20S,%20Bonilla%20GM,%20Menendez-Gonzalez%20JB,%20Gustafsson%20K,%20Fukushima%20T,%20et%20al.%20PSTK%20Inhibition%20activates%20cGAS-STING,%20precipitating%20ferroptotic%20cell%20death%20in%20leukemic%20stem%20cells.%20Blood.%202025;145:1903%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Liao D, Cui Y, Shi L, Zeng S, Wang H. USP34 regulates PIN1-cGAS-STING axis-dependent ferroptosis in cervical cancer via sumoylation. Int Immunopharmacol. 2025;147:113968.
</cite> [<a href="https://doi.org/10.1016/j.intimp.2024.113968" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39752760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liao%20D,%20Cui%20Y,%20Shi%20L,%20Zeng%20S,%20Wang%20H.%20USP34%20regulates%20PIN1-cGAS-STING%20axis-dependent%20ferroptosis%20in%20cervical%20cancer%20via%20sumoylation.%20Int%20Immunopharmacol.%202025;147:113968." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Bao Y, Pan Z, Zhao L, Qiu J, Cheng J, Liu L, Qian D. BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity. J Transl Med. 2024;22:519.
</cite> [<a href="https://doi.org/10.1186/s12967-024-05331-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11138045/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38816831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bao%20Y,%20Pan%20Z,%20Zhao%20L,%20Qiu%20J,%20Cheng%20J,%20Liu%20L,%20Qian%20D.%20BIBR1532%20combined%20with%20radiotherapy%20induces%20ferroptosis%20in%20NSCLC%20cells%20and%20activates%20cGAS-STING%20pathway%20to%20promote%20anti-tumor%20immunity.%20J%20Transl%20Med.%202024;22:519." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Su W, Gao W, Zhang R, Wang Q, Li L, Bu Q, Xu Z, Liu Z, Wang M, Zhu Y, et al. TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling. JHEP Rep. 2023;5:100695.
</cite> [<a href="https://doi.org/10.1016/j.jhepr.2023.100695" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10033999/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36968217/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Su%20W,%20Gao%20W,%20Zhang%20R,%20Wang%20Q,%20Li%20L,%20Bu%20Q,%20Xu%20Z,%20Liu%20Z,%20Wang%20M,%20Zhu%20Y,%20et%20al.%20TAK1%20deficiency%20promotes%20liver%20injury%20and%20tumorigenesis%20via%20ferroptosis%20and%20macrophage%20cGAS-STING%20signalling.%20JHEP%20Rep.%202023;5:100695." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381–96.
</cite> [<a href="https://doi.org/10.1038/s41568-022-00459-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10243716/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35338310/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lei%20G,%20Zhuang%20L,%20Gan%20B.%20Targeting%20ferroptosis%20as%20a%20vulnerability%20in%20cancer.%20Nat%20Rev%20Cancer.%202022;22:381%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C, Dai X, Li Z, Wu G. Ferroptosis: A novel Anti-tumor action for cisplatin. Cancer Res Treat. 2018;50:445–60.
</cite> [<a href="https://doi.org/10.4143/crt.2016.572" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5912137/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28494534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20J,%20Xu%20B,%20Han%20Q,%20Zhou%20H,%20Xia%20Y,%20Gong%20C,%20Dai%20X,%20Li%20Z,%20Wu%20G.%20Ferroptosis:%20A%20novel%20Anti-tumor%20action%20for%20cisplatin.%20Cancer%20Res%20Treat.%202018;50:445%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020;30:146–62.
</cite> [<a href="https://doi.org/10.1038/s41422-019-0263-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7015061/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31949285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lei%20G,%20Zhang%20Y,%20Koppula%20P,%20Liu%20X,%20Zhang%20J,%20Lin%20SH,%20Ajani%20JA,%20Xiao%20Q,%20Liao%20Z,%20Wang%20H,%20et%20al.%20The%20role%20of%20ferroptosis%20in%20ionizing%20radiation-induced%20cell%20death%20and%20tumor%20suppression.%20Cell%20Res.%202020;30:146%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R, Tang D. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63:173–84.
</cite> [<a href="https://doi.org/10.1002/hep.28251" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4688087/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26403645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20X,%20Ou%20Z,%20Chen%20R,%20Niu%20X,%20Chen%20D,%20Kang%20R,%20Tang%20D.%20Activation%20of%20the%20p62-Keap1-NRF2%20pathway%20protects%20against%20ferroptosis%20in%20hepatocellular%20carcinoma%20cells.%20Hepatology.%202016;63:173%E2%80%9384." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Wang W, Green M, Choi JE, Gijón M, Kennedy PD, Johnson JK, Liao P, Lang X, Kryczek I, Sell A, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270–4.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1170-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6533917/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31043744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20W,%20Green%20M,%20Choi%20JE,%20Gij%C3%B3n%20M,%20Kennedy%20PD,%20Johnson%20JK,%20Liao%20P,%20Lang%20X,%20Kryczek%20I,%20Sell%20A,%20et%20al.%20CD8(+)%20T%20cells%20regulate%20tumour%20ferroptosis%20during%20cancer%20immunotherapy.%20Nature.%202019;569:270%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>He H, Du L, Xue H, An Y, Zeng K, Huang H, He Y, Zhang C, Wu J, Shuai X. Triple tumor Microenvironment-Responsive ferroptosis pathways induced by Manganese-Based imageable nanoenzymes for enhanced breast cancer theranostics. Small Methods. 2023;7:e2300230.
</cite> [<a href="https://doi.org/10.1002/smtd.202300230" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37096886/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?He%20H,%20Du%20L,%20Xue%20H,%20An%20Y,%20Zeng%20K,%20Huang%20H,%20He%20Y,%20Zhang%20C,%20Wu%20J,%20Shuai%20X.%20Triple%20tumor%20Microenvironment-Responsive%20ferroptosis%20pathways%20induced%20by%20Manganese-Based%20imageable%20nanoenzymes%20for%20enhanced%20breast%20cancer%20theranostics.%20Small%20Methods.%202023;7:e2300230." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Wang Z, Zhou P, Li Y, Zhang D, Chu F, Yuan F, Pan B, Gao F. A bimetallic polymerization network for effective increase in labile iron pool and robust activation of cGAS/STING induces Ferroptosis-Based tumor immunotherapy. Small. 2024;20:e2308397.
</cite> [<a href="https://doi.org/10.1002/smll.202308397" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38072786/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Z,%20Zhou%20P,%20Li%20Y,%20Zhang%20D,%20Chu%20F,%20Yuan%20F,%20Pan%20B,%20Gao%20F.%20A%20bimetallic%20polymerization%20network%20for%20effective%20increase%20in%20labile%20iron%20pool%20and%20robust%20activation%20of%20cGAS/STING%20induces%20Ferroptosis-Based%20tumor%20immunotherapy.%20Small.%202024;20:e2308397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Li LG, Yang XX, Xu HZ, Yu TT, Li QR, Hu J, Peng XC, Han N, Xu X, Chen NN, et al. A Dihydroartemisinin-Loaded nanoreactor motivates Anti-Cancer immunotherapy by Synergy-Induced ferroptosis to activate cgas/sting for reprogramming of macrophage. Adv Healthc Mater. 2023;12:e2301561.
</cite> [<a href="https://doi.org/10.1002/adhm.202301561" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37567571/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20LG,%20Yang%20XX,%20Xu%20HZ,%20Yu%20TT,%20Li%20QR,%20Hu%20J,%20Peng%20XC,%20Han%20N,%20Xu%20X,%20Chen%20NN,%20et%20al.%20A%20Dihydroartemisinin-Loaded%20nanoreactor%20motivates%20Anti-Cancer%20immunotherapy%20by%20Synergy-Induced%20ferroptosis%20to%20activate%20cgas/sting%20for%20reprogramming%20of%20macrophage.%20Adv%20Healthc%20Mater.%202023;12:e2301561." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Wang H, Guan Y, Li C, Chen J, Yue S, Qian J, Dai B, Jiang C, Wen C, Wen L, et al. PEGylated Manganese-Zinc ferrite nanocrystals combined with intratumoral implantation of micromagnets enabled synergetic prostate cancer therapy via ferroptotic and Immunogenic cell death. Small. 2023;19:e2207077.
</cite> [<a href="https://doi.org/10.1002/smll.202207077" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36861297/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20H,%20Guan%20Y,%20Li%20C,%20Chen%20J,%20Yue%20S,%20Qian%20J,%20Dai%20B,%20Jiang%20C,%20Wen%20C,%20Wen%20L,%20et%20al.%20PEGylated%20Manganese-Zinc%20ferrite%20nanocrystals%20combined%20with%20intratumoral%20implantation%20of%20micromagnets%20enabled%20synergetic%20prostate%20cancer%20therapy%20via%20ferroptotic%20and%20Immunogenic%20cell%20death.%20Small.%202023;19:e2207077." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Liu J, Zhan J, Zhang Y, Huang L, Yang J, Feng J, Ding L, Shen Z, Chen X. Ultrathin clay Nanoparticles-Mediated mutual reinforcement of ferroptosis and cancer immunotherapy. Adv Mater. 2024;36:e2309562.
</cite> [<a href="https://doi.org/10.1002/adma.202309562" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37939375/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20J,%20Zhan%20J,%20Zhang%20Y,%20Huang%20L,%20Yang%20J,%20Feng%20J,%20Ding%20L,%20Shen%20Z,%20Chen%20X.%20Ultrathin%20clay%20Nanoparticles-Mediated%20mutual%20reinforcement%20of%20ferroptosis%20and%20cancer%20immunotherapy.%20Adv%20Mater.%202024;36:e2309562." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339:786–91.
</cite> [<a href="https://doi.org/10.1126/science.1232458" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3863629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23258413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20L,%20Wu%20J,%20Du%20F,%20Chen%20X,%20Chen%20ZJ.%20Cyclic%20GMP-AMP%20synthase%20is%20a%20cytosolic%20DNA%20sensor%20that%20activates%20the%20type%20I%20interferon%20pathway.%20Science.%202013;339:786%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 2013;339:826–30.
</cite> [<a href="https://doi.org/10.1126/science.1229963" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3855410/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23258412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20J,%20Sun%20L,%20Chen%20X,%20Du%20F,%20Shi%20H,%20Chen%20C,%20Chen%20ZJ.%20Cyclic%20GMP-AMP%20is%20an%20endogenous%20second%20messenger%20in%20innate%20immune%20signaling%20by%20cytosolic%20DNA.%20Science.%202013;339:826%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Gall A, Treuting P, Elkon KB, Loo YM, Gale M Jr, Barber GN, Stetson DB. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity. 2012;36:120–31.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2011.11.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3269499/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22284419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gall%20A,%20Treuting%20P,%20Elkon%20KB,%20Loo%20YM,%20Gale%20M%20Jr,%20Barber%20GN,%20Stetson%20DB.%20Autoimmunity%20initiates%20in%20nonhematopoietic%20cells%20and%20progresses%20via%20lymphocytes%20in%20an%20interferon-dependent%20autoimmune%20disease.%20Immunity.%202012;36:120%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Civril F, Deimling T, de Oliveira Mann CC, Ablasser A, Moldt M, Witte G, Hornung V, Hopfner KP. Structural mechanism of cytosolic DNA sensing by cGAS. Nature. 2013;498:332–7.
</cite> [<a href="https://doi.org/10.1038/nature12305" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3768140/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23722159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Civril%20F,%20Deimling%20T,%20de%20Oliveira%20Mann%20CC,%20Ablasser%20A,%20Moldt%20M,%20Witte%20G,%20Hornung%20V,%20Hopfner%20KP.%20Structural%20mechanism%20of%20cytosolic%20DNA%20sensing%20by%20cGAS.%20Nature.%202013;498:332%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Gao P, Ascano M, Wu Y, Barchet W, Gaffney BL, Zillinger T, Serganov AA, Liu Y, Jones RA, Hartmann G, et al. Cyclic [G(2’,5’)pA(3’,5’)p] is the metazoan second messenger [g(2’,5’)pa(3’,5’)p]roduced by DNA-activated Cyclic [g(2’,5’)pa(3’,5’)p]MP-AMP synthase. Cell. 2013;153:1094–107.
</cite> [<a href="https://doi.org/10.1016/j.cell.2013.04.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4382009/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23647843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20P,%20Ascano%20M,%20Wu%20Y,%20Barchet%20W,%20Gaffney%20BL,%20Zillinger%20T,%20Serganov%20AA,%20Liu%20Y,%20Jones%20RA,%20Hartmann%20G,%20et%20al.%20Cyclic%20%5BG(2%E2%80%99,5%E2%80%99)pA(3%E2%80%99,5%E2%80%99)p%5D%20is%20the%20metazoan%20second%20messenger%20%5Bg(2%E2%80%99,5%E2%80%99)pa(3%E2%80%99,5%E2%80%99)p%5Droduced%20by%20DNA-activated%20Cyclic%20%5Bg(2%E2%80%99,5%E2%80%99)pa(3%E2%80%99,5%E2%80%99)p%5DMP-AMP%20synthase.%20Cell.%202013;153:1094%E2%80%93107." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Kranzusch PJ, Lee AS, Berger JM, Doudna JA. Structure of human cGAS reveals a conserved family of second-messenger enzymes in innate immunity. Cell Rep. 2013;3:1362–8.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2013.05.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3800681/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23707061/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kranzusch%20PJ,%20Lee%20AS,%20Berger%20JM,%20Doudna%20JA.%20Structure%20of%20human%20cGAS%20reveals%20a%20conserved%20family%20of%20second-messenger%20enzymes%20in%20innate%20immunity.%20Cell%20Rep.%202013;3:1362%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Li X, Shu C, Yi G, Chaton CT, Shelton CL, Diao J, Zuo X, Kao CC, Herr AB, Li P. Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization. Immunity. 2013;39:1019–31.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2013.10.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3886715/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24332030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20X,%20Shu%20C,%20Yi%20G,%20Chaton%20CT,%20Shelton%20CL,%20Diao%20J,%20Zuo%20X,%20Kao%20CC,%20Herr%20AB,%20Li%20P.%20Cyclic%20GMP-AMP%20synthase%20is%20activated%20by%20double-stranded%20DNA-induced%20oligomerization.%20Immunity.%202013;39:1019%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Zhang X, Shi H, Wu J, Zhang X, Sun L, Chen C, Chen ZJ. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell. 2013;51:226–35.
</cite> [<a href="https://doi.org/10.1016/j.molcel.2013.05.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3808999/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23747010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20X,%20Shi%20H,%20Wu%20J,%20Zhang%20X,%20Sun%20L,%20Chen%20C,%20Chen%20ZJ.%20Cyclic%20GMP-AMP%20containing%20mixed%20phosphodiester%20linkages%20is%20an%20endogenous%20high-affinity%20ligand%20for%20STING.%20Mol%20Cell.%202013;51:226%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Ishikawa H, Barber GN. STING is an Endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 2008;455:674–8.
</cite> [<a href="https://doi.org/10.1038/nature07317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2804933/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18724357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ishikawa%20H,%20Barber%20GN.%20STING%20is%20an%20Endoplasmic%20reticulum%20adaptor%20that%20facilitates%20innate%20immune%20signalling.%20Nature.%202008;455:674%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009;461:788–92.
</cite> [<a href="https://doi.org/10.1038/nature08476" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4664154/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19776740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ishikawa%20H,%20Ma%20Z,%20Barber%20GN.%20STING%20regulates%20intracellular%20DNA-mediated,%20type%20I%20interferon-dependent%20innate%20immunity.%20Nature.%202009;461:788%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Shu C, Yi G, Watts T, Kao CC, Li P. Structure of STING bound to Cyclic di-GMP reveals the mechanism of Cyclic dinucleotide recognition by the immune system. Nat Struct Mol Biol. 2012;19:722–4.
</cite> [<a href="https://doi.org/10.1038/nsmb.2331" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3392545/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22728658/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shu%20C,%20Yi%20G,%20Watts%20T,%20Kao%20CC,%20Li%20P.%20Structure%20of%20STING%20bound%20to%20Cyclic%20di-GMP%20reveals%20the%20mechanism%20of%20Cyclic%20dinucleotide%20recognition%20by%20the%20immune%20system.%20Nat%20Struct%20Mol%20Biol.%202012;19:722%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Shang G, Zhang C, Chen ZJ, Bai XC, Zhang X. Cryo-EM structures of STING reveal its mechanism of activation by Cyclic GMP-AMP. Nature. 2019;567:389–93.
</cite> [<a href="https://doi.org/10.1038/s41586-019-0998-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6859894/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30842659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shang%20G,%20Zhang%20C,%20Chen%20ZJ,%20Bai%20XC,%20Zhang%20X.%20Cryo-EM%20structures%20of%20STING%20reveal%20its%20mechanism%20of%20activation%20by%20Cyclic%20GMP-AMP.%20Nature.%202019;567:389%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Motwani M, Pesiridis S, Fitzgerald KA. DNA sensing by the cGAS-STING pathway in health and disease. Nat Rev Genet. 2019;20:657–74.
</cite> [<a href="https://doi.org/10.1038/s41576-019-0151-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31358977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Motwani%20M,%20Pesiridis%20S,%20Fitzgerald%20KA.%20DNA%20sensing%20by%20the%20cGAS-STING%20pathway%20in%20health%20and%20disease.%20Nat%20Rev%20Genet.%202019;20:657%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Liu W, Kim GB, Krump NA, Zhou Y, Riley JL, You J. Selective reactivation of STING signaling to target Merkel cell carcinoma. Proc Natl Acad Sci U S A. 2020;117:13730–9.
</cite> [<a href="https://doi.org/10.1073/pnas.1919690117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7306767/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32482869/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20W,%20Kim%20GB,%20Krump%20NA,%20Zhou%20Y,%20Riley%20JL,%20You%20J.%20Selective%20reactivation%20of%20STING%20signaling%20to%20target%20Merkel%20cell%20carcinoma.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202020;117:13730%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Xia T, Konno H, Barber GN. Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral Oncolysis. Cancer Res. 2016;76:6747–59.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-16-1404" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27680683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xia%20T,%20Konno%20H,%20Barber%20GN.%20Recurrent%20loss%20of%20STING%20signaling%20in%20melanoma%20correlates%20with%20susceptibility%20to%20viral%20Oncolysis.%20Cancer%20Res.%202016;76:6747%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Wang Y, Hu J, Wu S, Fleishman JS, Li Y, Xu Y, Zou W, Wang J, Feng Y, Chen J, et al. Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. Signal Transduct Target Ther. 2023;8:449.
</cite> [<a href="https://doi.org/10.1038/s41392-023-01720-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10711040/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38072908/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Hu%20J,%20Wu%20S,%20Fleishman%20JS,%20Li%20Y,%20Xu%20Y,%20Zou%20W,%20Wang%20J,%20Feng%20Y,%20Chen%20J,%20et%20al.%20Targeting%20epigenetic%20and%20posttranslational%20modifications%20regulating%20ferroptosis%20for%20the%20treatment%20of%20diseases.%20Signal%20Transduct%20Target%20Ther.%202023;8:449." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Cheng G, Wu J, Ji M, Hu W, Wu C, Jiang J. TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway. BMC Cancer. 2023;23:825.
</cite> [<a href="https://doi.org/10.1186/s12885-023-11343-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10478367/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37667220/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng%20G,%20Wu%20J,%20Ji%20M,%20Hu%20W,%20Wu%20C,%20Jiang%20J.%20TET2%20inhibits%20the%20proliferation%20and%20metastasis%20of%20lung%20adenocarcinoma%20cells%20via%20activation%20of%20the%20cGAS-STING%20signalling%20pathway.%20BMC%20Cancer.%202023;23:825." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Cai X, Yu X, Tang T, Xu Y, Wu T. JMJD2A promotes the development of castration-resistant prostate cancer by activating androgen receptor enhancer and inhibiting the cGAS-STING pathway. Mol Carcinog. 2024;63:1682–96.
</cite> [<a href="https://doi.org/10.1002/mc.23753" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38818897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cai%20X,%20Yu%20X,%20Tang%20T,%20Xu%20Y,%20Wu%20T.%20JMJD2A%20promotes%20the%20development%20of%20castration-resistant%20prostate%20cancer%20by%20activating%20androgen%20receptor%20enhancer%20and%20inhibiting%20the%20cGAS-STING%20pathway.%20Mol%20Carcinog.%202024;63:1682%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Lin J, Guo D, Liu H, Zhou W, Wang C, Müller I, Kossenkov AV, Drapkin R, Bitler BG, Helin K, et al. The SETDB1-TRIM28 complex suppresses antitumor immunity. Cancer Immunol Res. 2021;9:1413–24.
</cite> [<a href="https://doi.org/10.1158/2326-6066.CIR-21-0754" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8647838/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34848497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20J,%20Guo%20D,%20Liu%20H,%20Zhou%20W,%20Wang%20C,%20M%C3%BCller%20I,%20Kossenkov%20AV,%20Drapkin%20R,%20Bitler%20BG,%20Helin%20K,%20et%20al.%20The%20SETDB1-TRIM28%20complex%20suppresses%20antitumor%20immunity.%20Cancer%20Immunol%20Res.%202021;9:1413%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Sun M, Han X, Li J, Zheng J, Li J, Wang H, Li X. Targeting KDM4 family epigenetically triggers antitumour immunity via enhancing tumour-intrinsic innate sensing and immunogenicity. Clin Transl Med. 2024;14:e1598.
</cite> [<a href="https://doi.org/10.1002/ctm2.1598" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10884983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38390756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20M,%20Han%20X,%20Li%20J,%20Zheng%20J,%20Li%20J,%20Wang%20H,%20Li%20X.%20Targeting%20KDM4%20family%20epigenetically%20triggers%20antitumour%20immunity%20via%20enhancing%20tumour-intrinsic%20innate%20sensing%20and%20immunogenicity.%20Clin%20Transl%20Med.%202024;14:e1598." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Tang M, Chen G, Tu B, Hu Z, Huang Y, DuFort CC, Wan X, Mao Z, Liu Y, Zhu WG, et al. SMYD2 inhibition-mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity. Sci Adv. 2023;9:eade6624.
</cite> [<a href="https://doi.org/10.1126/sciadv.ade6624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10266737/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37315132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tang%20M,%20Chen%20G,%20Tu%20B,%20Hu%20Z,%20Huang%20Y,%20DuFort%20CC,%20Wan%20X,%20Mao%20Z,%20Liu%20Y,%20Zhu%20WG,%20et%20al.%20SMYD2%20inhibition-mediated%20hypomethylation%20of%20Ku70%20contributes%20to%20impaired%20nonhomologous%20end%20joining%20repair%20and%20antitumor%20immunity.%20Sci%20Adv.%202023;9:eade6624." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Wu L, Cao J, Cai WL, Lang SM, Horton JR, Jansen DJ, Liu ZZ, Chen JF, Zhang M, Mott BT, et al. KDM5 histone demethylases repress immune response via suppression of STING. PLoS Biol. 2018;16:e2006134.
</cite> [<a href="https://doi.org/10.1371/journal.pbio.2006134" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6095604/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30080846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20L,%20Cao%20J,%20Cai%20WL,%20Lang%20SM,%20Horton%20JR,%20Jansen%20DJ,%20Liu%20ZZ,%20Chen%20JF,%20Zhang%20M,%20Mott%20BT,%20et%20al.%20KDM5%20histone%20demethylases%20repress%20immune%20response%20via%20suppression%20of%20STING.%20PLoS%20Biol.%202018;16:e2006134." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Zhang W, Liu W, Jia L, Chen D, Chang I, Lake M, Bentolila LA, Wang CY. Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress. Mol Cell. 2021;81:2148-65.e9.</cite> [<a href="https://doi.org/10.1016/j.molcel.2021.02.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8141018/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33743195/" class="usa-link">PubMed</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Chen T, Xu ZG, Luo J, Manne RK, Wang Z, Hsu CC, Pan BS, Cai Z, Tsai PJ, Tsai YS, et al. NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance. Cell Metab. 2023;35:1782–98. e8.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2023.07.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10726430/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37586363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20T,%20Xu%20ZG,%20Luo%20J,%20Manne%20RK,%20Wang%20Z,%20Hsu%20CC,%20Pan%20BS,%20Cai%20Z,%20Tsai%20PJ,%20Tsai%20YS,%20et%20al.%20NSUN2%20is%20a%20glucose%20sensor%20suppressing%20cGAS/STING%20to%20maintain%20tumorigenesis%20and%20immunotherapy%20resistance.%20Cell%20Metab.%202023;35:1782%E2%80%9398.%20e8." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Gao Y, Zhang N, Zeng Z, Wu Q, Jiang X, Li S, Sun W, Zhang J, Li Y, Li J, et al. LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non-small cell lung cancer. Clin Transl Med. 2022;12:e792.
</cite> [<a href="https://doi.org/10.1002/ctm2.792" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9005924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35415876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20Y,%20Zhang%20N,%20Zeng%20Z,%20Wu%20Q,%20Jiang%20X,%20Li%20S,%20Sun%20W,%20Zhang%20J,%20Li%20Y,%20Li%20J,%20et%20al.%20LncRNA%20PCAT1%20activates%20SOX2%20and%20suppresses%20radioimmune%20responses%20via%20regulating%20cGAS/STING%20signalling%20in%20non-small%20cell%20lung%20cancer.%20Clin%20Transl%20Med.%202022;12:e792." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Ma F, Lei YY, Ding MG, Luo LH, Xie YC, Liu XL. LncRNA NEAT1 interacted with DNMT1 to regulate malignant phenotype of cancer cell and cytotoxic T cell infiltration via epigenetic Inhibition of p53, cGAS, and STING in lung cancer. Front Genet. 2020;11:250.
</cite> [<a href="https://doi.org/10.3389/fgene.2020.00250" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7136539/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32296457/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20F,%20Lei%20YY,%20Ding%20MG,%20Luo%20LH,%20Xie%20YC,%20Liu%20XL.%20LncRNA%20NEAT1%20interacted%20with%20DNMT1%20to%20regulate%20malignant%20phenotype%20of%20cancer%20cell%20and%20cytotoxic%20T%20cell%20infiltration%20via%20epigenetic%20Inhibition%20of%20p53,%20cGAS,%20and%20STING%20in%20lung%20cancer.%20Front%20Genet.%202020;11:250." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Mondal I, Das O, Sun R, Gao J, Yu B, Diaz A, Behnan J, Dubey A, Meng Z, Eskandar E, et al. PP2Ac deficiency enhances tumor immunogenicity by activating STING-Type I interferon signaling in glioblastoma. Cancer Res. 2023;83:2527–42.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-22-3382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10525036/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37219874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mondal%20I,%20Das%20O,%20Sun%20R,%20Gao%20J,%20Yu%20B,%20Diaz%20A,%20Behnan%20J,%20Dubey%20A,%20Meng%20Z,%20Eskandar%20E,%20et%20al.%20PP2Ac%20deficiency%20enhances%20tumor%20immunogenicity%20by%20activating%20STING-Type%20I%20interferon%20signaling%20in%20glioblastoma.%20Cancer%20Res.%202023;83:2527%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Zhang KM, Zhao DC, Li ZY, Wang Y, Liu JN, Du T, Zhou L, Chen YH, Yu QC, Chen QS et al. Inactivated cGAS-STING signaling facilitates endocrine resistance by forming a positive feedback loop with AKT kinase in ER + HER2- breast cancer. Adv Sci (Weinh). 2024:e2403592.</cite> [<a href="https://doi.org/10.1002/advs.202403592" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11425221/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39023171/" class="usa-link">PubMed</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Man CH, Lam W, Dang CC, Zeng XY, Zheng LC, Chan NN, Ng KL, Chan KC, Kwok TH, Ng TC, et al. Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML. Blood. 2023;142:2002–15.
</cite> [<a href="https://doi.org/10.1182/blood.2023019782" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37738460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Man%20CH,%20Lam%20W,%20Dang%20CC,%20Zeng%20XY,%20Zheng%20LC,%20Chan%20NN,%20Ng%20KL,%20Chan%20KC,%20Kwok%20TH,%20Ng%20TC,%20et%20al.%20Inhibition%20of%20PLK4%20remodels%20histone%20methylation%20and%20activates%20the%20immune%20response%20via%20the%20cGAS-STING%20pathway%20in%20TP53-mutated%20AML.%20Blood.%202023;142:2002%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Chen YH, Chen HH, Wang WJ, Chen HY, Huang WS, Kao CH, Lee SR, Yeat NY, Yan RL, Chan SJ, et al. TRABID Inhibition activates cGAS/STING-mediated anti-tumor immunity through mitosis and autophagy dysregulation. Nat Commun. 2023;14:3050.
</cite> [<a href="https://doi.org/10.1038/s41467-023-38784-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10220035/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37237031/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20YH,%20Chen%20HH,%20Wang%20WJ,%20Chen%20HY,%20Huang%20WS,%20Kao%20CH,%20Lee%20SR,%20Yeat%20NY,%20Yan%20RL,%20Chan%20SJ,%20et%20al.%20TRABID%20Inhibition%20activates%20cGAS/STING-mediated%20anti-tumor%20immunity%20through%20mitosis%20and%20autophagy%20dysregulation.%20Nat%20Commun.%202023;14:3050." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Fu L, Ding H, Bai Y, Cheng L, Hu S, Guo Q. IDI1 inhibits the cGAS-Sting signaling pathway in hepatocellular carcinoma. Heliyon. 2024;10:e27205.
</cite> [<a href="https://doi.org/10.1016/j.heliyon.2024.e27205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10915403/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38449594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fu%20L,%20Ding%20H,%20Bai%20Y,%20Cheng%20L,%20Hu%20S,%20Guo%20Q.%20IDI1%20inhibits%20the%20cGAS-Sting%20signaling%20pathway%20in%20hepatocellular%20carcinoma.%20Heliyon.%202024;10:e27205." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Li JY, Zhao Y, Gong S, Wang MM, Liu X, He QM, Li YQ, Huang SY, Qiao H, Tan XR, et al. TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models. Nat Commun. 2023;14:865.
</cite> [<a href="https://doi.org/10.1038/s41467-023-36523-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9935546/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36797289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20JY,%20Zhao%20Y,%20Gong%20S,%20Wang%20MM,%20Liu%20X,%20He%20QM,%20Li%20YQ,%20Huang%20SY,%20Qiao%20H,%20Tan%20XR,%20et%20al.%20TRIM21%20inhibits%20irradiation-induced%20mitochondrial%20DNA%20release%20and%20impairs%20antitumour%20immunity%20in%20nasopharyngeal%20carcinoma%20tumour%20models.%20Nat%20Commun.%202023;14:865." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Liu X, Cen X, Wu R, Chen Z, Xie Y, Wang F, Shan B, Zeng L, Zhou J, Xie B, et al. ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint Blockade. Nat Commun. 2023;14:4066.
</cite> [<a href="https://doi.org/10.1038/s41467-023-39920-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10333294/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37429863/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20X,%20Cen%20X,%20Wu%20R,%20Chen%20Z,%20Xie%20Y,%20Wang%20F,%20Shan%20B,%20Zeng%20L,%20Zhou%20J,%20Xie%20B,%20et%20al.%20ARIH1%20activates%20STING-mediated%20T-cell%20activation%20and%20sensitizes%20tumors%20to%20immune%20checkpoint%20Blockade.%20Nat%20Commun.%202023;14:4066." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Fan Y, Gao Y, Nie L, Hou T, Dan W, Wang Z, Liu T, Wei Y, Wang Y, Liu B et al. Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy. Mol Cell. 2023;83:3520-32.e7.</cite> [<a href="https://doi.org/10.1016/j.molcel.2023.09.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37802025/" class="usa-link">PubMed</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Kim H, Kim H, Feng Y, Li Y, Tamiya H, Tocci S, Ronai ZA. PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity. Sci Transl Med. 2020;12:eaaz5683.
</cite> [<a href="https://doi.org/10.1126/scitranslmed.aaz5683" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7508354/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32641491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20H,%20Kim%20H,%20Feng%20Y,%20Li%20Y,%20Tamiya%20H,%20Tocci%20S,%20Ronai%20ZA.%20PRMT5%20control%20of%20cGAS/STING%20and%20NLRC5%20pathways%20defines%20melanoma%20response%20to%20antitumor%20immunity.%20Sci%20Transl%20Med.%202020;12:eaaz5683." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Liu J, Bu X, Chu C, Dai X, Asara JM, Sicinski P, Freeman GJ, Wei W. PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity. Nat Commun. 2023;14:2806.
</cite> [<a href="https://doi.org/10.1038/s41467-023-38443-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10188589/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37193698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20J,%20Bu%20X,%20Chu%20C,%20Dai%20X,%20Asara%20JM,%20Sicinski%20P,%20Freeman%20GJ,%20Wei%20W.%20PRMT1%20mediated%20methylation%20of%20cGAS%20suppresses%20anti-tumor%20immunity.%20Nat%20Commun.%202023;14:2806." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Rao K, Zhang X, Luo Y, Xia Q, Jin Y, He J. Lactylation orchestrates ubiquitin-independent degradation of cGAS and promotes tumor growth. Cell Rep. 2025;44:115441.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2025.115441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40106438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rao%20K,%20Zhang%20X,%20Luo%20Y,%20Xia%20Q,%20Jin%20Y,%20He%20J.%20Lactylation%20orchestrates%20ubiquitin-independent%20degradation%20of%20cGAS%20and%20promotes%20tumor%20growth.%20Cell%20Rep.%202025;44:115441." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Saha S, Ghosh M, Li J, Wen A, Galluzzi L, Martinez LA, Montrose DC. Serine depletion promotes antitumor immunity by activating mitochondrial DNA-Mediated cGAS-STING signaling. Cancer Res. 2024;84:2645–59.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-23-1788" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11326969/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38861367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saha%20S,%20Ghosh%20M,%20Li%20J,%20Wen%20A,%20Galluzzi%20L,%20Martinez%20LA,%20Montrose%20DC.%20Serine%20depletion%20promotes%20antitumor%20immunity%20by%20activating%20mitochondrial%20DNA-Mediated%20cGAS-STING%20signaling.%20Cancer%20Res.%202024;84:2645%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Xiang W, Lv H, Xing F, Sun X, Ma Y, Wu L, Lv G, Zong Q, Wang L, Wu Z, et al. Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation. Sci Adv. 2023;9:eadi2465.
</cite> [<a href="https://doi.org/10.1126/sciadv.adi2465" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10699784/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38055816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiang%20W,%20Lv%20H,%20Xing%20F,%20Sun%20X,%20Ma%20Y,%20Wu%20L,%20Lv%20G,%20Zong%20Q,%20Wang%20L,%20Wu%20Z,%20et%20al.%20Inhibition%20of%20ACLY%20overcomes%20cancer%20immunotherapy%20resistance%20via%20polyunsaturated%20fatty%20acids%20peroxidation%20and%20cGAS-STING%20activation.%20Sci%20Adv.%202023;9:eadi2465." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Duan Y, Hu Z, Han P, Lei B, Wang S, Wang Z, Hou Y, Lin Y, Li M, Xiao L et al. ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion. Nat Cell Biol. 2025.</cite> [<a href="https://doi.org/10.1038/s41556-025-01627-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40033100/" class="usa-link">PubMed</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Jacoberger-Foissac C, Cousineau I, Bareche Y, Allard D, Chrobak P, Allard B, Pommey S, Messaoudi N, McNicoll Y, Soucy G, et al. CD73 inhibits cGAS-STING and cooperates with CD39 to promote pancreatic cancer. Cancer Immunol Res. 2023;11:56–71.
</cite> [<a href="https://doi.org/10.1158/2326-6066.CIR-22-0260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9812927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36409930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jacoberger-Foissac%20C,%20Cousineau%20I,%20Bareche%20Y,%20Allard%20D,%20Chrobak%20P,%20Allard%20B,%20Pommey%20S,%20Messaoudi%20N,%20McNicoll%20Y,%20Soucy%20G,%20et%20al.%20CD73%20inhibits%20cGAS-STING%20and%20cooperates%20with%20CD39%20to%20promote%20pancreatic%20cancer.%20Cancer%20Immunol%20Res.%202023;11:56%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Wang Y, Zhu Y, Cao Y, Li Y, Zhang Z, Fleishman JS, Cheng S, Chen J, Ding M. The activation of cGAS-STING pathway offers novel therapeutic opportunities in cancers. Front Immunol. 2025;16:1579832.
</cite> [<a href="https://doi.org/10.3389/fimmu.2025.1579832" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12183172/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40552295/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Zhu%20Y,%20Cao%20Y,%20Li%20Y,%20Zhang%20Z,%20Fleishman%20JS,%20Cheng%20S,%20Chen%20J,%20Ding%20M.%20The%20activation%20of%20cGAS-STING%20pathway%20offers%20novel%20therapeutic%20opportunities%20in%20cancers.%20Front%20Immunol.%202025;16:1579832." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–72.
</cite> [<a href="https://doi.org/10.1016/j.cell.2012.03.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3367386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22632970/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dixon%20SJ,%20Lemberg%20KM,%20Lamprecht%20MR,%20Skouta%20R,%20Zaitsev%20EM,%20Gleason%20CE,%20Patel%20DN,%20Bauer%20AJ,%20Cantley%20AM,%20Yang%20WS,%20et%20al.%20Ferroptosis:%20an%20iron-dependent%20form%20of%20nonapoptotic%20cell%20death.%20Cell.%202012;149:1060%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401–21.
</cite> [<a href="https://doi.org/10.1016/j.cell.2022.06.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9273022/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35803244/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stockwell%20BR.%20Ferroptosis%20turns%2010:%20emerging%20mechanisms,%20physiological%20functions,%20and%20therapeutic%20applications.%20Cell.%202022;185:2401%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Yin L, Liu P, Jin Y, Ning Z, Yang Y, Gao H. Ferroptosis-related small-molecule compounds in cancer therapy: strategies and applications. Eur J Med Chem. 2022;244:114861.
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2022.114861" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36332549/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yin%20L,%20Liu%20P,%20Jin%20Y,%20Ning%20Z,%20Yang%20Y,%20Gao%20H.%20Ferroptosis-related%20small-molecule%20compounds%20in%20cancer%20therapy:%20strategies%20and%20applications.%20Eur%20J%20Med%20Chem.%202022;244:114861." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Tang D, Kroemer G, Ferroptosis. Curr Biol. 2020;30:R1292. -1292R1297.
</cite> [<a href="https://doi.org/10.1016/j.cub.2020.09.068" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33142092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tang%20D,%20Kroemer%20G,%20Ferroptosis.%20Curr%20Biol.%202020;30:R1292.%20-1292R1297." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Chen X, Kang R, Kroemer G, Tang D. Ferroptosis in infection, inflammation, and immunity. J Exp Med. 2021;218.</cite> [<a href="https://doi.org/10.1084/jem.20210518" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8126980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33978684/" class="usa-link">PubMed</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17:2054–81.
</cite> [<a href="https://doi.org/10.1080/15548627.2020.1810918" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8496712/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32804006/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20X,%20Li%20J,%20Kang%20R,%20Klionsky%20DJ,%20Tang%20D.%20Ferroptosis:%20machinery%20and%20regulation.%20Autophagy.%202021;17:2054%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35:830–49.
</cite> [<a href="https://doi.org/10.1016/j.ccell.2019.04.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31105042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hassannia%20B,%20Vandenabeele%20P,%20Vanden%20Berghe%20T.%20Targeting%20ferroptosis%20to%20iron%20out%20cancer.%20Cancer%20Cell.%202019;35:830%E2%80%9349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 2022;82:2215–27.
</cite> [<a href="https://doi.org/10.1016/j.molcel.2022.03.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9233073/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35390277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liang%20D,%20Minikes%20AM,%20Jiang%20X.%20Ferroptosis%20at%20the%20intersection%20of%20lipid%20metabolism%20and%20cellular%20signaling.%20Mol%20Cell.%202022;82:2215%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Jacquemyn J, Ralhan I, Ioannou MS. Driving factors of neuronal ferroptosis. Trends Cell Biol. 2024:S0962-8924(24)00022 – 9 [pii].</cite> [<a href="https://doi.org/10.1016/j.tcb.2024.01.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38395733/" class="usa-link">PubMed</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Chen X, Yu C, Kang R, Tang D. Iron metabolism in ferroptosis. Front Cell Dev Biol. 2020;8:590226.
</cite> [<a href="https://doi.org/10.3389/fcell.2020.590226" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7575751/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33117818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20X,%20Yu%20C,%20Kang%20R,%20Tang%20D.%20Iron%20metabolism%20in%20ferroptosis.%20Front%20Cell%20Dev%20Biol.%202020;8:590226." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>David S, Jhelum P, Ryan F, Jeong SY, Kroner A. Dysregulation of iron homeostasis in the central nervous system and the role of ferroptosis in neurodegenerative disorders. Antioxid Redox Signal. 2022;37:150–70.
</cite> [<a href="https://doi.org/10.1089/ars.2021.0218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34569265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?David%20S,%20Jhelum%20P,%20Ryan%20F,%20Jeong%20SY,%20Kroner%20A.%20Dysregulation%20of%20iron%20homeostasis%20in%20the%20central%20nervous%20system%20and%20the%20role%20of%20ferroptosis%20in%20neurodegenerative%20disorders.%20Antioxid%20Redox%20Signal.%202022;37:150%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>Dixon SJ, Winter GE, Musavi LS, Lee ED, Snijder B, Rebsamen M, Superti-Furga G, Stockwell BR. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem Biol. 2015;10:1604–9.
</cite> [<a href="https://doi.org/10.1021/acschembio.5b00245" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4509420/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25965523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dixon%20SJ,%20Winter%20GE,%20Musavi%20LS,%20Lee%20ED,%20Snijder%20B,%20Rebsamen%20M,%20Superti-Furga%20G,%20Stockwell%20BR.%20Human%20haploid%20cell%20genetics%20reveals%20roles%20for%20lipid%20metabolism%20genes%20in%20nonapoptotic%20cell%20death.%20ACS%20Chem%20Biol.%202015;10:1604%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91–8.
</cite> [<a href="https://doi.org/10.1038/nchembio.2239" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5610546/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27842070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Doll%20S,%20Proneth%20B,%20Tyurina%20YY,%20Panzilius%20E,%20Kobayashi%20S,%20Ingold%20I,%20Irmler%20M,%20Beckers%20J,%20Aichler%20M,%20Walch%20A,%20et%20al.%20ACSL4%20dictates%20ferroptosis%20sensitivity%20by%20shaping%20cellular%20lipid%20composition.%20Nat%20Chem%20Biol.%202017;13:91%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR96">
<span class="label">96.</span><cite>Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81–90.
</cite> [<a href="https://doi.org/10.1038/nchembio.2238" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5506843/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27842066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kagan%20VE,%20Mao%20G,%20Qu%20F,%20Angeli%20JP,%20Doll%20S,%20Croix%20CS,%20Dar%20HH,%20Liu%20B,%20Tyurin%20VA,%20Ritov%20VB,%20et%20al.%20Oxidized%20arachidonic%20and%20adrenic%20PEs%20navigate%20cells%20to%20ferroptosis.%20Nat%20Chem%20Biol.%202017;13:81%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>Hadian K, Stockwell BR, SnapShot. Ferroptosis Cell. 2020;181:1188–e11881.
</cite> [<a href="https://doi.org/10.1016/j.cell.2020.04.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8157339/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32470402/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hadian%20K,%20Stockwell%20BR,%20SnapShot.%20Ferroptosis%20Cell.%202020;181:1188%E2%80%93e11881." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR98">
<span class="label">98.</span><cite>Shah R, Shchepinov MS, Pratt DA. Resolving the role of lipoxygenases in the initiation and execution of ferroptosis. ACS Cent Sci. 2018;4:387–96.
</cite> [<a href="https://doi.org/10.1021/acscentsci.7b00589" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5879472/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29632885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shah%20R,%20Shchepinov%20MS,%20Pratt%20DA.%20Resolving%20the%20role%20of%20lipoxygenases%20in%20the%20initiation%20and%20execution%20of%20ferroptosis.%20ACS%20Cent%20Sci.%202018;4:387%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Zou Y, Li H, Graham ET, Deik AA, Eaton JK, Wang W, Sandoval-Gomez G, Clish CB, Doench JG, Schreiber SL. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16:302–9.
</cite> [<a href="https://doi.org/10.1038/s41589-020-0472-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7353921/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32080622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zou%20Y,%20Li%20H,%20Graham%20ET,%20Deik%20AA,%20Eaton%20JK,%20Wang%20W,%20Sandoval-Gomez%20G,%20Clish%20CB,%20Doench%20JG,%20Schreiber%20SL.%20Cytochrome%20P450%20oxidoreductase%20contributes%20to%20phospholipid%20peroxidation%20in%20ferroptosis.%20Nat%20Chem%20Biol.%202020;16:302%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR100">
<span class="label">100.</span><cite>Conrad M, Pratt DA. The chemical basis of ferroptosis. Nat Chem Biol. 2019;15:1137–47.
</cite> [<a href="https://doi.org/10.1038/s41589-019-0408-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31740834/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Conrad%20M,%20Pratt%20DA.%20The%20chemical%20basis%20of%20ferroptosis.%20Nat%20Chem%20Biol.%202019;15:1137%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR101">
<span class="label">101.</span><cite>Dai E, Chen X, Linkermann A, Jiang X, Kang R, Kagan VE, Bayir H, Yang WS, Garcia-Saez AJ, Ioannou MS et al. A guideline on the molecular ecosystem regulating ferroptosis. Nat Cell Biol. 2024.</cite> [<a href="https://doi.org/10.1038/s41556-024-01360-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11650678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38424270/" class="usa-link">PubMed</a>]</li>
<li id="CR102">
<span class="label">102.</span><cite>Stockwell BR, Jiang X. The chemistry and biology of ferroptosis. Cell Chem Biol. 2020;27:365–75.
</cite> [<a href="https://doi.org/10.1016/j.chembiol.2020.03.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7204503/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32294465/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stockwell%20BR,%20Jiang%20X.%20The%20chemistry%20and%20biology%20of%20ferroptosis.%20Cell%20Chem%20Biol.%202020;27:365%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438.
</cite> [<a href="https://doi.org/10.1155/2014/360438" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4066722/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24999379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ayala%20A,%20Mu%C3%B1oz%20MF,%20Arg%C3%BCelles%20S.%20Lipid%20peroxidation:%20production,%20metabolism,%20and%20signaling%20mechanisms%20of%20malondialdehyde%20and%204-hydroxy-2-nonenal.%20Oxid%20Med%20Cell%20Longev.%202014;2014:360438." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR104">
<span class="label">104.</span><cite>Dos Santos AF, Fazeli G, Xavier da Silva TN, Friedmann Angeli JP. Ferroptosis: mechanisms and implications for cancer development and therapy response. Trends Cell Biol. 2023.</cite> [<a href="https://doi.org/10.1016/j.tcb.2023.04.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37230924/" class="usa-link">PubMed</a>]</li>
<li id="CR105">
<span class="label">105.</span><cite>Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, Choi AM. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal. 2007;9:49–89.
</cite> [<a href="https://doi.org/10.1089/ars.2007.9.49" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17115887/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ryter%20SW,%20Kim%20HP,%20Hoetzel%20A,%20Park%20JW,%20Nakahira%20K,%20Wang%20X,%20Choi%20AM.%20Mechanisms%20of%20cell%20death%20in%20oxidative%20stress.%20Antioxid%20Redox%20Signal.%202007;9:49%E2%80%9389." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR106">
<span class="label">106.</span><cite>Bao WD, Pang P, Zhou XT, Hu F, Xiong W, Chen K, Wang J, Wang F, Xie D, Hu YZ, et al. Loss of Ferroportin induces memory impairment by promoting ferroptosis in alzheimer’s disease. Cell Death Differ. 2021;28:1548–62.
</cite> [<a href="https://doi.org/10.1038/s41418-020-00685-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8166828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33398092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bao%20WD,%20Pang%20P,%20Zhou%20XT,%20Hu%20F,%20Xiong%20W,%20Chen%20K,%20Wang%20J,%20Wang%20F,%20Xie%20D,%20Hu%20YZ,%20et%20al.%20Loss%20of%20Ferroportin%20induces%20memory%20impairment%20by%20promoting%20ferroptosis%20in%20alzheimer%E2%80%99s%20disease.%20Cell%20Death%20Differ.%202021;28:1548%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR107">
<span class="label">107.</span><cite>Chen PH, Wu J, Ding CC, Lin CC, Pan S, Bossa N, Xu Y, Yang WH, Mathey-Prevot B, Chi JT. Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism. Cell Death Differ. 2020;27:1008–22.
</cite> [<a href="https://doi.org/10.1038/s41418-019-0393-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7206124/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31320750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20PH,%20Wu%20J,%20Ding%20CC,%20Lin%20CC,%20Pan%20S,%20Bossa%20N,%20Xu%20Y,%20Yang%20WH,%20Mathey-Prevot%20B,%20Chi%20JT.%20Kinome%20screen%20of%20ferroptosis%20reveals%20a%20novel%20role%20of%20ATM%20in%20regulating%20iron%20metabolism.%20Cell%20Death%20Differ.%202020;27:1008%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR108">
<span class="label">108.</span><cite>Geng N, Shi BJ, Li SL, Zhong ZY, Li YC, Xua WL, Zhou H, Cai JH. Knockdown of Ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells. Eur Rev Med Pharmacol Sci. 2018;22:3826–36.
</cite> [<a href="https://doi.org/10.26355/eurrev_201806_15267" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29949159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Geng%20N,%20Shi%20BJ,%20Li%20SL,%20Zhong%20ZY,%20Li%20YC,%20Xua%20WL,%20Zhou%20H,%20Cai%20JH.%20Knockdown%20of%20Ferroportin%20accelerates%20erastin-induced%20ferroptosis%20in%20neuroblastoma%20cells.%20Eur%20Rev%20Med%20Pharmacol%20Sci.%202018;22:3826%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR109">
<span class="label">109.</span><cite>Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X. Ferroptosis is an autophagic cell death process. Cell Res. 2016;26:1021–32.
</cite> [<a href="https://doi.org/10.1038/cr.2016.95" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5034113/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27514700/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20M,%20Monian%20P,%20Pan%20Q,%20Zhang%20W,%20Xiang%20J,%20Jiang%20X.%20Ferroptosis%20is%20an%20autophagic%20cell%20death%20process.%20Cell%20Res.%202016;26:1021%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR110">
<span class="label">110.</span><cite>Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ 3rd, Kang R, Tang D. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12:1425–8.
</cite> [<a href="https://doi.org/10.1080/15548627.2016.1187366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4968231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27245739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hou%20W,%20Xie%20Y,%20Song%20X,%20Sun%20X,%20Lotze%20MT,%20Zeh%20HJ%203rd,%20Kang%20R,%20Tang%20D.%20Autophagy%20promotes%20ferroptosis%20by%20degradation%20of%20ferritin.%20Autophagy.%202016;12:1425%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR111">
<span class="label">111.</span><cite>Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59:298–308.
</cite> [<a href="https://doi.org/10.1016/j.molcel.2015.06.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4506736/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26166707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20M,%20Monian%20P,%20Quadri%20N,%20Ramasamy%20R,%20Jiang%20X.%20Glutaminolysis%20and%20transferrin%20regulate%20ferroptosis.%20Mol%20Cell.%202015;59:298%E2%80%93308." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR112">
<span class="label">112.</span><cite>Gu Y, Li Y, Wang J, Zhang L, Zhang J, Wang Y. Targeting ferroptosis: paving new roads for drug design and discovery. Eur J Med Chem. 2023;247:115015.
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2022.115015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36543035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gu%20Y,%20Li%20Y,%20Wang%20J,%20Zhang%20L,%20Zhang%20J,%20Wang%20Y.%20Targeting%20ferroptosis:%20paving%20new%20roads%20for%20drug%20design%20and%20discovery.%20Eur%20J%20Med%20Chem.%202023;247:115015." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR113">
<span class="label">113.</span><cite>Wang Y, Wu S, Li Q, Sun H, Wang H. Pharmacological Inhibition of ferroptosis as a therapeutic target for neurodegenerative diseases and strokes. Adv Sci (Weinh). 2023;10:e2300325.
</cite> [<a href="https://doi.org/10.1002/advs.202300325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10460905/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37341302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Wu%20S,%20Li%20Q,%20Sun%20H,%20Wang%20H.%20Pharmacological%20Inhibition%20of%20ferroptosis%20as%20a%20therapeutic%20target%20for%20neurodegenerative%20diseases%20and%20strokes.%20Adv%20Sci%20(Weinh).%202023;10:e2300325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR114">
<span class="label">114.</span><cite>Sun Y, Xia X, Basnet D, Zheng JC, Huang J, Liu J. Mechanisms of ferroptosis and emerging links to the pathology of neurodegenerative diseases. Front Aging Neurosci. 2022;14:904152.
</cite> [<a href="https://doi.org/10.3389/fnagi.2022.904152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9273851/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35837484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20Y,%20Xia%20X,%20Basnet%20D,%20Zheng%20JC,%20Huang%20J,%20Liu%20J.%20Mechanisms%20of%20ferroptosis%20and%20emerging%20links%20to%20the%20pathology%20of%20neurodegenerative%20diseases.%20Front%20Aging%20Neurosci.%202022;14:904152." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR115">
<span class="label">115.</span><cite>Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688–92.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1705-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6883167/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31634900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bersuker%20K,%20Hendricks%20JM,%20Li%20Z,%20Magtanong%20L,%20Ford%20B,%20Tang%20PH,%20Roberts%20MA,%20Tong%20B,%20Maimone%20TJ,%20Zoncu%20R,%20et%20al.%20The%20CoQ%20oxidoreductase%20FSP1%20acts%20parallel%20to%20GPX4%20to%20inhibit%20ferroptosis.%20Nature.%202019;575:688%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR116">
<span class="label">116.</span><cite>Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, Goya Grocin A, da Xavier TN, Panzilius E, Scheel CH, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693–8.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1707-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31634899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Doll%20S,%20Freitas%20FP,%20Shah%20R,%20Aldrovandi%20M,%20da%20Silva%20MC,%20Ingold%20I,%20Goya%20Grocin%20A,%20da%20Xavier%20TN,%20Panzilius%20E,%20Scheel%20CH,%20et%20al.%20FSP1%20is%20a%20glutathione-independent%20ferroptosis%20suppressor.%20Nature.%202019;575:693%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR117">
<span class="label">117.</span><cite>Nakamura T, Hipp C, Santos Dias Mourão A, Borggräfe J, Aldrovandi M, Henkelmann B, Wanninger J, Mishima E, Lytton E, Emler D, et al. Phase separation of FSP1 promotes ferroptosis. Nature. 2023;619:371–7.
</cite> [<a href="https://doi.org/10.1038/s41586-023-06255-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10338336/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37380771/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nakamura%20T,%20Hipp%20C,%20Santos%20Dias%20Mour%C3%A3o%20A,%20Borggr%C3%A4fe%20J,%20Aldrovandi%20M,%20Henkelmann%20B,%20Wanninger%20J,%20Mishima%20E,%20Lytton%20E,%20Emler%20D,%20et%20al.%20Phase%20separation%20of%20FSP1%20promotes%20ferroptosis.%20Nature.%202023;619:371%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR118">
<span class="label">118.</span><cite>Kraft V, Bezjian CT, Pfeiffer S, Ringelstetter L, Müller C, Zandkarimi F, Merl-Pham J, Bao X, Anastasov N, Kössl J, et al. GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6:41–53.
</cite> [<a href="https://doi.org/10.1021/acscentsci.9b01063" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6978838/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31989025/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kraft%20V,%20Bezjian%20CT,%20Pfeiffer%20S,%20Ringelstetter%20L,%20M%C3%BCller%20C,%20Zandkarimi%20F,%20Merl-Pham%20J,%20Bao%20X,%20Anastasov%20N,%20K%C3%B6ssl%20J,%20et%20al.%20GTP%20cyclohydrolase%201/tetrahydrobiopterin%20counteract%20ferroptosis%20through%20lipid%20remodeling.%20ACS%20Cent%20Sci.%202020;6:41%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR119">
<span class="label">119.</span><cite>Soula M, Weber RA, Zilka O, Alwaseem H, La K, Yen F, Molina H, Garcia-Bermudez J, Pratt DA, Birsoy K. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol. 2020;16:1351–60.
</cite> [<a href="https://doi.org/10.1038/s41589-020-0613-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8299533/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32778843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Soula%20M,%20Weber%20RA,%20Zilka%20O,%20Alwaseem%20H,%20La%20K,%20Yen%20F,%20Molina%20H,%20Garcia-Bermudez%20J,%20Pratt%20DA,%20Birsoy%20K.%20Metabolic%20determinants%20of%20cancer%20cell%20sensitivity%20to%20canonical%20ferroptosis%20inducers.%20Nat%20Chem%20Biol.%202020;16:1351%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR120">
<span class="label">120.</span><cite>Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, Koppula P, Wu S, Zhuang L, Fang B, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593:586–90.
</cite> [<a href="https://doi.org/10.1038/s41586-021-03539-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8895686/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33981038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mao%20C,%20Liu%20X,%20Zhang%20Y,%20Lei%20G,%20Yan%20Y,%20Lee%20H,%20Koppula%20P,%20Wu%20S,%20Zhuang%20L,%20Fang%20B,%20et%20al.%20DHODH-mediated%20ferroptosis%20defence%20is%20a%20targetable%20vulnerability%20in%20cancer.%20Nature.%202021;593:586%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR121">
<span class="label">121.</span><cite>Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, Cai Y, Gu W, Stockwell BR, Jiang X. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186(13):2748–64.e22.</cite> [<a href="https://doi.org/10.1016/j.cell.2023.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10330611/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37267948/" class="usa-link">PubMed</a>]</li>
<li id="CR122">
<span class="label">122.</span><cite>Freitas FP, Alborzinia H, Dos Santos AF, Nepachalovich P, Pedrera L, Zilka O, Inague A, Klein C, Aroua N, Kaushal K, et al. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature. 2024;626:401–10.
</cite> [<a href="https://doi.org/10.1038/s41586-023-06878-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38297129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Freitas%20FP,%20Alborzinia%20H,%20Dos%20Santos%20AF,%20Nepachalovich%20P,%20Pedrera%20L,%20Zilka%20O,%20Inague%20A,%20Klein%20C,%20Aroua%20N,%20Kaushal%20K,%20et%20al.%207-Dehydrocholesterol%20is%20an%20endogenous%20suppressor%20of%20ferroptosis.%20Nature.%202024;626:401%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR123">
<span class="label">123.</span><cite>Li Y, Ran Q, Duan Q, Jin J, Wang Y, Yu L, Wang C, Zhu Z, Chen X, Weng L, et al. 7-Dehydrocholesterol dictates ferroptosis sensitivity. Nature. 2024;626:411–8.
</cite> [<a href="https://doi.org/10.1038/s41586-023-06983-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11298758/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38297130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Y,%20Ran%20Q,%20Duan%20Q,%20Jin%20J,%20Wang%20Y,%20Yu%20L,%20Wang%20C,%20Zhu%20Z,%20Chen%20X,%20Weng%20L,%20et%20al.%207-Dehydrocholesterol%20dictates%20ferroptosis%20sensitivity.%20Nature.%202024;626:411%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR124">
<span class="label">124.</span><cite>Lan J, Cai D, Gou S, Bai Y, Lei H, Li Y, Chen Y, Zhao Y, Shen J, Wu X, et al. The dynamic role of ferroptosis in cancer immunoediting: implications for immunotherapy. Pharmacol Res. 2025;214:107674.
</cite> [<a href="https://doi.org/10.1016/j.phrs.2025.107674" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40020885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lan%20J,%20Cai%20D,%20Gou%20S,%20Bai%20Y,%20Lei%20H,%20Li%20Y,%20Chen%20Y,%20Zhao%20Y,%20Shen%20J,%20Wu%20X,%20et%20al.%20The%20dynamic%20role%20of%20ferroptosis%20in%20cancer%20immunoediting:%20implications%20for%20immunotherapy.%20Pharmacol%20Res.%202025;214:107674." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR125">
<span class="label">125.</span><cite>Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, Sun Y, Zeng F, Chen X, Deng G. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9:55.
</cite> [<a href="https://doi.org/10.1038/s41392-024-01769-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10920854/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38453898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20Q,%20Meng%20Y,%20Li%20D,%20Yao%20L,%20Le%20J,%20Liu%20Y,%20Sun%20Y,%20Zeng%20F,%20Chen%20X,%20Deng%20G.%20Ferroptosis%20in%20cancer:%20from%20molecular%20mechanisms%20to%20therapeutic%20strategies.%20Signal%20Transduct%20Target%20Ther.%202024;9:55." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR126">
<span class="label">126.</span><cite>Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21:47.
</cite> [<a href="https://doi.org/10.1186/s12943-022-01530-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8840702/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35151318/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20C,%20Liu%20X,%20Jin%20S,%20Chen%20Y,%20Guo%20R.%20Ferroptosis%20in%20cancer%20therapy:%20a%20novel%20approach%20to%20reversing%20drug%20resistance.%20Mol%20Cancer.%202022;21:47." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR127">
<span class="label">127.</span><cite>Wang Y, Hu J, Fleishman JS, Li Y, Ren Z, Wang J, Feng Y, Chen J, Wang H. Inducing ferroptosis by traditional medicines: a novel approach to reverse chemoresistance in lung cancer. Front Pharmacol. 2024;15:1290183.
</cite> [<a href="https://doi.org/10.3389/fphar.2024.1290183" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11158628/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38855750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Hu%20J,%20Fleishman%20JS,%20Li%20Y,%20Ren%20Z,%20Wang%20J,%20Feng%20Y,%20Chen%20J,%20Wang%20H.%20Inducing%20ferroptosis%20by%20traditional%20medicines:%20a%20novel%20approach%20to%20reverse%20chemoresistance%20in%20lung%20cancer.%20Front%20Pharmacol.%202024;15:1290183." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR128">
<span class="label">128.</span><cite>Koeberle SC, Kipp AP, Stuppner H, Koeberle A. Ferroptosis-modulating small molecules for targeting drug-resistant cancer: challenges and opportunities in manipulating redox signaling. Med Res Rev. 2023;43:614–82.
</cite> [<a href="https://doi.org/10.1002/med.21933" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10947485/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36658724/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Koeberle%20SC,%20Kipp%20AP,%20Stuppner%20H,%20Koeberle%20A.%20Ferroptosis-modulating%20small%20molecules%20for%20targeting%20drug-resistant%20cancer:%20challenges%20and%20opportunities%20in%20manipulating%20redox%20signaling.%20Med%20Res%20Rev.%202023;43:614%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR129">
<span class="label">129.</span><cite>Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, Wang H. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat. 2023;66:100916.
</cite> [<a href="https://doi.org/10.1016/j.drup.2022.100916" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36610291/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Wu%20X,%20Ren%20Z,%20Li%20Y,%20Zou%20W,%20Chen%20J,%20Wang%20H.%20Overcoming%20cancer%20chemotherapy%20resistance%20by%20the%20induction%20of%20ferroptosis.%20Drug%20Resist%20Updat.%202023;66:100916." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR130">
<span class="label">130.</span><cite>Zhang T, Sun B, Zhong C, Xu K, Wang Z, Hofman P, Nagano T, Legras A, Breadner D, Ricciuti B, et al. Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma. Transl Lung Cancer Res. 2021;10:1857–72.
</cite> [<a href="https://doi.org/10.21037/tlcr-21-303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8107764/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34012798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20T,%20Sun%20B,%20Zhong%20C,%20Xu%20K,%20Wang%20Z,%20Hofman%20P,%20Nagano%20T,%20Legras%20A,%20Breadner%20D,%20Ricciuti%20B,%20et%20al.%20Targeting%20histone%20deacetylase%20enhances%20the%20therapeutic%20effect%20of%20Erastin-induced%20ferroptosis%20in%20EGFR-activating%20mutant%20lung%20adenocarcinoma.%20Transl%20Lung%20Cancer%20Res.%202021;10:1857%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR131">
<span class="label">131.</span><cite>Markowitsch SD, Schupp P, Lauckner J, Vakhrusheva O, Slade KS, Mager R, Efferth T, Haferkamp A, Juengel E. Artesunate inhibits growth of Sunitinib-Resistant renal cell carcinoma cells through cell cycle arrest and induction of ferroptosis. Cancers (Basel). 2020;12:3150.
</cite> [<a href="https://doi.org/10.3390/cancers12113150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7692972/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33121039/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Markowitsch%20SD,%20Schupp%20P,%20Lauckner%20J,%20Vakhrusheva%20O,%20Slade%20KS,%20Mager%20R,%20Efferth%20T,%20Haferkamp%20A,%20Juengel%20E.%20Artesunate%20inhibits%20growth%20of%20Sunitinib-Resistant%20renal%20cell%20carcinoma%20cells%20through%20cell%20cycle%20arrest%20and%20induction%20of%20ferroptosis.%20Cancers%20(Basel).%202020;12:3150." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR132">
<span class="label">132.</span><cite>Jiang Z, Lim SO, Yan M, Hsu JL, Yao J, Wei Y, Chang SS, Yamaguchi H, Lee HH, Ke B, et al. TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. J Clin Invest. 2021;131:e139434.
</cite> [<a href="https://doi.org/10.1172/JCI139434" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8262501/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33855973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20Z,%20Lim%20SO,%20Yan%20M,%20Hsu%20JL,%20Yao%20J,%20Wei%20Y,%20Chang%20SS,%20Yamaguchi%20H,%20Lee%20HH,%20Ke%20B,%20et%20al.%20TYRO3%20induces%20anti-PD-1/PD-L1%20therapy%20resistance%20by%20limiting%20innate%20immunity%20and%20tumoral%20ferroptosis.%20J%20Clin%20Invest.%202021;131:e139434." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR133">
<span class="label">133.</span><cite>Luo Y, Bai XY, Zhang L, Hu QQ, Zhang N, Cheng JZ, Hou MZ, Liu XL. Ferroptosis in cancer therapy: mechanisms, small molecule inducers, and novel approaches. Drug Des Devel Ther. 2024;18:2485–529.
</cite> [<a href="https://doi.org/10.2147/DDDT.S472178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11198730/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38919962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luo%20Y,%20Bai%20XY,%20Zhang%20L,%20Hu%20QQ,%20Zhang%20N,%20Cheng%20JZ,%20Hou%20MZ,%20Liu%20XL.%20Ferroptosis%20in%20cancer%20therapy:%20mechanisms,%20small%20molecule%20inducers,%20and%20novel%20approaches.%20Drug%20Des%20Devel%20Ther.%202024;18:2485%E2%80%93529." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR134">
<span class="label">134.</span><cite>Luo L, Wang H, Tian W, Li X, Zhu Z, Huang R, Luo H. Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications. Theranostics. 2021;11:9937–52.
</cite> [<a href="https://doi.org/10.7150/thno.65480" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8581438/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34815796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luo%20L,%20Wang%20H,%20Tian%20W,%20Li%20X,%20Zhu%20Z,%20Huang%20R,%20Luo%20H.%20Targeting%20ferroptosis-based%20cancer%20therapy%20using%20nanomaterials:%20strategies%20and%20applications.%20Theranostics.%202021;11:9937%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR135">
<span class="label">135.</span><cite>Lu J, Tai Z, Wu J, Li L, Zhang T, Liu J, Zhu Q, Chen Z. Nanomedicine-induced programmed cell death enhances tumor immunotherapy. J Adv Res. 2024;62:199–217.
</cite> [<a href="https://doi.org/10.1016/j.jare.2023.09.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11331180/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37743016/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lu%20J,%20Tai%20Z,%20Wu%20J,%20Li%20L,%20Zhang%20T,%20Liu%20J,%20Zhu%20Q,%20Chen%20Z.%20Nanomedicine-induced%20programmed%20cell%20death%20enhances%20tumor%20immunotherapy.%20J%20Adv%20Res.%202024;62:199%E2%80%93217." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR136">
<span class="label">136.</span><cite>Zafar H, Raza F, Ma S, Wei Y, Zhang J, Shen Q. Recent progress on nanomedicine-induced ferroptosis for cancer therapy. Biomater Sci. 2021;9:5092–115.
</cite> [<a href="https://doi.org/10.1039/d1bm00721a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34160488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zafar%20H,%20Raza%20F,%20Ma%20S,%20Wei%20Y,%20Zhang%20J,%20Shen%20Q.%20Recent%20progress%20on%20nanomedicine-induced%20ferroptosis%20for%20cancer%20therapy.%20Biomater%20Sci.%202021;9:5092%E2%80%93115." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR137">
<span class="label">137.</span><cite>Cai J, Xu X, Saw PE. Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance. Sci China Life Sci. 2024;67:19–40.
</cite> [<a href="https://doi.org/10.1007/s11427-022-2340-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37728804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cai%20J,%20Xu%20X,%20Saw%20PE.%20Nanomedicine%20targeting%20ferroptosis%20to%20overcome%20anticancer%20therapeutic%20resistance.%20Sci%20China%20Life%20Sci.%202024;67:19%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR138">
<span class="label">138.</span><cite>Yang H, Yao X, Liu Y, Shen X, Li M, Luo Z. Ferroptosis nanomedicine: clinical challenges and opportunities for modulating tumor metabolic and immunological landscape. ACS Nano. 2023;17:15328–53.
</cite> [<a href="https://doi.org/10.1021/acsnano.3c04632" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37573530/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20H,%20Yao%20X,%20Liu%20Y,%20Shen%20X,%20Li%20M,%20Luo%20Z.%20Ferroptosis%20nanomedicine:%20clinical%20challenges%20and%20opportunities%20for%20modulating%20tumor%20metabolic%20and%20immunological%20landscape.%20ACS%20Nano.%202023;17:15328%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR139">
<span class="label">139.</span><cite>Li C, Wu X, Zheng C, Xu S, Liu Y, Qin J, Fan X, Ye Y, Fei W. Nanotechnology-integrated ferroptosis inducers: a Sharp sword against tumor drug resistance. J Mater Chem B. 2022;10:7671–93.
</cite> [<a href="https://doi.org/10.1039/d2tb01350a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36043505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20C,%20Wu%20X,%20Zheng%20C,%20Xu%20S,%20Liu%20Y,%20Qin%20J,%20Fan%20X,%20Ye%20Y,%20Fei%20W.%20Nanotechnology-integrated%20ferroptosis%20inducers:%20a%20Sharp%20sword%20against%20tumor%20drug%20resistance.%20J%20Mater%20Chem%20B.%202022;10:7671%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR140">
<span class="label">140.</span><cite>Wei X, Sun L, Deng J, Yang Q, Zhao J, Zhou S. A multifunctional exosome with dual homeostasis disruption augments cGAS-STING-Mediated tumor immunotherapy by boosting ferroptosis. Nano Lett. 2024;24:14263–72.
</cite> [<a href="https://doi.org/10.1021/acs.nanolett.4c03862" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39475013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei%20X,%20Sun%20L,%20Deng%20J,%20Yang%20Q,%20Zhao%20J,%20Zhou%20S.%20A%20multifunctional%20exosome%20with%20dual%20homeostasis%20disruption%20augments%20cGAS-STING-Mediated%20tumor%20immunotherapy%20by%20boosting%20ferroptosis.%20Nano%20Lett.%202024;24:14263%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR141">
<span class="label">141.</span><cite>Zhao H, Jin S, Liu Y, Wang Q, Tan B, Wang S, Han WK, Niu X, Zhao Y. A second Near-Infrared Window-Responsive Metal-Organic-Framework-Based photosensitizer for tumor immunotherapy via synergistic ferroptosis and STING activation. J Am Chem Soc. 2025;147:4871–85.
</cite> [<a href="https://doi.org/10.1021/jacs.4c13241" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39854684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20H,%20Jin%20S,%20Liu%20Y,%20Wang%20Q,%20Tan%20B,%20Wang%20S,%20Han%20WK,%20Niu%20X,%20Zhao%20Y.%20A%20second%20Near-Infrared%20Window-Responsive%20Metal-Organic-Framework-Based%20photosensitizer%20for%20tumor%20immunotherapy%20via%20synergistic%20ferroptosis%20and%20STING%20activation.%20J%20Am%20Chem%20Soc.%202025;147:4871%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR142">
<span class="label">142.</span><cite>Deng X, Liu T, Zhu Y, Chen J, Song Z, Shi Z, Chen H. Ca &amp; Mn dual-ion hybrid nanostimulator boosting anti-tumor immunity via ferroptosis and innate immunity awakening. Bioact Mater. 2024;33:483–96.
</cite> [<a href="https://doi.org/10.1016/j.bioactmat.2023.11.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10730349/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38125638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deng%20X,%20Liu%20T,%20Zhu%20Y,%20Chen%20J,%20Song%20Z,%20Shi%20Z,%20Chen%20H.%20Ca%20&amp;%20Mn%20dual-ion%20hybrid%20nanostimulator%20boosting%20anti-tumor%20immunity%20via%20ferroptosis%20and%20innate%20immunity%20awakening.%20Bioact%20Mater.%202024;33:483%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR143">
<span class="label">143.</span><cite>Tan J, Ding B, Chen H, Meng Q, Li J, Zhang W, Yang Z, Ma X, Han D, Yang M et al. Gallium-Magnesium layered double hydroxide for elevated tumor immunotherapy through Multi-Network synergistic regulation. Adv Mater. 2025;37(21) :e2501256.</cite> [<a href="https://doi.org/10.1002/adma.202501256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40190140/" class="usa-link">PubMed</a>]</li>
<li id="CR144">
<span class="label">144.</span><cite>Lei H, Li Q, Li G, Wang T, Lv X, Pei Z, Gao X, Yang N, Gong F, Yang Y, et al. Manganese molybdate nanodots with dual amplification of STING activation for cycle treatment of metalloimmunotherapy. Bioact Mater. 2024;31:53–62.
</cite> [<a href="https://doi.org/10.1016/j.bioactmat.2023.07.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10432900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37601278/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lei%20H,%20Li%20Q,%20Li%20G,%20Wang%20T,%20Lv%20X,%20Pei%20Z,%20Gao%20X,%20Yang%20N,%20Gong%20F,%20Yang%20Y,%20et%20al.%20Manganese%20molybdate%20nanodots%20with%20dual%20amplification%20of%20STING%20activation%20for%20cycle%20treatment%20of%20metalloimmunotherapy.%20Bioact%20Mater.%202024;31:53%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR145">
<span class="label">145.</span><cite>Ding Q, Tang W, Li X, Ding Y, Chen X, Cao W, Wang X, Mo W, Su Z, Zhang Q, et al. Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint Blockade immunotherapy in bladder cancer. J Control Release. 2023;363:221–34.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2023.09.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37717657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ding%20Q,%20Tang%20W,%20Li%20X,%20Ding%20Y,%20Chen%20X,%20Cao%20W,%20Wang%20X,%20Mo%20W,%20Su%20Z,%20Zhang%20Q,%20et%20al.%20Mitochondrial-targeted%20brequinar%20liposome%20boosted%20mitochondrial-related%20ferroptosis%20for%20promoting%20checkpoint%20Blockade%20immunotherapy%20in%20bladder%20cancer.%20J%20Control%20Release.%202023;363:221%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR146">
<span class="label">146.</span><cite>Liang JL, Jin XK, Zhang SM, Huang QX, Ji P, Deng XC, Cheng SX, Chen WH, Zhang XZ. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy. Sci Bull (Beijing). 2023;68:622–36.
</cite> [<a href="https://doi.org/10.1016/j.scib.2023.02.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36914548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liang%20JL,%20Jin%20XK,%20Zhang%20SM,%20Huang%20QX,%20Ji%20P,%20Deng%20XC,%20Cheng%20SX,%20Chen%20WH,%20Zhang%20XZ.%20Specific%20activation%20of%20cGAS-STING%20pathway%20by%20nanotherapeutics-mediated%20ferroptosis%20evoked%20endogenous%20signaling%20for%20boosting%20systemic%20tumor%20immunotherapy.%20Sci%20Bull%20(Beijing).%202023;68:622%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR147">
<span class="label">147.</span><cite>Hu H, Zheng S, He C, Zheng Y, Wei Q, Chen S, Wu Z, Xu Y, Zhao B, Yan C. Radiotherapy-sensitized cancer immunotherapy via cGAS-STING immune pathway by activatable nanocascade reaction. J Nanobiotechnol. 2024;22:234.</cite> [<a href="https://doi.org/10.1186/s12951-024-02502-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11080188/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38724978/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20H,%20Zheng%20S,%20He%20C,%20Zheng%20Y,%20Wei%20Q,%20Chen%20S,%20Wu%20Z,%20Xu%20Y,%20Zhao%20B,%20Yan%20C.%20Radiotherapy-sensitized%20cancer%20immunotherapy%20via%20cGAS-STING%20immune%20pathway%20by%20activatable%20nanocascade%20reaction.%20J%20Nanobiotechnol.%202024;22:234." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR148">
<span class="label">148.</span><cite>Wang W, Gao Y, Xu J, Zou T, Yang B, Hu S, Cheng X, Xia Y, Zheng Q. A NRF2 regulated and the immunosuppressive microenvironment reversed nanoplatform for cholangiocarcinoma Photodynamic-Gas therapy. Adv Sci (Weinh). 2024;11:e2307143.
</cite> [<a href="https://doi.org/10.1002/advs.202307143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11005733/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38308097/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20W,%20Gao%20Y,%20Xu%20J,%20Zou%20T,%20Yang%20B,%20Hu%20S,%20Cheng%20X,%20Xia%20Y,%20Zheng%20Q.%20A%20NRF2%20regulated%20and%20the%20immunosuppressive%20microenvironment%20reversed%20nanoplatform%20for%20cholangiocarcinoma%20Photodynamic-Gas%20therapy.%20Adv%20Sci%20(Weinh).%202024;11:e2307143." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR149">
<span class="label">149.</span><cite>Guo Y, Lv T, Li Z, Wei X, Yang C, Li W, Hou X, Wang Z, Qian R. Acidity-activatable dynamic hybrid nanoplatforms derived from extracellular vesicles of M1 macrophages enhance cancer immunotherapy through synergistic triple immunotherapy. J Nanobiotechnol. 2024;22:430.</cite> [<a href="https://doi.org/10.1186/s12951-024-02719-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11264854/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39033108/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20Y,%20Lv%20T,%20Li%20Z,%20Wei%20X,%20Yang%20C,%20Li%20W,%20Hou%20X,%20Wang%20Z,%20Qian%20R.%20Acidity-activatable%20dynamic%20hybrid%20nanoplatforms%20derived%20from%20extracellular%20vesicles%20of%20M1%20macrophages%20enhance%20cancer%20immunotherapy%20through%20synergistic%20triple%20immunotherapy.%20J%20Nanobiotechnol.%202024;22:430." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR150">
<span class="label">150.</span><cite>Chen H, Wang D, Liu J, Chen J, Hu Y, Ni Y. Augmenting antitumor immune effects through the coactivation of cGAS-STING and NF-κB crosstalk in dendritic cells and macrophages by engineered manganese ferrite nanohybrids. ACS Appl Mater Interfaces. 2025;17:13375–90.
</cite> [<a href="https://doi.org/10.1021/acsami.4c18570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39964151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20H,%20Wang%20D,%20Liu%20J,%20Chen%20J,%20Hu%20Y,%20Ni%20Y.%20Augmenting%20antitumor%20immune%20effects%20through%20the%20coactivation%20of%20cGAS-STING%20and%20NF-%CE%BAB%20crosstalk%20in%20dendritic%20cells%20and%20macrophages%20by%20engineered%20manganese%20ferrite%20nanohybrids.%20ACS%20Appl%20Mater%20Interfaces.%202025;17:13375%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR151">
<span class="label">151.</span><cite>Aishajiang R, Liu Z, Liang Y, Du P, Wei Y, Zhuo X, Liu S, Lei P, Wang T, Yu D. Concurrent amplification of ferroptosis and immune system activation via Nanomedicine-Mediated radiosensitization for Triple-Negative breast cancer therapy. Adv Sci (Weinh). 2025;12:e2407833.
</cite> [<a href="https://doi.org/10.1002/advs.202407833" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11831504/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39721034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aishajiang%20R,%20Liu%20Z,%20Liang%20Y,%20Du%20P,%20Wei%20Y,%20Zhuo%20X,%20Liu%20S,%20Lei%20P,%20Wang%20T,%20Yu%20D.%20Concurrent%20amplification%20of%20ferroptosis%20and%20immune%20system%20activation%20via%20Nanomedicine-Mediated%20radiosensitization%20for%20Triple-Negative%20breast%20cancer%20therapy.%20Adv%20Sci%20(Weinh).%202025;12:e2407833." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR152">
<span class="label">152.</span><cite>Xu G, Liang Q, Gao L, Xu S, Luo W, Wu Q, Li J, Zhang Z, Liang H, Yang F. Developing an Arene binuclear Ruthenium(II) complex to induce ferroptosis and activate the cGAS-STING pathway: targeted inhibiting growth and metastasis of triple negative breast cancer. J Med Chem. 2024;67:19573–85.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.4c01908" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39436824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20G,%20Liang%20Q,%20Gao%20L,%20Xu%20S,%20Luo%20W,%20Wu%20Q,%20Li%20J,%20Zhang%20Z,%20Liang%20H,%20Yang%20F.%20Developing%20an%20Arene%20binuclear%20Ruthenium(II)%20complex%20to%20induce%20ferroptosis%20and%20activate%20the%20cGAS-STING%20pathway:%20targeted%20inhibiting%20growth%20and%20metastasis%20of%20triple%20negative%20breast%20cancer.%20J%20Med%20Chem.%202024;67:19573%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR153">
<span class="label">153.</span><cite>Chai H, Xia R, Ouyang N, Yao J, Hu J, Sun M, Miao P. Membrane encapsulated Fe(3)O(4)@MnO@cGAMP nanocatalyst for cancer therapy: cGAS-STING immune pathway activation. Adv Healthc Mater. 2025;14(15):e2501587.</cite> [<a href="https://doi.org/10.1002/adhm.202501587" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40231491/" class="usa-link">PubMed</a>]</li>
<li id="CR154">
<span class="label">154.</span><cite>Sun Y, Ma YY, Shangguan S, Ruan Y, Bai T, Xue P, Zhuang H, Cao W, Cai H, Tang E, et al. Metal ions-anchored bacterial outer membrane vesicles for enhanced ferroptosis induction and immune stimulation in targeted antitumor therapy. J Nanobiotechnol. 2024;22:474.</cite> [<a href="https://doi.org/10.1186/s12951-024-02747-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11311927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39123234/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20Y,%20Ma%20YY,%20Shangguan%20S,%20Ruan%20Y,%20Bai%20T,%20Xue%20P,%20Zhuang%20H,%20Cao%20W,%20Cai%20H,%20Tang%20E,%20et%20al.%20Metal%20ions-anchored%20bacterial%20outer%20membrane%20vesicles%20for%20enhanced%20ferroptosis%20induction%20and%20immune%20stimulation%20in%20targeted%20antitumor%20therapy.%20J%20Nanobiotechnol.%202024;22:474." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR155">
<span class="label">155.</span><cite>Li Y, Liu B, Zheng Y, Hu M, Liu LY, Li CR, Zhang W, Lai YX, Mao ZW. Photoinduction of ferroptosis and cGAS-STING activation by a H(2)S-Responsive Iridium(III) complex for Cancer-Specific therapy. J Med Chem. 2024;67:16235–47.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.4c01065" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39250558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Y,%20Liu%20B,%20Zheng%20Y,%20Hu%20M,%20Liu%20LY,%20Li%20CR,%20Zhang%20W,%20Lai%20YX,%20Mao%20ZW.%20Photoinduction%20of%20ferroptosis%20and%20cGAS-STING%20activation%20by%20a%20H(2)S-Responsive%20Iridium(III)%20complex%20for%20Cancer-Specific%20therapy.%20J%20Med%20Chem.%202024;67:16235%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR156">
<span class="label">156.</span><cite>Chen H, Ding B, Tan J, Meng Q, Li J, Zhang W, Zheng P, Liu B, Ma P, Lin J. Silver molybdate nanoparticles for enhanced tumor immunotherapy through pyroptosis conversion and ferroptosis induction. Angew Chem Int Ed Engl. 2025;64:e202501530.
</cite> [<a href="https://doi.org/10.1002/anie.202501530" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39961790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20H,%20Ding%20B,%20Tan%20J,%20Meng%20Q,%20Li%20J,%20Zhang%20W,%20Zheng%20P,%20Liu%20B,%20Ma%20P,%20Lin%20J.%20Silver%20molybdate%20nanoparticles%20for%20enhanced%20tumor%20immunotherapy%20through%20pyroptosis%20conversion%20and%20ferroptosis%20induction.%20Angew%20Chem%20Int%20Ed%20Engl.%202025;64:e202501530." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR157">
<span class="label">157.</span><cite>Li D, Ha E, Zhou Z, Zhang J, Zhu Y, Ai F, Yan L, He S, Li L, Hu J. Spark PtMnIr nanozymes for Electrodynamic-Boosted multienzymatic tumor immunotherapy. Adv Mater. 2024;36:e2308747.
</cite> [<a href="https://doi.org/10.1002/adma.202308747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38108600/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20D,%20Ha%20E,%20Zhou%20Z,%20Zhang%20J,%20Zhu%20Y,%20Ai%20F,%20Yan%20L,%20He%20S,%20Li%20L,%20Hu%20J.%20Spark%20PtMnIr%20nanozymes%20for%20Electrodynamic-Boosted%20multienzymatic%20tumor%20immunotherapy.%20Adv%20Mater.%202024;36:e2308747." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR158">
<span class="label">158.</span><cite>Zheng S, Guo Y, Han Q, Peng X, Sheng R, Liu S, Li Z. STING agonists and PI3Kγ inhibitor co-loaded ferric ion-punicalagin networks for comprehensive cancer therapy. Int J Biol Macromol. 2024;282:136776.
</cite> [<a href="https://doi.org/10.1016/j.ijbiomac.2024.136776" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39454928/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20S,%20Guo%20Y,%20Han%20Q,%20Peng%20X,%20Sheng%20R,%20Liu%20S,%20Li%20Z.%20STING%20agonists%20and%20PI3K%CE%B3%20inhibitor%20co-loaded%20ferric%20ion-punicalagin%20networks%20for%20comprehensive%20cancer%20therapy.%20Int%20J%20Biol%20Macromol.%202024;282:136776." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR159">
<span class="label">159.</span><cite>Guo S, Guan T, Ke Y, Lin Y, Tai R, Ye J, Deng Z, Deng S, Ou C. Biologically logic-gated Trojan-horse strategy for personalized triple-negative breast cancer precise therapy by selective ferroptosis and STING pathway provoking. Biomaterials. 2025;315:122905.
</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2024.122905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39471713/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20S,%20Guan%20T,%20Ke%20Y,%20Lin%20Y,%20Tai%20R,%20Ye%20J,%20Deng%20Z,%20Deng%20S,%20Ou%20C.%20Biologically%20logic-gated%20Trojan-horse%20strategy%20for%20personalized%20triple-negative%20breast%20cancer%20precise%20therapy%20by%20selective%20ferroptosis%20and%20STING%20pathway%20provoking.%20Biomaterials.%202025;315:122905." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR160">
<span class="label">160.</span><cite>Qiu C, Xia F, Tu Q, Tang H, Liu Y, Liu H, Wang C, Yao H, Zhong L, Fu Y, et al. Multimodal lung cancer theranostics via manganese phosphate/quercetin particle. Mol Cancer. 2025;24:43.
</cite> [<a href="https://doi.org/10.1186/s12943-025-02242-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11796208/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39905491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiu%20C,%20Xia%20F,%20Tu%20Q,%20Tang%20H,%20Liu%20Y,%20Liu%20H,%20Wang%20C,%20Yao%20H,%20Zhong%20L,%20Fu%20Y,%20et%20al.%20Multimodal%20lung%20cancer%20theranostics%20via%20manganese%20phosphate/quercetin%20particle.%20Mol%20Cancer.%202025;24:43." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR161">
<span class="label">161.</span><cite>Wang J, Wang Z, Li L, Wang M, Chang J, Gao M, Wang D, Li C. Ultra-small Janus nanoparticle-induced activation of ferroptosis for synergistic tumor immunotherapy. Acta Biomater. 2024;181:362–74.
</cite> [<a href="https://doi.org/10.1016/j.actbio.2024.04.032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38663684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20J,%20Wang%20Z,%20Li%20L,%20Wang%20M,%20Chang%20J,%20Gao%20M,%20Wang%20D,%20Li%20C.%20Ultra-small%20Janus%20nanoparticle-induced%20activation%20of%20ferroptosis%20for%20synergistic%20tumor%20immunotherapy.%20Acta%20Biomater.%202024;181:362%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12372235/bin/13046_2025_3520_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (271.9KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Experimental &amp; Clinical Cancer Research : CR are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s13046-025-03520-6"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/13046_2025_Article_3520.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (11.8 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372235/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372235/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372235%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372235/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372235/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372235/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40846966/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372235/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40846966/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372235/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372235/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="O0fw4i1x9on8FsyIIjdR7EnFjYQSsjiUgx4zEXyIQbnwPwu2IQv9g99GRbQ1aplU">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
